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Chapter 1 
GENERAL INTRODUCTION 
INTRODUCTION 
In an organism a complex and harmonious interaction of organs, 
tissues, cells and subcellular organelles occurs. A high degree of 
cooperation is necessary to sustain life. This delicate integrity is 
endangered by various threats from the outside world. The organism 
developed a defense mechanisms for protection like fighting and hiding. 
Also within the organism itself an intraorganismic defense mechanism is 
present, which is referred to as the immune system. This system is based 
upon three principles: recognition, processing and response. Recognition 
is a noncovalent interaction between a signal molecule, carrying 
information and a receptor molecule, which is able to recognize the signal. 
By this process the organism is capable to discriminate between itself 
(self) and the outside world (non-self). This information is analyzed 
(processing) and the organism can response to eliminate the intruding 
organism. The smallest unit able to provoke such a reaction is referred to 
as an antigen. 
Within the animal world many different types of defense reactions 
can be distinguished differing in speed of the response, the presence or 
absence of memory, processing of the stimulating signals and the 
elimination of the antigenic intruders. Two major categories of defense 
can be distinguished with regard to the effector mechanism. The first is 
called the humoral system and is mediated by soluble factors in the body 
fluids, whereas the other category is the cellular system, because it is 
elicited by cells. 
The humoral reactions can be divided into an inducible and a 
noninducible 
respectively, 
group, which 
to counteract 
the 
refers to the 
the exposure of 
humoral factor. 
ability disability 
an organism to antigen by 
Noninducible factors are increasing the level 
secreted into the 
of 
body fluids at a constant rate. Already in 1916 
Cantuzene discovered that if the landsnail Helix pomatia was infected with 
bacteria these bacteria clumped together due to the presence of an 
agglutinin after which they were removed. This factor is produced and 
2 
secreted at a constant rate, which is not influenced by external factors. 
Another example of this nature is provided by the complement system found 
in vertebrates. A number of proteins (complement factors) present in the 
serum can assemble into a complex molecular structure on the cell membrane. 
Subsequently various effector mechanisms can be activated, like punching 
holes in the target cell by the complex resulting in direct cell death. 
Also cellular effector reactions can be activated by these complement 
factors. The inducible humoral factors are normally absent or only present 
in small amounts in the body fluids. After the introduction of antigenic 
material a rapid increase of the factor can be seen, followed by a gradual 
decrease after withdrawal of the antigen. The lobster Panulirus produces a 
bactericidin that shows the described fluctuation after bacterial infection 
(Evans et al, 1968). A certain degree of memory can be observed in this 
species characterized by an enhanced reaction after a 
the bacteria. The specificity, however, is low 
bacteria can also induce this secondary reaction. 
second exposure to 
since other types of 
Antibodies in the 
vertebrates do have the same inducibility, but in contrast to the previous 
example they have an exquisite specificity for the antigen. 
The cellular defense system can be divided into an aggressive and a 
nonagressive type. The nonagressive type can be illustrated by findings of 
Wilson (1907) in the sponge. Single cell suspensions of sponges were made 
and these cells were grown in seawater. 
able to differentiate. After a few days 
These cells aggregated and were 
functional sponges developed 
again. 
types 
Repeating this experiment, but now by mixing cells of two different 
of sponges, only cells of the same type aggregated. 
implicated that such cells are able to discriminate between 
same type (self) and cells of another type (nonself). 
These findings 
cells of the 
Three types of aggressive cellular reactions can be distinguished: 
the hyperplastic reaction, engulfment and cellular cytotoxic reactions. 
The hyperplastic reaction can be illustrated with the coral Hydractinia 
echinata (Ivker, 1972). Colonies of the same type fuse upon contact with 
each other. Contact between different types produces abnormal hyperplastic 
stolons in one of the two colonies. These stolons strangle the other 
colony, cutting off the food supply, which results in death. The 
engulfment reaction is divided according to the size of the processed 
particles: pinocytosis (fluid droplets), phagocytosis (small particles) and 
encapsulation (large multicellular material). Pinocytosis and phagocytosis 
were for the first time described by Ernst Haeckel (1862) in a small 
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mollusk (Thetys Fimbria). He found that after injection of indigo dye into 
the blood vessels many of the blood cells contained small particles of the 
dye within a few hours. More detailed analysis of this phenomenon revealed 
that cell projections upon contact between cells and dye was followed by 
enveloping and swallowing of the material. In the cell the dye was 
confined to a vacuole in which eventually enzymes were released resulting 
in degredation of the dye. The cellular cytotoxic reactions are primarily 
directed against intracellular parasites like virusses. These reactions 
are executed by specialized cells (killer or cytotoxic cells) that bind 
directly to an infected cell. Subsequently cell lysis is caused by changes 
in the permeability of the membrane. Obviously these cytotoxic cells are 
able to recognise an infected cell due to membrane alterations induced by 
the virus. This type of reaction will be discussed in detail later. 
In vertebrates a higher degree of specialization of the defense 
system can be observed. Recognition, transfer of signals and effector 
function are executed by specialized cells. This diversification requires 
a special regulatory type of cells, that either enhance (helper cells) or 
suppress (suppressor cells) the response. Together with these specialized 
cells also less sophisticated defense cells are still present in 
vertebrates, 
engulfment. 
humans and 
which are still able to exert the ancient process of 
This thesis will deal mainly with the immune system found in 
rodents. Therefore further consideration will be given to the 
organization of the specific immune system in vertebrates. 
The immune system of vertebrates is basically a dual system 
existing of a humoral and a cellular immune branch. Although both systems 
are capable to respond to any antigenic material, in most cases one defense 
line is favoured. The cellular system is more effective against cancer 
cells, fungi, parasites, intracellular viral infections and foreign 
tissues, whereas the humoral immune response is highly effective against 
extracellular phases of bacterial and viral infections. The cells 
responsible for both types of immune responses are the lymphocytes. They 
can be divided into (bone marrow derived) B lymphocytes and (thymus 
dependent) T lymphocytes. The cellular immune response is mediated by T 
cells. These cells can be activated by contact with an intruding organism 
resulting in a reaction that includes binding and killing of the organism. 
Other types of T cells are involved in the regulation of both cellular and 
humoral responses. B lymphocytes account for the humoral immune reponse. 
After recognition of the antigen B lymphocytes will start to proliferate 
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and differentiate into plasma cells which secrete antibodies. These 
antibodies can ,specifically bind to the antigen and thereby activate 
several elimination processes. Besides lymphocytes other types of cells 
play an important role in the immune sytem i.e. the so-called accessory 
cells. An important example of such accessory cells are the macrophages. 
These cells can attack virtually all non-self material in a non-specific 
manner by a primitive engulfment reaction. Furthermore, macrophages are 
very important for the accumulation, processing and presentation of 
antigenic material to lymphocytes. The immunogenicity of the antigen is 
highly increased by this kind of macrophage pretreatment. Also other cells 
of the hematopoietic system, such as dendritic reticular cells, can be 
involved in various stages of the immune response. This variety of 
response mechanisms results in a highly specific defense system, which is 
quite capable to counteract most antigenic intruders. One of the most 
appealing examples of such a foreign invader is an allogeneic organ or 
tissue transplant. Although the intrusion of this particular type of 
foreign material is very much wanted, the immune system will react in its 
natural way in an attempt to eliminate it by mounting a vigorous response. 
TRANSPLANTATION 
Transplantation is the transfer of living cells, tissues or organs 
from one part of the body to another or from one individual to another. We 
can distinguish between an orthotopic transplantation, when the graft is 
placed in the normal anatomical position, and a heterotopic situation, when 
the graft is replaced at an other site. Furthermore transplantation can be 
autogeneic (self), syngeneic (genetically identical), allogeneic (between 
two different inbred strains or different not inbred individuals) and 
xenogeneic (between different species). 
The fate of a graft will be determined by the genetic relationship 
of the donor and acceptor. When no difference exists the graft will be 
accepted, otherwise the graft will be rejected. The allograft reaction can 
be divided into three phases. First a recognition phase: each 
transplantation will involve some damage of the transplanted cells and 
tissues. These cells will be phagocytized by leukocyte (macrophages, 
polymorphonuclear cells and granulocytes) of the host. Macrophages will 
process this cell debris and expose certain antigenic determinants on their 
surface. Subsequently these will be recognized by lymphocytes. Also 
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direct contact 
itself can occur. 
of lymphocytes 
After this 
with the antigenic sites within the graft 
recognition phase, in which rather low 
numbers of immunocompetent cells are involved, 
follows. The activated lymphocytes proliferate 
an amplification phase 
and secrete various 
substances that mobilize other cells such as macrophages, granulocytes, B 
lymphocytes, natural killer (NK) cells and T lymphocytes. The last phase 
is the effector phase in which a massive attack is mounted towards the 
graft. Part of this attack is specifically directed against donor cells 
carrying a foreign antigen but also a non-specific (recruited) attack 
occurs, which may even include host cells (Review: Porter, 1983). 
Allograft reactions can be distinguished in first set and second set 
reactions. The latter type of response occurs when the acceptor is already 
pre-sensitized and this process is characterized by an accelerated and 
enhanced reaction. A more defined classification of the graft rejection 
will be discussed in a later stage of this thesis. 
The primary rule of transplantation is: a graft is rejected 
whenever it possesses histocompatibility (H) antigens, which are absent in 
the recipient. 
genes (Klein, 
These antigens are encoded for the histocompatibility (H) 
1975).. About the total number of H-loci difference of 
opinion exist, but the lowest estimations in rodents are thirty and figures 
up to a hundred are mentioned. Counce et al (1956) described a marked 
difference in intensity of allograft reaction caused by 3 loci as compared 
to other loci. They introduced the notion of major and minor H-loci. 
Later this division of 'strong' and 'weak' loci was thought to be rather 
arbitrary, but nowadays it is evident that a fundamental difference exists 
between one group of loci and the other H-loci. This group of loci, the 
major histocompatibility complex (MHC) exerts the strongest effect on 
allograft rejection. MHC-antigens can activate lymphocytes without the 
context of MHC-antigens (unrestricted) whereas antigen recognition, 
including minor H-antigens, only occurs in the context of MHC-antigens. 
The MHC is a group of closely linked loci, that can be divided into 
two separate classes, according to the structure of the molecules they 
encode for (Fig. 1.1 ). The first group encodes for molecules which are 
referred to as class I molecules. They consist of two polypeptide chains. 
One of them, the heavy chain, with covalently attached to it one or two 
carbohydrate moieties, has a comparable molecular weight (MW) in several 
species: MW 44,000 in mouse (Klein, 1975; Klein, 1979) and MW 45,000 in rat 
(Sporer et al, 1978; Blankenhorn et al, 1978). This heavy chain consists 
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Figure 1.1 Structure of Class I and Class II molecules 
CHO: sugar moiety 
of an intracellular, a transmembrane and a extracellular segment. This 
last part consists of two disulfide loops and an amino terminal segment. A 
light chain, the so-called $2-microgobulin ($2M), is noncovalently attached 
to the heavy chain. $2M is a polypeptide with a molecular weight of 12,000, 
which-is folded in a single disulfide loop, with no direct attachment to 
the membrane. Class I antigens are found on all nucleated cells. The 
second group of MHC molecules are the Class II molecules. Class II 
molecules consist of two noncovalently bound polypeptides: an a chain with 
a molecular weight of 31,000 to 34,000 and a a chain with a molecular 
weight of 26,000 to 29,000 (Wettstein et al, 1981; Fukumoto et al, 1982). 
Class II antigens are normally found only on certain cells of the immune 
system. Although they are absent on resting T cells, activation of these 
cells results in class II expression. These antigens can also be induced 
on a wide variety of different cells (Mason, 1984). 
The rat, a frequently used animal in transplantation research, has 
a MHC system comparable to that ofother mammals. This gene complex, 
previously referred to as AgB system or H-1 complex is nowadays called the 
RT-1 system (GOnther and Stark, 1977; Report of the first international 
workshop on alloantigenic systems in the rat, 1978; Workshop report, 1979). 
For a more detailed description of the MHC complex the reader is referred 
to Gill et al (1983). The structure of the RT1 complex is quite comparable 
to that of the MHC of the mouse: two class II loci (RT1 .Band RT1.D) are 
enclosed by two class I loci (RT1 .A and RT1 .E) (Fig. 1 .2). Another class I 
locus (RT1 .C) is located outside the conventionally defined MHC. It is 
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Figure 1.2 The structure of the major histocompatibility complex of the rat, the RT-1 system (Gill et al, 
1983) Glo-1 and Neu-1 are loci controlling the activity of the glyoxalase and the neuramidase 
enzymes. The squares are the loci coding for the class I antigens RT-1.A and RT-1.E. The circles 
are the loci coding for the class II antigens RT-1.B and RT-1.D. The dw-3 (body weight) and ft 
(fertility) loci comprise the growth and reproduction complex. The numbers under the arroW's are 
the map distance in eM. The r-numbers above the arro1o1s refer to the recombinant strains. 
suggested that this locus might be an equivalent to the Qa/Tla loci of the 
mouse (Stock and GGnther, 1982). Blankenhorn et al (1983) demonstrated 
that the RT1 .B and RT1 .D loci code for I-A and I-E like class II molecules, 
respectively. They are associated with a strong mixed lymphocyte reaction 
(MLR) i.e. the proliferation of cells that is found, when lymphocytes of 
two genetically different individuals are cocultured. The capabilty to 
respond to small polypeptide antigens is also located in this region (Lobel 
and Cramer, 1981 ). The class I molecules have a high degree of homology 
with those of the mouse (Gill et al, 1983). Liebert et al (1982, 1983) 
found that they provide the major stimulus for cytotoxic T cell activity. 
Both class I and class II antigens can initiate the allograft reaction. 
This has been confirmed by many studies in the rat for transplantation of a 
variety of organs such as kidney, heart, pancreas and skin (GGnther and 
Stark, 1977; Guttman et al, 1980; Pinto et al 1983; Gallico et al, 1979). 
The relative importance of the separate loci is still discussed. Gallico 
et al (1979) claim that a full MHC-difference is needed for a strong 
rejection. Guttmann et al (1980) reported that either a class or a class 
II difference is sufficient. On the other hand, several studies with 
congenic rat strains showed a strong allograft reaction for a class II 
difference, whereas a mere class I difference resulted in a variety of 
reaction patterns ranging from weak to strong (Razing et al, 1983; Lowry 
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and Gurley, 1983; Guttman et al, 1985). Therefore the influence of class I 
loci is not easy to interpret. Rozing et al (1983) suggested that the 
potential of the recipients to respond to MHC-antigens could be different 
for the various inbred strains. This would explain the different data 
reported by several groups. Another reason for the observed discrepancies 
is that the MHC-antigens in the graft are presented in various ways 
depending on the type of graft. In recent years the various lymphocyte 
populations and their relative importance in the allograft reaction have 
been extensively studied. B lymphocytes and the humoral immune response do 
participate in the allograft reaction. However, most authors agree, that 
the B cells are not able to iniate an allograft reaction by themselves. 
This has been confirmed by studies with athymic rodents i.e. nude mice and 
nude rats. Although recently for both nude mice as well as nude rats the 
presence of small numbers of T lymphocytes were reported (Raff, 1973; 
Brooks et al, 1980), these animals probably lack the right activation 
signal, since allogeneic as well as xenogeneic grafts are not rejected 
(Rygaard, 1969; Kindred, 1979; Festing et al, 1978). Similar results were 
obtained in another T cell deprived model in which animals are 
thymectomized and lethally irradiated followed by reconstitution of bone 
marrow (ATXBM). These animals also failed to reject allografts (Brunner 
and Cerottini, 1971 ). Although it is therefore well documented that T 
cells play a central role in the allograft reaction the actual cellular 
mechanism is still not completely understood. 
T CELL SYSTEM 
All cells of the haematopoietic system follow an analogous 
differentiation pathway. They are derived from a common cell, the 
pluripotent haematopoietic stem cell (HSC) (Till and McCullogh, 1961 ). A 
pluripotent HSC is an undifferentiated cell characterized by the potential 
for extensive proliferation, self-renewal capacity (formation of new HSC) 
and capability of differentiation (production of different hematopoietic 
cells). Also T lymphocytes derive from the HSC (Abrahamson et al, 1977). 
They differentiate into so-called precursor T cells or prothymocytes. 
These cells migrate to the thymus and after intrathymic proliferation and 
maturation they leave the thymus as T lymphocytes and subsequently migrate 
to the T cell domains of the peripheral lymphoid tissues. The fact that 
thymus lymphocytes originate from migrant cells rather than from 
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mesenchymal or epithelial elements of thymus itself was most convincingly 
demonstrated by Moore and Owen (1965) in fowl embryos. Haematopoietic cell 
chimerism was established between embryos of different sexes. This enabled 
analysis of the thymus lymphocytes using chromosomal sex markers. Dividing 
thymocytes were analyzed and about half of these cells originated from the 
other partner. Kadish and Bash (1976) defined these migrants 
(prothymocytes) as those cells that after transfer in lethally irradiated 
animals have the capacity to repopulate the thymus with donor specific 
lymphocytes. Prothymocytes in adult animals are mainly found in the bone 
marrow. The frequency of prothymocytes in bone marrow has been estimated 
in mice as <0.1~ (Lepault et al, 1983). 
Ontogenetic studies highly increased our knowledge of prothymocytes 
and their entry into the thymus. The earliest blood forming cells appear·. 
in the yolk sac, whereafter the site of blood formation is gradually taken 
over by the fetal liver and the fetal spleen (Moore and Owen, 1967; Owen 
and Ritter, 1969). In extensive studies in avian embryos using chicken-
quail chimeras three successive waves of the influx of prothymocytes into 
the thymus were observed, suggesting discrete receptive periods in 5, 11 
and 17 days old embryos (Jotereau et al, 1980; Jotereau and Le Douarin, 
1982). The authors proposed the production of chemotactic factor(s) from 
the epithelial part of the thymus during these receptive periods. 
The thymus gland consists of several different components. It 
originates from the primitive pharynx as an epitheliomesenchymal rudiment 
(Review, LeDouarin, 1977). It is generally accepted that the epithelium is 
endodermal in origin and derived from the third pharyngeal pouch, although 
some ectodermal participation has been proposed (Cordier and Haumont, 
1980). The mesenchymal part that participates in the thymus structure is 
at least in part derived from mesenchyme of the pharyngeal arch. During 
ontogeny, at first an inner epithelial mass surrounded by a capsule of 
mesenchym (Jenkinson et al, 1981) is formed. Subsequently immigration of 
hematopoietic cells and antigen presenting cells (APC) from the fetal liver 
occurs (Bartlett and Pyke, 1982). In adults the thymus consists of two 
separate lobes, which are subdivided into small lobules (Hoshino, 1963; van 
Ewijk, 1984) consisting of distinct lymphoid as well as stromal cells. 
Each lobule can be divided into two regions: a peripheral cortical area and 
an inner medullary area, separated by the cortico-medullary region (CMR). 
The cortical area is densily populated with mainly small sized lymphocytes 
(85%-90% of all thymus lymphocytes), whereas the medulla contains 
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relatively few medium-sized lymphocytes (10~-15~) (Weissman, 1973). 
Cortical lymphocytes can be distinguished from medullary cells by 
several criteria. For instance the nuclear enzyme terminal 
deoxynucleotidyl transferase (TdT) is expressed by cortical cells, but not 
by medullary or mature T cells (Barton et al, 1976; Goldschneider et al, 
1977; Gregoire et al, 1979). They also differ in their binding properties 
to the lectin peanut agglutinin (PNA). Cortical cells bind high levels of 
PNA in contrast to the low levels that are bound by medullary thymocytes. 
Also subpopulation markers proved to be useful tools to distinguish the 
separate cell populations in the thymus. Cantor and Boyse (1977) described 
an alloantigenic system on T lymphocytes of the mouse i.e Lyt 1 and Lyt 2. 
Peripheral T cells express only one of these molecules on their cell 
surface. The majority (70~) of the cortical cells, however, express both 
antigens Lyt1+Lyt2+ (Review Scollay and Shortman, 1984). The medullary 
cells (10-15~) are very similar to peripheral T cells since they express 
only one of these two antigens. Also an association between mature or 
immature phenotype and function can be found, since cortical cells are 
rather deficient in function and most medullary cells seem to be functional 
(Chen et al, 1982). 
One of the first models of differentiation within the thymus was 
based upon studies of Weissmann (1973), who demonstrated that medullary 
cells can be derived from cortical lymphocytes. In this socalled "straight 
through" model, proposed by Cantor and Boyse in 1977, prothymocytes enter 
the cortex, express an immature cortical phenotype (Lyt1+2+) and then 
mature as they migrate to the medulla, selectively loosing one of the two 
surface antigens. This model, however, is not in accordance with recent 
cell turnover data reported by several groups. Bryant (1972) determined a 
turnover time of approximately three days for the cortical lymphocyte 
population. The proliferation in thymus is predominantly located within 
the cortex since more than 95~ of thymic mitoses are found in this area 
(Bryant, 1972). The number of cells that leave the thymus each day has 
been calculated by Scollay et al (1980). Intrathymic injection in situ of 
fluorescein isothiocyanate (FITC) was used for labeling the migrating 
cells. In adult mice only one percent of the thymocyte pool migrates to 
the periphery. The low number of migrants compared with the high rate of 
proliferation within the thymus indicates that many of the thymocytes never 
leave this organ. Biochemical data of McPhee et al (1979) confirmed such a 
high rate of intrathymic cell death. Although the proliferation rate in 
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the medulla is rather low, compared to that of the cortex, this area can 
produce enough cells to give rise to all emigrating cells (Scollay and 
Shortman, 1983). Several models have been proposed to comply with these 
controversial data. Shortman and Jackson (1974) suggest that prothymocytes 
are already committed into two lineages: one lineage migrates straight to 
the medulla and gives rise to functional T cells. The other lineage 
migrates to the cortex and differentiates to non-functional cells, the 
'dead end cells'. Mathieson (1982) and Scollay (1983) have proposed the 
following model: they suggest that both functional subsets may develop 
independently. One subpopulation enters the subcapsular region of the 
cortex. Here these cells differentiate expressing the Lyt1 and the Lyt2 
alloantigens. A selected minority of the cells of the cortex may develop 
to mature T cells and migrate to the medulla. Another subpopulation may 
develop in the medulla independently of the cortex. 
Maturing T lymphocytes leave the thymus and migrate to the 
peripheral lymphoid tissues. The presence of specific homing receptors for 
spleen, lymph nodes and plaques of Peyer (Gallatin et al, 1983; Jalkanen et 
al, 1986) indicates a controlled lymphocytic traffic between blood and 
lymphoid organs. Some cells are heading for the spleen while others go to 
the lymph nodes. The number of cells emigrating each day from the thymus 
is four times greater than the total number of lymphocytes in the blood 
(Bryant, 1972, Scollay and Shortman, 1983). Furthermore most studies 
indicate that the lifespan of the circulating T 
extremely long (Gowans and Knight, 1964; Ford, 1969). 
thymus migrants, however, apparently die shortly 
cell population is 
The majority of the 
after reaching the 
lymphoid organs and only migrants encountering their specific antigen will 
be stimulated and transformed into a long lived cell. The expansion of the 
total peripheral T cell population seems to be largely antigen dependent. 
This is confirmed by the finding that the T cell mass in germfree animals 
is only about 10% of that found in normal animals Sprent and Miller (1979). 
Kendall Smith (1984) postulated therefore that the thymus is a 
developmental organ, that is active only during the growth period. In that 
period it generates the total T cell repertoire of the adult. Throughout 
life the expansion of this repertoire depends upon antigenic stimulation. 
T lymphocytes have an important regulatory function in a great 
variety of immunological processes. Until recently T lymphocytes could 
only be identified in mice by anti Thy-1 alloantisera and in man by the 
property that they bind to sheep red blood cells (SRBC) or by functional 
, 2 
testing, such as mitogen response (Greaves and Janossy, 1972). A first 
indication for the existence of functionally different T cell 
subpopulations came from experimental studies, in which Gershon and 
coworkers (Gershon et al, 1974) showed that T cells provided help in the 
humoral immune response against T cell dependent antigens. Under certain 
circumstances they also displayed suppressive activity (Gershon and Kondo, 
1972). Two functionally distinct subpopulations of T lymphocytes were 
initially defined by Cantor and Boyse (1975), which could be separated by 
different phenotype expression of surface antigens. T lymphocytes involved 
in helper phenomemona and delayed hypersensitivity expressed the Lyt1 
alloantigen, whereas T lymphocytes active in cytotoxic as well as in 
suppressive reactions carried the Lyt2 alloantigen. Recently a more 
specific marker for the T helper cells in the mouse has been described i.e. 
the L3T4 antigen (Dialynas et al, 1983). Initially the Lyt system was 
defined with alloantisera. 
complicated and difficult. 
immunization and afterwards 
Raising this kind of specific alloantisera is 
Highly purified antigen is necessary for 
extensive absorption is required in order to 
remove non-specific antibodies. A major problem is also the isolation of 
antigens for which no specific antibody is available. With regard to the 
problems involved in raising specific antisera, the introduction of the 
hybridoma technique proved to be a major step forward. Already in the 
1960's occasionally fusion of cells had been observed in cell cultures. 
The incidence could be increased by adding ultraviolet light treated Sendai 
virus or polyethyleneglycol (PEG). Kohler and Milstein (1975) demonstrated 
that also antibody secreting cells could be immortalized by fusion with 
myeloma cells. From the total mixtur.e of fused cells, also referred to as 
hybrid cells, one specific cell can be isolated by subcloning. Subcloning 
consists of diluting the cells in such a fashion, that after 
distributionover wells of microculture plates, the majority of these wells 
contain growing cells which are derived from a single cell. Using this 
method, clones of identical hybrid cells can be isolated in large numbers. 
These cells produce monospecific antibodies, which can be obtained in large 
quantities. These so-called monoclonal antibodies (MCA) provide an 
invaluable and highly sensitive tool for the dissection of the immune 
system. In the recent years many MCA have been developed against surface 
antigens of different types of cells in various species. In humans for 
instance the equivalents of the Lyt 2 and L3T4 antigens were detected i.e. 
the CDS and the CD4 alloantigens, respectively (Bernard et al, 1984). A 
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homology with the mouse system was also found for the function of these T 
cell subpopulations. Although a highly positive correlation exists between 
the surface alloantigens and the function of cells, it is not an absolute 
one. It became possible to maintain T cell lines in culture for long 
periods. Meuer et al (1984) isolated cytotoxic T lymphocyte (CTL) lines. 
Most of these CTL lines possessed the normal cytotoxic phenotype, but a few 
CTL lines expressed the helper phenotype. Several other exceptions have 
been described of the correlation between phenotype and function for cloned 
T cell lines in the recent years. 
RATIONALE OF THE PRESENT STUDY 
The immune system in vertebrates is a highly specialized type of 
defense system. Especially T lymphocytes play a dominant role in the 
management of the various parts of this defense. In transplantation the 
reaction against the foreign tissue is initiated by cells of this T cell 
system. In order to avoid an undesired allograft reaction it is necessary 
to obtain more information about the mechanism of the allograft reaction 
and especially about the role of the T cell system in this process. 
Subpopulations of T cells are involved in both effector and regulatory 
functions. These subpopulations take part in different functions, which 
highly correlate with the expression of distinct surface molecules. 
Therefore specific antibodies directed against these surface antigens are 
excellent tools for the monitoring and dissecting the immune system. After 
MCA became available for the human immune system, immunological monitoring 
of transplantation patients has been practised on a large scale. 
Particularly data on monitoring in kidney transplantation, which has been 
and still is the most successful and widely practised form of non-
privileged organ transplantation, have been reported in the previous years. 
In humans, however, the situation is very complicated. The complex 
structure of the human MHC (the human leukocyte antigen: HLA system) and 
the outbred situation of humans make it virtually impossible to find two 
individuals that are genetically identical. Therefore variable 
contributions of differences in MHC and non-MHC loci between donor and 
recipient will always be a complicating factor for the interpretation of 
the results. A major source of variation also is the mode of treatment of 
the allograft reaction and the different techniques of immunological 
monitoring. Many transplantation centres are using immunosuppressive 
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agents such as corticosteroids and antimetabolites; which are highly non-
specific. Recently, treatment with the antibiotic Cyclosporin A, anti 
lymphocyte sera (ALS) and anti-T cell globulin (ATG) are also favoured. 
For the immunological monitoring of the graft some centres follow the 
clinical status of the patients, whereas other centres apply flow 
cytometric, histochemical or functional techniques for this purpose. Also 
the site of monitoring is different: monitoring within the graft itself or 
analysis of the peripheral blood lymphocytes is practised. It is clear, 
that the interpretation and the comparison of the clinical data is very 
difficult. Therefore experimental studies in animals are frequently used 
in order to obtain more information of the immUnological basis of allograft 
rejection. Moreover these kind of studies are performed to achieve an 
improvement of immunosuppressive treatment. The rat is the animal of 
transplantation research since, in contrast to the mouse, kidney and heart 
transplantation is technically possible. At present congenic and 
recombinant inbred rat strains are available for immunogenetic research. 
The analysis of the cellular composition of the immune system of the 
rat requires the production of specific antibodies. This thesis describes 
the optimalization of the hybridoma technique and the production of a 
series of mouse anti-rat MCA. Subsequently antibodies were selected for 
reactivity against surface molecules of T lymphocytes. From the available 
hybrid cell lines producing these type of antibodies, a representative 
number was selected for further study. New distribution patterns of 
lymphocytes in various stages along the T cell differentiation were 
detected. Characterization of these antibodies has been performed with 
regard to antibody properties, recognized surface molecules, but also the 
cells expressing these antigens in bone marrow, thymus and peripheral 
lymphoid organs. A possible involvement of these surface antigens in the 
function of the T cells was studied. 
Subsequently, a series of transplantation experiments were 
performed, in which the alloreaction was studied using the selected panel 
of antibodies. Besides monitoring of alterations within the peripheral 
immune system and at the site of action (the graft), also changes in the 
functional repertoire were studied and will be described. 
In the last part the immunosuppressive potential of the monoclonal 
antibodies has been studied in the initial phase after transplantation. 
The essential factors for immunosuppression will be discussed. 
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Chapter 2 
HYBRIDOMA TECHNIQUE 
INTRODUCTION 
A major contribution to the recognition and elimination of foreign 
invaders is provided by a highly specialized type of proteins: the 
antibodies or immunoglobulins (Ig). The molecule (Fig. 2.1) consists of 
four polypeptides, two heavy chains (H-chains) and two light chains (L-
chains) held together by disulfide bridges. Each chain is divided in a 
variable (V) region and a constant (C) region. The VL and VH region form 
the V domain. The C-region of the H- and L-chains form the CH domains. 
For a detailed description of the structure of the antibody molecule the 
reader is referred to Klein (1982). 
Figure 2.1 A schematic drat.7ing of the human IgG antibody molecule. 
(Hood et al, 1978) 
Antibodies have two distinct functions which are reflected within 
the structure of the molecule: The two V-domains are involved in antigen 
recognition and binding. The C-domains are involved in effector functions 
such as complement activation. Two different forms of the Ig molecules are 
found: one is membrane-bound and located on the surface of B cells. This 
molecule is involved in antigen recognition and B cell activation. The 
second type is the secretory form of Ig, which is directly involved in 
antigen binding and elimination. 
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Antibodies are produced by a specialized type of lymphocytes: the B 
lymphocytes. B lymphocytes belong to the progeny of the pluripotent 
haematopoietic stem cell. In adults the precursor B cells differentiate 
within the bone marrow. From the moment a B lymphocyte is committed to 
antibody synthesis the antigen-binding specificity is irreversibly defined 
for this particular cell as well as for the complete progeny of this cell. 
Recognition and binding of the surface Ig molecules to antigen induces the 
proliferation and differentiation of B lymphocytes resulting in the 
production of plasma cells, all producing and secreting antibodies with the 
same antigen specifity as the original B cell. 
Besides their essential function for the defense of the organism, 
antibodies are very important tools in immunological research through their 
ability to react specifically with foreign material. Immunization of 
animals with purified antigen will induce a strong humoral response, which 
results in an antiserum usually containing high amounts of specific 
antibodies. Such specific antisera have been applied in many detection 
techniques and are the basis of a wide variety of radio immune assays (RIA) 
and enzyme linked immune sorbent assay (ELISA) systems. However, there are 
also some disadvantages connected with the production of such antisera. 
The concentration of the antibodies will fluctuate in time, since the life 
span of the plasma cell is relatively short (2-3 weeks). Another 
complication is that of non-specificity. It is almost impossible to 
isolate pure antigen for antibody induction. Moreover, most antigenic 
sources contain a wide variety of determinants, each capable of activating 
its specific B cell. Even one particular determinant is capable to induce 
several clones of B cells. At first highly specific B cells will be 
switched on but especially after repeated immunization also B cells with a 
lower degree of specificity will be activated. The net result of an 
immunization is therefore the activation of many B cells, producing 
antibodies with 
heterogeneous pool, 
present, but also 
a broad spectrum of specificities. 
various antibodies against the desired 
antibodies against other determinants. 
Within this 
antigen are 
In order to 
obtain a specific antiserum extensive purification is required for the 
removal of the non-specific antibodies. For this purpose one needs the 
availabilty of these particular antigens. A variety of biochemical 
techniques is used to purify the required antigen. 
The disadvantages of the development of conventional antisera 
motivated many investigators to search for new methods for the production 
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of specific antisera. The solution came from Kohler and Milstein (1975) by 
means of the hybridoma technique. They fused antibody-producing cells with 
mouse tumour cells. The hybrid cells continued to produce the antibody of 
the first fusion partner, but also inherited the property of continuous 
growth of the tumour cells. By cell cloning procedures they managed to 
select the progeny of a single cell, thereby, by definition,- establishing a 
monospecific antibody producing line. 
The hybridoma technique as such is based on the phenomenon of 
somatic cell fusion. The frequency of the fusion event can be increased by 
reagents like polyethyleneglycol (PEG), which induce alterations of the 
cell membrane. After fusion of the membranes also the cytoplasm and 
eventually the nuclei fuse. Fusion is a rare event even in the presence of 
PEG. Therefore the hybrid cells must be separated from the parental cells. 
A very elegant strategy has been devised by Littlefield (1964). The 
principle of this approach is that the main biosynthetic route of the 
pyrimidines and purines can be blocked by aminopterine (a folic acid 
antagonist). In normal cells DNA still can be synthesized via alternative 
pathways, provided that thymidine and hypoxanthine are available. 
Thymidine is processed by the enzym thymidine kinase (TK), whereas 
hypoxanthine requires the enzyme guanine phosphoribosyl transferase 
(HGPRT). Myeloma cells, deficient for one of these enzymes, can be 
obtained by growing cells in the presence of either 8-azaguanine or 5-
bromodeoxyuridine. The cells, which are resistant to these drugs, fail to 
produce the enzym HGPRT or TK respectively . When these cells are grown in 
medium containing aminopterin, supplemented with thymidine and hypoxanthine 
(HAT-medium), they will die. In contrast, hybrids which received the 
ability to produce either TK or HGPRT from the the other fusion partner 
will survive in HAT-medium. 
The hybridoma technique has distinct advantages over the 
conventional approach. One is obviously the immortalization of a single 
plasma cell. Like tumour cells, they can be kept in culture for an 
indefinite period of time. In this way a continuous source of 
with a single specificity is available. Another advantage 
antibody 
is the 
possibility to dissect complex biological systems without the necessity of 
having purified antigens for immunization or adsorption. Starting with a 
rather impure antigen for immunization, the fusion will produce hybrid 
cells against a wide variety of antigenic determinants. By subcloning, 
i.e. the production of clones of cells which are derived from a single 
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cell, the desired hybrid cells can be isolated ~rom this pool o~ clones.· 
These hybrid clones produce monospeci~ic antibodies and, by screening the 
culture supernatants, it is possible to select one particular clone. This 
property o~ the hybridoma technique has made it an invaluable tool ~or the 
production o~ monoclonal antibodies (MCA) against polymorphic antigenic 
systems, such as antigens encoded ~or by the major histocompatibility 
complex (MHC) and sur~ace antigens o~ B and T lymphocyte subpopulations. 
It is hardly possible to obtain such monospeci~ic antibodies using the 
conventional approach. For the experiments described in this thesis 
recognition o~ various cell types consistuing the immune system o~ the rat 
was required. The obvious choice ~or the development o~ these speci~ic 
antibodies was the hybridoma technique. This chapter will describe and 
discuss the adaptation and optimization o~ this technique ~or the 
production o~ MCA against cellular antigens o~ rats. The hybridoma 
technique consists o~ two essential parts. The ~irst one is the actual 
~usion in order to obtain the hybrid cells. The second part starts 
immediately a~ter plating o~ the hybrid cells. This part depends on the 
availability o~ a ~ast and reliable technique ~or selecting the correct 
hybrid cells. In the ~irst section the ~usion technique will be discussed. 
In the second part several screening techniques will be compared and 
discussed. 
FUSION 
Since we wanted to produce monoclonal antibodies against rat cells, 
mice were immunized and mouse myeloma lines were used ~or hybridization. 
In all experiments, spleen cells o~ immunized BALB/c mice were used ~or 
~usion. In the ~usion experiments rat cells, such as thymocytes or 
lymphoid tumour cells were used ~or immunization. Mice were primed 
intraperitoneally with 107 cells in phosphate bu~~ered saline (pH 7.2). 
Four weeks later these animals were intravenously boostered with 5x10 7 
cells. Four days later the spleen o~ the mice were isolated and single 
cell suspensions were prepared ~or the actual ~usion. No adjuvants were 
required in the immunization procedure o~ these experiments. When raising 
MCA against antigens with low immunogenic properties or against soluble 
antigens, the application o~ adjuvants might be considered. 
The hybridoma technique was per~ormed according to the method o~ 
Fazekas de St.Groth and Scheidegger (1980). This technique was modi~ied 
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for application in the rat system: single cell suspensions of spleens of 
immunized mice were prepared as described in detail previously (Razing et 
al, 1977). Spleen cells (2x107 ) were fused with 5x10 7 SP2/0 myeloma cells 
(SP2/0-Ag14; Shulman et al,1978). The myeloma cells have to be grown half 
confluently and are brought in suspension at the time of fusion. Spleen 
cells and myeloma cells were mixed and washed in medium without serum. The 
cells were carefully resuspended in 1 ml PEG solution, which consists of 
0.5 g PEG (PEG 4000 fllr die Gas-chromatographie, Merck, BRD) supplemented 
with 0.05 ml dimethylsulfoxid (DMSO) dissolved in 0.5 ml aquadest. This 
mixture is kept at 37'C for approximately 2 min followed by gradual 
dilution in buffered medium (without serum). The fused cells were plated 
in 24 well culture trays in a density of 104 spleen cells/well. Because 
the spleen cells are the limiting factor for the number of hybridoma cells, 
that can be formed the cellular input is expressed as the number of spleen 
cells of the fusion mixture. These wells contained feeder cells, i.e. 
Balb/c macrophages (2.5x104 cells/well), which were harvested from the 
peritoneal cavity and plated 24 hours before the fusion. The cells were 
cultured at 37°C in humidified air (5% co2 ) in RPMI-1640 medium (Seromed, 
BRD) containing 15% fetal calf serum (FCS; Batch nr. 100.378; Hyclone, 
USA). The FCS batch was selected for growth sustaining properties for 
hybrid cells in test fusion experiments. This culture medium contained HAT 
(Hypoxanthine, 10-4M; Thymidine, 1 .6 x 10-5M; Aminopterin, 4 x 10-7 ) for 
selecting the hybrids. 
Myeloma cells lack the enzyme for the alternative pathway for DNA 
synthesis, whereas the spleen cells have only a limited lifespan. The 
hybrid cells with the enzyme producing capacity of the spleen cell and the 
immortality inherited from the myeloma cell will survive in this selective 
medium. After two weeks the HAT-medium can be removed gradually from the 
culture medium. At the same time the first growing hybrid clones can be 
detected with the microscope. Approximately one week later culture 
supernatants can be harvested for the primary screening of antibody 
production. Selection of hybrid clones should be done at an early stage in 
order to avoid mai.ntenance of uncounted non-specific clones. 
Plating large numbers of cells per well has been the approach in 
the original protocols (Goding, 1980). However, a high number of wells 
will contain more than one hybrid and overgrowth by non-producers will 
occur in many cases. For this reason we plated the fused cell in limiting 
numbers. A disadvantage of this approach, however, is that the rather 
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unstable hybrids are very intolerant to dilution. They seem to need the 
presence of other cells for growth. The application of feeder cells 
prevents the negative dilution effects. Reduction of the toxicity of the 
plastic culture trays has been suggested by Goding (1980), but the exact 
function of the feeder cells is still unknown. Using selected batches of 
FCS (data not shown) and feeder cells in the medium during the first weeks 
of culture, highly improves the yield of hybridomas, when the cells are 
plated in low numbers (Fazekas de St.Groth and Scheidegger, 1980). Plating 
of low numbers of cells (10 4 cells/well), as used in our protocol, normally 
results in approximately 70 percent positive wells. De Blas et al (1981) 
investigated the correlation between the percentage of wells with growth 
and the degree of monoolonality. The estimation of the number of clones in 
a single well was based on the Poisson probability model. According to 
this correlation, approximately 60 percent of the wells with growing hybrid 
cells (70% of all wells) contain clones derived from a single hybrid cell. 
This is in agreement with the high degree of monoclonality of the hybrid 
clones we obtained in a series of experiments. 
The selected hybrid clones were grown to larger quantities and stored 
in liquid nitrogen. Hybridomas in thi~ early period of culture can be lost 
for two major reasons. First of all they will lose a number of chromosomes 
with the possibility of losing either the capacity of antibody production 
or the growth property of the myeloma. The second problem is that part of 
the wells will contain more than one hybrid clone. In the case of mixed 
clones, due to the growth of more than one hybrid cell in one well, 
subcloning will be necessary in an early phase. Subcloning is done by 
plating hybrid cells in a low concentration (0.3 cells/well) in microtiter 
plates. These cells must be grown in the presence of feeder cells, as was 
described for growth of fused cells. Monoclonality of clones can be tested 
with isoelectricfocussing (IEF) as described by Nicoletti et al (1980). 
Culture supernatant of the parent clone, containing the produced antibodies 
is harvested and compared with supernatants of several subclones. These 
antibodies give a characteristic IEF pattern, which is fully identical if 
the parental hybrid cells were derived from a single cell and only partly 
identical if the parent cells were derived from more than one cells. In 
figure 2.2 culture supernatants of several parent clones (lanes A-G) are 
shown together with one subclone (lanes A-G). 
For the further characterization of the antibodies and other 
experiments large quantities of MCA were required. For this purpose Balb/c 
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Figure 2.2 Screening of culture supernatants of seven hydridoma's 
using agarose-IEF. Supernatants of parent clones (left 
sides of lanes A-G) were tested together with 
supernatants of a subclone (right side of lanes A-G). 
female mice (15-30 weeks of age) were intraperitoneally injected with 3x106 
hybrid cells. Tumour growth should be evident after 2-4 weeks and up to 10 
ml of ascites fluid can be harvested from one mouse. The levels of 
antibody in these ascites may range from 5 to 25 mg/ml. Occasionally some 
hybrids fail. to produce ascites and ascitis production may be favoured by 
injecting 0-5 ml pristane (2,6;10,14-tetramethyl pentadecane) one week 
prior to the injection of hybrid cells. 
SELECTION OF THE HYBRIDS 
One of the limitations of the hybridoma technique is the problem to 
detect the hybrid clone which produces antibodies with the desired 
specificity. The source of antigen used for immunization, but also for the 
selection of the antibody produced by the hybrid cells is rather impure. 
For this reason such a screening technique has to be highly sensitive for 
the detection of small amounts of antibodies. It was the intention to 
produce monoclonal antibodies against T cell subpopulations, therefore the 
screening technique must also be able to detect antibodies, that recognize 
only a small cell population of the cells used for the primary selection . 
. A fast automated system is required for screening large numbers of 
supernatants for reactivity. Such a technique enables a primary selection 
of hybrid clones in an early stage. This is important because growing, 
27 
expansion and cloning o£ hybrids are time and material consuming. For this 
purpose three techniques are compared £or the speci£ic use in the hybridoma 
technique. 
Screening o£ large numbers o£ culture supernatants using either a 
radio-immuno-assay (RIA) or an enzyme-linked-immuno-sorbent-assay (ELISA) 
was made possible by coating 96-wells microtitration plates with target 
cells to (Brown et al, 1979). An elegant alternative is the analysis o£ 
the reactivity using a £luorescence technique. In the latter case a 
£luorescence activated cell sorter (FAGS) is used. All three techniques 
were tested £or the ability to detect a low concentration o£ antibody, but 
also to detect a small number c£ cells recognized by speci£ic antibody. 
For the RIA and ELISA techniques target cells were coated to wells 
o£ vinyl microtitration plates, as described by Stocker and Heusser (1978). 
Single cell suspensions were prepared o£ thymus o£ Lewis rats and Balb/c 
mice. All procedures i.e. washing and incubation were done in phosphate 
bu££ered saline (PBS,pH 7.2), supplemented with 1~ bovine serum albumin 
(BSA) and 0.1~ natriumazide unless stated otherwise. Target cells were 
adjusted to a concentration o£ 5.107 cells/ml in BSA £ree medium and 
subsequently injected into the wells (50 ~1). The cells were spinned to 
the bottom and coated to the wells by adding 0.25~ glutaraldehyde during 5 
min. at 0 'C. This fixation reagent was removed by washing and the wells 
were subsequently £illed with 150 ~1 PBS and stored at 4 'c until £urther 
use. 
For all screening techniques a££inity column puri£ied rabbit-anti-
mouse Ig (RAM-Ig) was used and subsequently (Fab)2 £ragments were made by 
pepsin digestion. A££inity chromatography was per£ormed with Sepharose-CL-
4B coated with mouse Ig £or positive selection o£ RAM-Ig and with rat Ig 
£or removal o£ antibodies directed against the rat. This RAM-Ig(Fab)2 
preparation was used £or conjugation with enzyme, radiolabel 
£luorochrome, respectively as described in the next sections. Puri£ication 
o£ RAM-Ig is necessary because there is a high degree o£ conformity between 
mouse Ig and rat Ig, which will result in many cross reactive antibodies in 
the sera. 
For RIA, RAM-Ig(Fab)2 was labelled with 125r. For this conjugation 
the jodogen method was used (Markwell and Fox, 1978). The microtiter 
plates with the coated target cells were washed three times and 
subsequently £illed with the unlabelled mouse antibody. A£ter incubation 
£or hour at room temperature the wells were thoroughly washed and 
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incubated with the 125r-RAM-Ig· in an appropriate dilution. A:fter this 
second incubation, which. was per:formed under the same conditions, the 
unbound tracer was removed by washing. The single wells were isolated by 
cutting them :from the plates with a hot wire cutter and the activity o:f the 
bound antibody was counted in the ~-counter. 
For ELISA, RAM-Ig(Fab)2 was conjugated with the enzyme s-
galactosidase in the presence o:f the coupling reagent m-maleimido-benzoyl-
N-hydroxy-succimide ester according to the method o:f O'Sullivan et al 
(1978). Isolation o:f this conjugate was established by gel :filtration on 
Sepharose-4B. The procedure o:f the :first step is identical to the one used 
in the RIA. In the second incubation the a-galactosidase conjugate is 
added in optimal concentration and incubated :for one hour at room 
temperature. The unbound conjugate is removed by washing and the quantity 
o:f conjugate bound to the coated target cells is determined by the 
reactivity towards the substrate 0-nitrophenyl-D-galacto pyranoside. This 
reaction is stopped with Na2co 3 (1M) and the concentration o:f the yellow 
reaction product was measured at 405 nm in a Titertek Multiscan. 
For :fluorescence staining, RAM-Ig (Fab) 2 was conjugated with 
:fluoresceine isothiocyanate (FITG) antibody, dialysed against 0.1M 
carbonate bu:f:fer (pH 9.2).This was done by mixing RAM-Ig(Fab) 2 with FITG 
(1mg/ml DMSO) and incubating it :for 2 hours at room temperature. The 
reaction was stopped by dialysis against PBS (pH 7.2), wherea:fter a 
:fluorochrome/ protein ratio o:f 1 .8 was :found. Single cell suspensions o:f 
the thymus were prepared as described by Rozing et al (1977). The cells 
were washed and suspended in RPMI 1640 medium, supplemented with 1% BSA and 
0.1% natrium azide ( RPMI-BSA). After centri:fugation o:f the cells, sampres 
o:f approximately 10 6 cells were incubated :for 30 min at 0°G, :first with 
test antibody and subsequently with FITG-RAM-Ig(Fab) 2 at optimal 
concentration. The cells were washed with RPMI-BSA and resuspended in 
ml. A:fter staining the samples were analysed on a FAGS II (Becton & 
Dickinson), equipped with an argon laser (Spectra Physics) at 488 nm. 
Forward light scatter windows were set to exclude erythrocytes and dead 
cells. Analysis of scatter and :fluorescence signals was done with a Data 
ND-100 pulse height analyser. Cells were stained with a range of antibody 
dilutions and the mean :fluorescence intensity o:f each dilution was 
determined. 
The sensitivity to. detect a low amount o:f antibody has been 
determined with a de:fined monoclonal antibody against Thy1 .1. This mouse 
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Figure 2.3 Dilution analysis of monoclonal antibody. Binding of various concentrations of MRC 
OX-7 (10 mg/ml) to rat thymocytes was tested in FAGS, RIA and ELISA. The results 
are expressed as percentage of the highest response. The mean value of three 
indepent assays are sho\rlt'l, the standard error of the mean (SEM) did not exceed a 
value of 10~. 
monoclonal anti-Thy-1 .. 1 antibody (MRC OX-7; Mason and Williams, 1980) was 
purchased from Seralab, U.K. and is directed against rat Thy-1 and mouse 
Thy-1 .1. It recognizes about 95% of the lymphocytes in the rat thymus. To 
test the sensitivity level of the various systems a dilution analysis of 
the anti-Thy-1 .1 antibody (10 mg/ml) binding with rat thymocytes as target 
cells was done. For FACS analysis the mean fluorescence intensity per cell 
has been determined for the various dilutions, whereas for RIA and ELISA 
analysis, counts per minute (cpm) and extinction were 
measured,respectively. The results have been expressed as percentages, 
relative to the highest response, which was considered to be 100 percent 
(Fig. 2.3). Both RIA and ELISA systems proved to be superior to FACS 
analysis, since there was a 10-20 fold difference in sensitivity between 
the first two techniques compared to the FACS analysis. The detection 
limit is considered as the minimum concentration of antibody that can be 
distinguished from the background i.e. the background value plus twice the 
SEM of the back ground value. The detections limits as were determined in 
these experiments were 5 ~g/ml for the FACS, 0.3 ~g/ml for the RIA and 0.6 
~g/ml for the ELISA, respectively. This showed that the RIA is slightly 
more sensitive than an ELISA. All three screening systems had sufficient, 
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Figure 2.4 Comparison of the cellular sensitivity of RIA, ELISA and FACS analysis. 
Binding of MRC OX-7 antibody to thymocytes of rat (LEW) and mouse (Balb/c) 
in various combinations was tested. The background values of the 
respective techniques were adjusted to the same level for a proper 
comparison of the sensitivity. 
though sometimes marginal (FAGS), sensitivity to cover the normal observed 
range of monoclonal antibody concentrations in culture supernatants (1-
10ug; personal observation). 
For the sensitivity to detect a low percentage of positive cells 
within a cell population thymocytes of Lewis rats (Olac, Bicester,UK) were 
mixed with thymocytes of Balb/c mice. This technique can be used because 
the anti-Thy-1 antibody is directed against the Thy1 .1 allele, which is 
present on rat thymocytes, whereas the Balb/c cells express the Thy1 .2 
allele. The cell mixtures contained the following percentages of rat 
cells: 100, 50, 25, 12.5, 6.2, 3.1, 1 .6, 0.8 and 0. Thus obtained mixtures 
were coated on wells of microtitration plates as described before and 
screened with monoclonal anti-Thy1 .1 antibody in optimal concentration. 
Subsequently these mixtures were incubated with the respective labelled 
antibodies and analysed. For comparison the scales of the various 
techniques were adjusted in figure 2.4, in order to fix the respective 
background values at the same level. Data are expressed as cpm for RIA, 
extinction for ELISA and percentage of cells positive for a given 
fluorescence intensity in FAGS analysis. From these data it appears that 
both FAGS and RIA have sufficient sensitivity to measure small percentages 
(1 .5%) of positive cells. ELISA is somewhat less sensitive, resulting in a 
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lower limit of 3~ in these experiments. Furthermore, since the FACS also 
provides the percentage of positive cells, this way of analysis, in 
contrast to RIA and ELISA, discriminates between binding of the monoclonal 
antibodies to the entire population and binding to a (minor) subpopulation. 
For detection of low concentrations of antibodies the RIA displays 
the highest sensitivity (see also Fig. 2.5), whereas the ELISA almost 
approaches the same degree of sensitivity. For the detection of minor 
populations of positive cells both the RIA and the FACS are highly 
sensitive. The advantage of analysis with the FACS is the possibility to 
discriminate between recognition of determinants on all cells or 
determinants only present on a minority of the population. For the RIA an 
ELISA such a discrimination is impossible. When similar experiments are 
performed using a marker, which is present at a low density (W3/13, 
approximately 3.8 x 104 molecules/cell) on the cell membrane (Williams et 
al, 1978), FACS proved to have a higher discriminating ability than RIA. 
On the other hand the sensitivity to detect low amounts of such an antibody 
is significantly lower than for the Thy-1 .1 antibody (data not shown). 
Staining with low amounts of antibody will correlate with a decrease of 
fluorescence intensity. The intensity of positive cells with a low antigen 
density may approach the intensity of the negative population. Screening 
of culture supernatant with the FACS will therefore include the risk of 
missing several hybrids that produce specific antibody. Also the handwork 
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Figure 2.5 Primary screening (RIA) of culture supernatants of ;o 
hybrids for specific binding on rat thymus cells. The 
hybrids were selected for specific Ig production. MCA MRC 
OX-7 (Thy-1), w;;u (T cells) and MRC OX-4 (B cells) were 
used as reference antibodies (Reference HCA are shown in 
Table ;.;). 
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involved in this technique is not suited for the screening of large numbers 
of samples. Both RIA an ELISA are highly sensitive techniques quite 
capable to detect specific antibodies within the normal concentration range 
found in culture supernatants. Moreover both techniques are highly suited 
for screening on a large scale. Therefore ELISA and RIA are the techniques 
of preference for primary screening in the hybridoma technique. The choice 
between these techniques will depend on the practical circumstances. RIA 
is the most sensitive and should be the technique of choice, when surface 
antigens on small percentages of target cells are be expected. ELISA is 
even faster than RIA and especially when large numbers of samples have to 
be screened, this is an important advantage. Although radioactivity is not 
involved, the substrate of .a-galactoside is highly toxic. After the 
primary selection, analysis with FAGS, using culture supernatants of 
further grown hybrid clones, will provide valuable information about the 
cellular distribution. 
Fusion experiments 
The hybridoma technique, with the modifications described in this 
chapter, is schematically illustrated in figure 2.6. A series of fusion 
Day 0: 
Balb/c mice 
107 cells i.v. 
7
1 6 weeks 
5x10 cells 
i.v. 1 4days 
2 x 10 7 spleen cells X 
SP2/0 fusion line 
in vitro 
5 x 107 SP2/0 cells 
Plating in H~T-medtm 104 cells per well 
Day 17: 
I ( 15% FCS selected batch) 
Primary screening using RI~. ELlS~ 
GroiJth, selectlon and cloning 
Figure 2.6 Hybridoma technique used for the production of mouse anti-rat monoclonal antibodies 
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experiments Yere done for the production of monoclonal mouse anti-rat 
antibodies, Yhich are directed against surface antigens of cells of the T 
cell lineage. Balb/c mice Yere immunized with various types of cells of 
the T cell lineage. After primary screening with RIA or ELISA a total of 
230 hybrid clones was selected, that produced antibodies reacting with the 
target cells (summarized in Table 2.1 ). In figure 2.5 an example of such a 
primary screening using a RIA is shown. Positive hybrids were selected, 
subcloned and ascites was prepared for further experiments. Further 
selection and characterization of these monoclonal antibodies will be 
described in more detail in the next chapter. 
In order to obtain monoclonal antibodies, directed against surface 
molecules of distinct T cell subpopulations, a series of hybridization 
experiments have been carried out. Most of the subpopulation markers 
described in mice and man are expressed on the majority of the thymocytes. 
Therefore thymocytes have been used extensively as a source of antigen for 
immunization. But also lymphoid tumour cells or spleen cells have served 
as a source of antigen (Table 2.1 ). Primary screening of growing hybrids 
in either a RIA or an ELISA was always done on the same cell source as used 
for immunization (see previous chapter). 
Table 2.1 Hybrid clones selected for production of specific 
antibodies. 
Experiment Clones Immunizinga 
Nr cells 
26 Tumour cells 
69 Thymocytes 
22 Thymocytes 
4 Thymocytes 
21 Cortison resistent thymocytes 
34 Lymphoid tumour cells 
>4 Lymphoid tumour cells 
Rat 
strain 
(AD x BN)F1 
Lewis 
Le\rlis 
Lewis 
Lewis 
PVG 
PVG 
a. Cells used for immunization and primary selection. 
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Chapter 3 
CHARACTERIZATION OF MOUSE ANTI-RAT ANTIBODIES 
PRIMARY CHARACTERIZATION 
The 230 hybrids mentioned at the end of the previous chapter 
(chapter 2.1 ), which were selected on the criterium of producing antibodies 
with a positive reaction with the target cells used for immunization, were 
further defined and characterized. 
Immune histology on spleen and thymus was performed to check the anti-T 
cell versus the anti-non T cell reactivity of the antibodies produced by 
hybrids. Selected anti-T cell hybrids were then tested on cell 
suspensions of spleen, thymus and lymph nodes in a flow cytometric 
analysis assay (FACS) for the quantitation of their T cell reactivity. 
Further insight was finally obtained on the specific reactivity of these 
hybrids with defined lymphoid subsets in two colour fluorescence analysis 
on lymph node cells. 
Based on the data obtained in these experiments a final selection 
of MCA was made with a differential recognition pattern within the T cell 
population. 
Immune histology 
A first characterization of the reactivity pattern of the 
monoclonal antibodies obtained with mature T lymphocytes as antigen was 
established using immunohistochemistry on lymphoid organs as spleen and 
thymus. Therefore tissue specimens were snap frozen and stored at -70'C. 
Cryostate sections (6-8 um) were picked up, air-dried, fixed in acetone for 
10 minutes at room temperature (RT) and rinsed three times for 10 min. with 
phosphate buffered saline pH 7.4 (PBS; 0.01M). The sections were covered 
with mouse anti-rat monoclonal antibody and incubated for 60 min. at 
roomtemperature (RT). Ascitis fluid containing the relevant MCA was used 
at an appropriate dilution in PBS supplemented with 1% (v/v) normal rat 
serum (NRS) and 2% (w/v) bovine serum albumin (BSA, Povite, Oss, The 
Netherlands). After washing in PBS the incubation was repeated with rabbit 
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anti-mouse immmunoglobulin conjugated with horseradish peroxidase (Miles, 
Slough, England). The sections were stained for peroxidase activity using 
3-3' diaminobenzidine-tetrachloride (DAB; Sigma USA) in a concentration of 
5 mg/ml in 0.05 M Tris/HCl buffer (pH 7.6), containing 0.01% hydrogen 
peroxide. A final incubation in 5% (w/v) cu2so4 solution was added to the 
procedure for improving the staining intensity. 
The spleen is a highly vascularised organ, which can be considered 
as an encapsulated·vascular filter. It filters the blood and can remove 
damaged blood cells and foreign substances. The spleen can be divided into 
two different compartments. The red~ provides the microenvironment for 
differentiation of erythrocytes, granulocytes and megakaryocytes (reviewed 
by Tavassoli, 1975). The second compartment, the white pulp is primarily 
Figure ~- 1 Screening of culture supernatants using immune peroxydase histology. Gryostate sections of 
the spleen were stained with culture supernatants of clone 1-7A6 (A), clone ~-11B2 (B), 
clone J-11G6 (G) and clone 5-4B5 (D). Legends: follicles (F), marginal zone (M), red 
pulp (R) and PALS (P). 
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Figure 3. 2 Screening of culture supernatants using immune peroxydase histology. Cryostate sections of 
spleen were stained with supernatant of clone 1-7A6 (A), clone 5-7 A~ (B), clone 5-4A~ (C) 
and clone 4-7A6 (D). Legends: follicles (F), marginal zone (M), red pulp (R) and PALS (P). 
lymphoid of nature. Three different areas can be distinguished in the 
white pulp. In the center an arteriole is surrounded by a layer of 
concentric sheats of reticular cells containing large numbers of lymphoid 
cells. This is the peripheral arteriolar lymphatic sheath (PALS) where 
mainly lymphocytes of the T cell lineage are found. Inserted at several 
sites in the periphery of the PALS spherical and ovoid accumulations of 
lymphocytes are located, the socalled follicles. The PALS is surrounded by 
a loose meshwork of connective tissue, which is refered to as the marginal 
zone. The follicles and the marginal zone are predominantly populated by B 
cells (Gutman and Weissman, 1972; Weissman et al, 1976; Van Ewijk et al, 
1977; Rozing et al, 1978). This distinct localization pattern of BandT 
cells in the spleen enabled us to classify the recognition pattern of the 
antibodies produced by the selected hybrids as specific for T cells, but 
also T and B cells or non-lymphoid cells. Also a first indication on the 
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quantitative aspects of the reactivity among the cell population recognized 
was obtained using such an immunohistological procedure. This is 
illustrated by some examples of reaction patterns in figure 3.1 and figure 
3.2. 
In figure 3.1 several of the distribution patterns observed in this 
type of screening are shown. Many of the culture supernatants contained 
antibodies that were directed against surface antigens predominantly 
expressed by cells of the PALS area (Fig. 3.1A). Some of the antibodies 
reacted with cells located within follicles as well as in the marginal zone 
(Fig. 3.1B), whereas other antibodies appeared to react with cells 
throughout the white pulp (Fig.3.1C). A remarkably different distribution 
pattern as well as morphology of recognized cells can be observed in figure 
3.1D. This antibody reacted with a non-lymphoid type of cells, mainly 
located in the red pulp. Most of the tested antibodies predominantly 
reacted with cells of the PALS and only with small numbers of cells in the 
follicles and marginal zone. With this type of antibody a variation in 
labelled cell numbers can be observed. In figure 3.2 four antibodies are 
shown which react with a diminishing number of cells in this area. From 
such antibodies that are apparently directed against T lymphocytes several 
representative antibodies were selected for further characterization. 
These MCA are listed in Table 3.1, together with the cells used for 
immunization and the number of the hybrid clone producing this antibody. 
Table 3. 1 Mouse monoclonal antibodies directed against 
rat leukocytes 
Antibodya Cells used 
for immunization 
ER-1 Lymphoid tumour (AO xBN)F1 
ER-2 Lymphoid tumour (PVG) 
ER-3 Lymphoid tumour (PVG) 
ER-4 Thymocytes (LEW) 
ER-7 Lymphoid tumour (PVG) 
ER-8 Thymocytes (LEW) 
ER-9 Lymphoid tumour (PVG) 
ER-10 Thymocytes (LEW) 
ER-12 Spleen cells (LEW) 
ER-13 Spleen cells (LEW) 
ER-14 Lymphoid tumour (AO xBN)F1 
ER-17 Thymocytes (LEW) 
ER-18 Thymocytes (LEW) 
ER-19 Lymphoid tumour (PVG) 
Clone 
number 
1-7A6 
5-7A3 
4-7A6 
2-2D3 
5-4A3 
2-10C1 
4-10B1 
2-10C1 
3-11B2 
3-1 1C6 
1-4D4 
2-7A5 
2-4D3 
4-8C1 
a. ER stands for Erasmus University Rotterdam 
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In immune histochemistry a rough estimation of the number of 
positive cells for a given MCA can be obtained. Therefore a precise 
quantitation is still needed. For this purpose the relevant MCA have been 
analysed on the fluorescence activated cell sorter (FACS). 
FACS analysis 
The FACS is a highly sensitive tool for the quantification of 
positive versus negative cells. To do so, all antibodies, both those which 
were developed by us and those which were applied for reference purposes, 
were directly conjugated with fluorescein isothiocyanate (FITC) or with 
tetramethylrhodamine isothiocyanate (TRITC). Therefore antibodies were 
purified from ascites by ammoniumsulphate (50~) precipitation and DEAE 
chromatography. Subsequently the antibodies were conjugated under standard 
conditions as described by Goding (1976) with the appropriate fluorochrome. 
Single cell suspensions of spleen, fymph nodes and thymus were prepared and 
stained with FITC conjugated antibodies in a single step incubation as 
described in the second chapter. In these experiments PVG female rats, 12 
weeks of age, were used. The cell suspensions were analysed on a FACS II 
(Becton Dickinson, USA) equipped with an argon laser (Spectra Physics) at 
488 nm in the following setting: laser 200 mW, photomultiplier 560 V, 
fluorescence gain ranging from 4-16. Forward light scatter windows were 
!DODD 
i
1[JDDD 
Fluorescence intensity 
Figw-e 3.3 Fluorescence profiles of monoclonal antibodies on lymph node cells. On the 
horizontal axis the fluorescence intensity is shown, whereas the vertical axis 
represents the number of cells displaying a certain intensity a. ER-1, b.ER-2, 
c. ER-3, d. control (Leu-4) e. ER-7 f. ER-8 g. ER-9 and ER-10. The arrows 
indicate the separation between the positive and negative cells 
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used to exclude erythrocytes and dead cells. Scatter and fluorescence 
signals were analysed with a Nuclear Data ND-100 pulse height analyser 
interphased with a PDP-11 computer system (Digital, USA) for data storage 
and analysis. The fluorescence intensity of the cell is a reflection of 
the density of the labelled surface molecule. The data of all cells is 
combined in a fluorescence profile, in which by means of an electronic 
window the positive cells can be distinguished from the negative cells. 
The fluorescence profiles of several antibodies on lymph node cells are 
shown in figure 3.3. A clear distinction between positive and negative 
cells for the antibodies ER-1 and ER-2 can be detected (Fig. 3.3a and b). 
This clear distinction between cells which are negative and positive for 
these antibodies, is caused by the fact that the amount of surface antigens 
recognized by ER-1 or ER-2 is about equal on all positive cells and is 
quite different from negative cells. The other antibodies, on the other 
hand, display a remarkable heterogeneity in their staining profiles. No 
clear separation of positive and negative cells was possible, because cells 
were found displaying all grades of fluorescence intensity. Nevertheless, 
by comparing such profiles with relevant controls (Fig. 3.3d), it is 
possible to calculate the number of positive cells also for these MCA By 
this method the percentage of positive cells has been determined in thymus, 
spleen and lymph nodes of young adult rats using a panel of MCA , which had 
Table 3. 2 Flow cytometric analysis of MGA 
in various lymphoid organs 
Percentage a 
Antibody Thymus Spleen Lymph Node 
ER-1 98 49 58 
ER-2 90 28 ;6 
ER-3 92 20 21 
ER-4 96 1 2 
ER-7 94 25 31 
ER-9 96 23 26 
ER-10 98 25 28 
a. Analysis was done with a FAGS. For thymus, spleen and 
lymph nodes the scatter gates were set on the 
lymphocyte peak and percentage of positive cells is 
expressed as part of these cells. Mean percentage or 
positive cells in three separate experiments are 
shown. In these analyses 12 weeks old PVG male rats 
\i/ere used. 
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been selected for their T cell reactivity in immune peroxidase histology 
(Table 3.2). 
As shovn in Table 3.2 most antibodies recognized a considerable 
number of cells in the spleen and lymph nodes. The percentages, ho~ever, 
varied greatly. ER-1 for instance labelled 50~ of the spleen cells and 
even more (58%) of lymph node cells. ER-4 on the other hand recognized 
only thymocytes, but no spleen or lymph node cells. The reactivity of 
other MCA ~as in bet~een these t~o. Ho~ever all MCA labelled the vast 
majority of thymocytes. 
Two colour fluorescence analysis 
The T cell reactivity of the selected MCA as suggested by immune 
peroxidase histology on spleen sections could be confirmed by double 
fluorescence analysis using specific B and T cell markers. For this 
comparison, but also in other experiments of this chapter, the selected 
antibodies ~ere compared ~ith a panel of reference antibodies ~hich are 
summarized in Table 3.3. Part of these experiments ~ere done on the FAGS. 
Table ,5.:;:. Monoclonal antibodies used for reference purposes 
Antibody Target Reference 
description 
MARK-1 8-lymphocytes Ba.2in et al, 1984 
W3/13 !-lymphocytes Williams et al, 1977 
w:;/25 T helper cells Williams et al, 1977 
MRC OX-4 B lymphocytes (Ia) McMaster and Williams, 1979 
MRC OX-8 T suppr./cytotoxic Brideau et al, 1980 
MRC OX-7 rat Thy-1 Mason and Williams, 1980 
MRC OX-19 !-lymphocytes Dallman et al , 1984 
Therefore all antibodies, including reference MCA ~ere labelled ~ith FITC. 
At first all MCA ~ere compared ~ith a specific B cell marker. For this 
purpose a MCA that is directed against the kappa chain of the rat Ig (MARK-
1 ), kindly provided by Dr.H.Bazin, Bruxelles, Belgium (Bazinet al, 1983), 
~as used. Lymph node cells of Le~is rats (Le~is/Olac, Bicester, England) 
~ere stained ~ith the MCA alone or in combination ~ith MARK-1. When the 
MCA do not recognize B cells but only T cells, staining of cells ~ith the 
MCA and MARK-1 at the same time must give a percentage of positive cells 
that is the complete summation of the figures of the single staining ~ith 
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the ·MCA and of MARK-1. As shown in Table 3.4 all tested antibodies 
demonstrated a complete summation in the double staining situation compared 
with the individual figures. This kind of summation therefore confirms 
that the tested antibodies do not react with B lymphocytes. 
Table 3.4 Double fluorescence analysis of 
monoclonal antibodies 
Antibody Percentagea 
MCA MCA + MARK-1b 
41.3 
ER-1 55.9 97.5 
ER-2 39.8 81.4 
ER-3 17.4 57.9 
ER-7 29.4 71.3 
ER-9 27.0 70.1 
ER-10 24.8 64.9 
a. Analysis "'"'" done with a FAGS II. Mesenteric 
lymph node cells (PVG rats; 12 weeks of age) 
were analysed with scatter gates set on the 
lymphocyte peak. Mean percentages of two 
separate experiments are shown. 
b. MARK-1 is directed against the kappa chain 
on rat B cells. 
Further experiments were done to relate the reactivity pattern 
with three recently described mouse anti rat monoclonal anti T cell 
antibodies. These MCA (W3/13, W3/25 and MRC OX-8) were kindly provided by 
Dr.A.F.Williams, Oxford, England; Table 3.3). In contrast to the preceding 
technique in which only one fluorochrome was used, the lymph node cells 
were now double stained with FITC and TRITC conjugated antibodies. Two 
fluorescence analysis enables a separation of cells according to the 
phenotype. Cells may express either one of the surface antigens, defined 
by the MCA or they may express both surface antigens. Using this technique 
it can be defined whether the T cell subpopulations, defined by the newly 
developed MCA belong to the helper T cell subpopulation or to the 
cytotoxic T cell subpopulations as defined by the MCA W3/25 and MRC OX-8. 
The preparations were analysed on a Zeiss fluorescence microscope equipped 
with an IV/F vertical illuminator and the appropriate filter combination 
for red (TRITC-labelled cells) and green (FITC-labelled cells) distinction. 
The two colour analysis, listed in Table 3.5, revealed that ER-1 and W3/13 
recognize the same cell population. Since the ER-1 antigen was exclusively 
expressed by W3/13+ cells (Exp. 1 ), this confirms -that ER-1 recognizes all 
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T lymphocytes. W3/25 and MRC OX-a recognize different cell populations 
(Exp. 2), although a small number of the the cells expressed both surface 
antigens. In the following experiments (Expts. 3-7) the antibodies were 
compared with W3/25 and MRC OX-a expression. Comparison of ER-2 and W3/25 
indicated that these antibodies too stain the same cell population (Exp.3). 
Not a single cell could be detected that was stained by only one of these 
two antibodies. Similarly to the W3/25 distribution (Exp.2) also a small 
number of ER-2+MRC ox-a+ could be detected (Exp.3). ER-3 and ER-10, on the 
other hand did stain all MRC OX-a+ cells (Exp. 4- and 7), because only ER-3 
a. 
b. 
Table 3.5 1\lo colour fluorescence analysis of lymph node 
cells 
Exp. Percentage a 
Nr FITG TRITG Green Red Red+Green 
ER-1 5~.6 
51.7 
ER-1 52.5 
W~/25 ~5.a 
MRG ox-a 1a.9 
W~/25 MRG ox-a }4.6 19.2 2.1 
ER-2 ~4.2 
W3/25 ER-2 0 0 35.9 
MRG OX-a ER-2 17.1 :S:S.6 1.2 
ER-:S 20.a 
MRG ox-a ER-:S 2.6 1a.6 
W~/25 ER-3 3>.4 1a.6 2.5 
ER-7 :so.a 
MRG ox-a ER-7 11.4 24.2 6.2 
W~/25 ER-7 11.2 5.2 26.4 
ER-9 29.4 
MRG ox-a ER-9 9.0 19.4 11.2 
W:S/25 ER-9 12. a 9.6 22.5 
ER-10 24.4 
MRG ox-a ER-10 5.~ 19.1 
W:S/25 ER-10 2a.6 1a.6 6.1 
Antibodies were directly conjugated ~o~!th FITG and/or TRITG 
Mesenteric lymph node cells of PVG rats (10 -12 1o1eeks of age) 
were used. Analyses were done IJ!th a Zeiss fluorescence 
microscope and fluorescent cells are expressed as a 
percentage of all nucleated cells. Positive cells were green 
(F!TG), red (TRITG) or red/green (TRITG + FITC) 
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(ER-10) positive cells or ER-3+ (ER-10+) MRC OX-8+ double positive cells 
were ~ound. Comparing these ·antibodies with W3/25 antibody showed that a 
minor subpopulation o~ the W3/25+ cells were stained by these two 
antibodies. Finally, ER-7 and ER-9 recognize to a varying degree part o~ 
both W3/25+ and the MRC ox-a+ subpopulations (Exp. 5 and 6). Two colour 
~luorescence analysis o~ these antibodies with MRC OX-8 revealed that part 
o~ the cells expressed only one o~ the recognized sur~ace antigens. 
However, also cells with both sur~ace antigens were detected. These 
results were in agreement with the results with W3/25. There~ore, both the 
W3/25 and the MRC OX-8 de~ined subpopulations, are ~urther divided into at 
least two di~~erent populations. The distribution o~ the described 
antibodies in the lymph node cells as de~ined by these experiments is 
schematically represented in ~igure 3.4. 
Figure :>.4 Subpopulations of peripheral T lymphocytes defined by the selected monoclonal 
mouse anti -rat antibodies. 
a. T helper cell population defined by W:>/25 
b. T cytotoxic/suppressor population defined by MRC OX-8 
In conclusion a panel o~ mouse anti rat monoclonal antibodies was 
obtained, that is directed against sur~ace molecules o~ cells o~ the T cell 
lineage. ER-1 gives a pattern highly similar to that o~ W3/13. This is 
true ~or both the cellular distribution in thymus and peripheral lymphoid 
organs as well as ~or the FACS ~luorescence pro~iles (data not shown). The 
other antibodies react obviously with only a part o~ the T lymphocytes in 
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spleen and lymph nodes. ER-2 recognizes (like W3/25) the helper T cell 
population, whereas ER-3 and ER-10 demonstrated a highly comparable 
reactivity with MRC-OX-8 in staining the suppressor/cytotoxic subset, 
though with a small, but significant percentage of the helper subset too. 
ER-7 and ER-9 are, in combination with existing antibodies most likely 
candidates for a further distinction of functional T cell subpopulations 
into smaller subsets. 
Subpopulation of T cells in lymphoid follicles 
From immunohistological studies it became obvious, that the small 
population of ER-2+ER-3+ cells observed in the two colour fluorescence 
analysis (Table 3.5) has a specific localization pattern. Some MCA reacted 
not only to cells in the specific T cell areas, but also reacted to a few 
cells in B cell areas (follicles). Since B cell reactivity of the MCA 
could be excluded, the presence of cells expressing specific T cell markers 
in such B cell regions was investigated in more detail. Secondary 
follicles, which develop upon antigenic stimulation can be distinguished 
from primary follicles. Secondary follicles consist of a central area 
(germinal centre) surrounded by a mantle zone (lymphocyte corona). They 
are important for the generation of (immunological) memory cells 
(Nieuwenhuis and Opstelten, 1984). From experiments using athymic animals 
it was clear that T cells are essential for the development of such 
secondary follicles (Jacobson et al, 1974). The way in which T lymphocytes 
are involved in the induction and persistence of these germinal centres is 
obscure. The presence of T cells in germinal centres was also reported in 
mice by Guttman et al (1972) and in man by Poppema et al (1981 ). These 
cells belonged mainly to the T helper population (Poppema et al, 1981; 
Rouse et al, 1982; Bailey et al, 1982). In the rat the reported data ofT 
cells in the follicles were conflicting (Goldschneider and McGregor, 1973; 
Barclay, 1981 and Mayrhofer et al, 1983). The availability of several new 
antibodies directed against subpopulations of T lymphocytes offered an 
opportunity to define the phenotype of these cells more specifically. 
For the primary follicles germfree AO and Spraque Dawley (SD) rats 
were used. For the secondary follicles AO rats were intraveneously 
immunized with 109 SRBC. Serial sections of spleen tissue were stained 
with a panel of antibodies and subsequently the bound antibody was 
determined with the peroxidase technique. The serial sections of germfree 
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Figure 3.5. Immunoperoxidase histology of serial spleen sections of germfree and immunized rats. The sections 
of germfree animals 1.a1ere stained \Jith MRC OX-19 (A), "Whereas the sections of immunized animals 
were stained with MRC OX-19 (B), ER-1 (C), ER-2 (D), MRC OX-8 (E) and ER-3 (F). f= follicle 
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rats revealed a low number of putative T lymphocytes within the primary 
follicles, as defined by antibodies that label all T lymphocytes like MRC 
OX-19 (Fig. 3.5A). The cells were randomly dispersed throughout the 
follicles and a part of the T cells belonged to the T helper population 
(ER-2 positive), whereas a somewhat smaller population was labelled with 
ER-3 and MRC OX-8 (data not shown). In the secondary follicles an 
increased number of cells were stained with the "panT cell" antibodies, as 
illustrated for MRC OX-19 in figure 3.5A and B. These T cells were mainly 
found in the corona of the secondary follicles (Fig. 3.5B and C). For ER-
2 (Fig.3.5D) the number of positive cells seemed to approach those observed 
for the pan T cell antibodies (Fig. 3.5B-C). The distribution of the 
vario.us subpopulations revealed only a low number of MRC OX-8+ cells in the 
corona of the germinal centres (Fig. 3.5E). Quite surprisingly ER-3 did 
not follow the expected MRC OX-8 pattern. This antibody (Fig. 3.5F) did 
recognize cell numbers to the same extent as ER-2 (Fig. 3.5D). 
Subsequently experiments using double immunohistochemical staining of 
tissue sections with ER-2/peroxidase and ER-3/alkaline phosphatase 
conjugates were done (F.Kroese et al, in preparation). Staining of spleen 
sections showed that the majority of ER-3 positive cells in secondary 
follicles expressed also the ER-2 antigen. The majority of the follicular 
T cells thus seem to be a subset of the T-helper population characterized 
by the presence of the ER-3 defined surface antigen. Whether this 
subpopulation of ER-2+ ER-3+ cells is unique for this area or is also 
present in the PALS still has to be studied. Also in the human the 
follicular T lymphocyt'es are a special subset of the T-helper subpopulation 
(Poppema et al, 1983; Porwit-Ksiazek et al, 1983). The Leu-7 determinant, 
normally present on natural killer (NK) cells is also expressed on the 
majority of T cells with a helper phenotype in the follicles. In this 
context, it should be emphasized that also the ER-3 defined antigen is 
expressed on NK cells of the rat (Reynolds, unpublished results). In 
addition to T cell regulation, recently NK cell regulation of B-lymphocyte 
responses were described by Brieve et al (1984). This unique subset of the 
helper T cells will be isolated for experiments to determine their role in 
the germinal centre activity. 
From these studies it is obvious that several MCA of the selected 
panel, alone or in combination, enable a further specification of the T 
cell system, depending on site, differentiation stage or state of 
activation of the cells expressing such markers. This should be kept in 
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mind when evaluating the data obtained with such MCA in a highly aroused 
immune system due to a major antigenic challenge such as an allograft. In 
this respect also further insight in the actual structures recognized by 
the various MCA on the cell surface, and the possible role of these 
molecules in T cell functions is needed. Experiments performed to address 
these questions are described in the next section. 
FURTHER CHARACTERIZATION 
The primary characterization of the selected MCA described so far 
has been carried out on tissues from normal rats. In these tissues the 
immune system is in a homeostatic balance. After organ- or tissue 
transplantation the situation may change dramatically due to the severely 
increased antigenic pressure. Changes in cellular composition and 
phenotypical expression will probably occur, as compared to the normal 
resting situation. In order to interprete such changes properly one should 
have insight in the overall reactivity pattern of the relevant MCA . 
Therefore the selected panel of MCA was further analysed and characterized. 
First the reactivity of the panel was established with T cells at 
early stages of their differentiation and maturation process. Furthermore 
information is needed on the target antigen not only on the cellular level, 
but also at the receptor level. Therefore the cell surface antigens 
recognized by several of these MCA were determined and their role in a 
variety of T cell functions established. Finally, also the physical 
properties of the MCA were investigated and described in the last part of 
this chapter. 
Differentiation and maturation 
Most if not all of the characteristics of the selected panel of MCA 
described so far were obtained using mature T cells in peripheral lymphoid 
organs and thymocytes. Since the surface markers recognized by these MGA 
may be considered as differentiation antigens, i.e. they discriminate 
between T cells and other cells, as well as within the T cell population, 
it was of interest to study the expression of these molecules also during 
the process of early prothymic T cell development. Therefore we looked at 
the reactivity of these antibodies in the bone marrow. 
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Bone marrow of PVG rats was collected by flushing the femora and 
tibia with RPMI-1640 supplemented by 0.1~ BSA. Single cell suspensions 
were stained with FITC-conjugated antibody and analysed on a FACS II. 
Surprisingly most of the subpopulation markers, defined by these MCA 
reacted with a considerable number of cells in the bone marrow (Table 3.6). 
This was not expected since most T-cell markers in mice (Reinherz et al, 
1980) and man (Ledbetter and Herzenberg, 1979), but also in the rat (Mason 
et al, 1983), are first expressed on cells in the thymus. Only ER-2 is 
almost negative in this compartment, which is a further similarity between 
this antibody and the reaction pattern described for W3/25 (Williams et al, 
1977). For the other antibodies the reactivity ranged between about 65 
percent (ER-1 and ER-10) and 22 percent for ER-4. Most antibodies reacted 
predominantly with the large cell fraction. ER-9 and ER-14 on the other 
hand, were found to be an exception, since they labelled an equal 
percentage of large and small cells. ER-4, labelled only cells of the 
small fraction. These cells have a lymphoid nature and possibly also the 
pro-thymocytes are included within this population. ER-3 and ER-10 did not 
react with a the same number of cells in the bone marrow, which is a 
further confirmation that these antibodies are directed against different 
surface molecules, as suggested before. The cell numbers recognized by 
Table ; . 6. Percentage of bone marro~o~ cells 
stained by mouse anti-rat antibodies 
Antibody Percentage a 
small cells large cells all cells 
ER-1 15 47 6:> 
ER-2 
ER-; 12 :>5 46 
ER-4 21 2 22 
ER-7 11 :52 45 
ER-9 25 :51 58 
ER-10 19 46 65 
ER-14 15 15 :51 
a. Bone marrow \rla.S analysed l.Jith FAGS using 
different scatter windo\JS for total_. small and 
large fractions. Percentages of the separate 
populations ~o~ere expressed as part of all bone 
marrow cells. Mean percentage of three 
separate experiments is show, in lolhich 12-14 
\&leek old PVG male rats were used. 
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these antibodies in the bone marrow indicate that these surface antigens 
are also expressed by cells of other hematopoietic lineages. A further 
analysis of the reaction of these antibodies with non-lymphoid cells is in 
progress. 
Pro-thymocyte differentiation 
The precursor of the thymocytes, the prothymocyte, is a specialized 
cell, committed to the T-cell differentiation line and discrete from both 
the precursors of B-cells and the pluripotent stem cell (HSC) (Abrahamson 
et al, 1977; Jones-Villeneuve et al, 1980). However, based upon 
morphological and physical criteria such as buoyant density, sedimentation 
velocity and surface charge, prothymocytes cannot be distinguished from HSC 
and pre-B cells. For the rat it has been reported that the 25 kD Thy-1 
molecule (Greiner et al, 1982) and the 95 kD W3/13 molecule (Dyer and Hunt, 
1981) are present on prothymocytes. Both molecules, however, can also be 
detected on the HSC (Dyer and Hunt, 1981; Goldschneider et al 1978), pre-B 
cells and plasma cells (Ritter et al, 1978; Williams et al, 1977; Vaessen 
et al, 1985), some myeloid cell types and their precursors (Dyer and Hunt, 
1981; Ritter et al, 1978). The W3/13 molecule is also present on all 
mature T cells (Goldschneider et al, 1978). 
Although studies with these markers gave a great deal of 
information about the early phase of lymphoid differentiation, in rats more 
specific markers are still needed. The reactivity pattern of ER-4 in the 
bone marrow and the peripheral lymphoid organs suggested that this antibody 
could be such a marker. This reactivity pattern is summarized in Table 
Table 3. 7 Percentage of positive cells in several 
lymphoid tissues 
Antibody Bone marrow Spleen Lymph node 
juv.a adultb juv. adult juv. adult 
ER-4 35 20 28 1 18 1 
MRG OX-7 35 31 25 3 16 4 
MRG OX-19 3 23 36 44 53 
a. Juvenile: 4 weeks old rats 
b. Adult: 12-20 week old rats 
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3.7. Cells of bone marrow, spleen and lymph nodes of adult (12-20 weeks of 
age) and young (4 weeks of age) Lewis rats (LEW/Ola, Bicester, England) 
were stained and analyzed with a FAGS. MRC OX-7, as a marker for early 
cells defined by Thy-1 expression, and MRC OX-19, as a marker for mature T 
cells (Dallman et al, 1984) were used as reference antibodies. 
All three antibodies recognized virtually all thymocytes in 
juvenile (data not shown) and adult rats (Table 3.2). The reactivity of 
ER-4 and MRC OX-7 was highly similar in the peripheral lymphoid organs at 
both ages; hardly any cells were labelled in adult animals whereas about 
25% of the cells in young animals were recognized. While both antibodies 
recognized equal numbers of bone marrow cells (35%) in juvenile animals, 
ER-4 labelled a consistently lower percentage in the adult situation. 
Since in adult animals ER-4 did not react with mature T lymphocytes (Table 
2.3), we analysed in the juvenile animals the relation between MRC OX-19 
and ER-4 positive cells. 
Table ~. 8 Double analysis with 
monoclonal antibodies 
Percentage a 
Antibody Bone marrowb Spleenc 
ER-4 21 28 
MRC OX-7 ~1 2~ 
MRC OX-19 2 2~ 
ER-4 + MRC OX-7 ~9 nd 
ER-4 + MRC OX-19 22 ~2 
a. Percentage of all viable cells 
analyzed on a FACS II 
b. Bone marrow from adult rats 
c. Spleen cells from 4 111eek old rats 
nd. not done 
In spleen cells of young rats ER-4 and MRC OX-19 were expressed on 
different cell populations (Table 3.8), since the double staining 
percentage is a precise summation of the individual figures. Furthermore 
it is obvious from these data, that in bone marrow of adult rats there is a 
considerable overlap between the ER-4 and MRC OX-7 positive cells. Since 
staining with ER-4 and MRC OX-7 together did not give 52 percent positive 
cells (21% + 31%), but 39 percent, about 13 percent of these cells 
expressed the ER-4+MRC OX-7+ phenotype. 
The reactivity of MRC OX-7 and ER-4 in young animals urged us to 
study the fluctuation of the distribution pattern of these antibodies 
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during ontogeny. From day 14 of gestation up to twenty weeks after birth 
at several time points spleen and bone marrow suspensions were prepared and 
analyzed. Only a low percentage -(Fig. 3.6) of ER-4 or MRC OX-7 positive 
cells were present in both organs at the time of birth. A fast increase of 
the positive cells resulted in about 35 percent of ER-~+ and MRC OX-7+ 
cells in the spleen at three weeks after birth and in bone marrow (BM) one 
week later. From this time point onwards the cells, binding to these 
markers, gradually disappeared from the spleen. In the bone marrow the 
~positive cells 
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Figure ~.6 Reactivity of MCA ER-4 and MRC OX-7 in bone marrow 
and pleen during ontogeny. The percentage ER-4 (e) and 
MRC OX-7 (0) positive cells in bone marrow are shown. 
Furthermore the ER-4 <•) and MRC OX-7 (D) positive 
cells in the spleen are given. All values represent 
the percentage of all viable cells 
reactivity of MRC OX-7 remained at the same level, whereas ER-4 positive 
cells diminished between 6 to 16 weeks after birth and remained present at 
a level of about 15 percent for at least one year. BM cells of 7 weeks old 
rats were stained with FITC-conjugated ER-4 antibody and sorted on FACS II 
into an ER-4 positive and an ER-4 negative cell population. After sorting 
the ER-4 positive bone marrow fraction had a purity of 95~ and a viability 
of 80~. The ER-4 negative fraction had a similar purity and a viability of 
75 percent. From both populations cytocentrifuge preparations were made 
for nuclear terminal deoxynucleotidyl tranferase (TdT) and cig staining, as 
well as for May GrOnwald-Giemsa staining for morphological examination. 
The ER-4 positive cell population consisted predominantly of small to 
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medium sized cells, with a lymphoid morphology. In this population only a 
few eosinophylic cells were observed. In the ER-4 negative cell population 
all cells from the erythroid and myeloid series were present. TdT staining 
was carried out with a test kit from Bethesda Research Lab. Inc. under 
standard conditions. In the second step TRITC-conjugated goat anti-rabbit 
Ig was used. In the ER-4 positive fraction approximately 5-10% of the 
cells were TdT positive and also part of the cells were cig positive. 
Barton et al (1980) described a lactate dehydrogenase (LDH) 
isoenzyme profile which is specific for rat thymocytes. Therefore the ER-4 
sorted cell fractions were subsequently tested for the LDH pattern. The 
determination of the profiles was kindly done by Dr. J.Plum, State 
University, Gent, Belgium, according to the method described by Plum and De 
Smet (1980). In figure 3.7 the various profiles are shown. The most 
striking result was the absence of the LDH-5' band in the ER-4 positive 
cells, representing a comparable profile as described by Barton et al 
(1980) for the prothymocytes. Both thymocytes and these ER-4+ bone marrow 
Figure ;5. 7 LDH-isoenzyme profiles of bone marro\J cells from 12 week old RP rats. In 
lane 1: FAGS sorted ER-4 positive cells, lane 2: FAGS sorted ER-4 
negative cells, lane :>: unsorted stained cells and in lane 4: unsorted, 
unstained cells. From left to right hand the isoenzyme bands LDH-5, 
LDH-5', LDH-4, LDH-~ and LDH-2 can be seen 
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cells ·lacked this isoenzyme. The ER-4 negative fraction contained this 
isoenzyme, but lacked the LDH-2 and the LDH-3 bands, while only a weak LDH-
4,·· band · compared ··with the ER-4 + cells was found. This population was very 
heterogeneous in morphology and consisted of all cell types from the 
myeloid and erythroid series. 
In. conclusion, in bone marrow the ER-4 antigen is only expressed by 
cells fn an early stage of the T cell differentiation. Double labelling 
experiments with MRC OX-19 and ER-4 indicated furthermore that also in 
spleens of young animals the differentiation antigen recognized by ER-4 is 
not present on mature T-cells. Comparison of the cells recognized by ER-4 
with those labelled by MRC OX-7 in the bone marrow showed also striking 
differences. In adult rats ER-4 reacted with a consistently lower 
percentage of bone marrow cells. Where ER-4 recognized predominantly small 
to medium sized cells with a lymphoid morphology, MRC OX-7 was also 
expressed by blastoid cells and cells of the erythroid and myeloid 
lineages. Also the LOR-profile of the ER-4 positive cells and the presence 
of TdT positive cells within this population support the hypothesis that 
ER-4 positive bone marrow cells belong to the early phase of T cell 
differentiation. Another confirmation for this hypothesis came from the 
ontogenic study. In this experiment a low percentage of ER-4 positive 
cells could be demonstrated in both BM and spleen just before and after 
birth. Shortly after birth the number of ER-4 positive cells started to 
increase, reaching maximal levels between 3 and 4 weeks after birth. 
Thereafter the numbers of positive cells started to decrease in these 
organs. At 16 weeks of age hardly any ER-4 positive cells could be 
detected in the spleen, whereas the percentage of positive cells in the 
bone marrow was only half of that found at 4 weeks of age. These 
observations strongly resemble the data given by Gregoire et al (1979) for 
the presence of prothymocytes, TdT+ cells, in the bone marrow and spleen. 
The absolute percentage of ER-4 positive cells in bone marrow exceeds the 
figures of TdT+ cells. The data therefore indicates that the TdT positive 
cells are present within the ER-4+ population. This difference between 
percentages might be due to the fact that not all prothymocytes are TdT+ 
(Greiner et al, 1982; Gregoire et al, 1979). Possibly ER-4 antigen is 
expressed on all prothymocytes in contrast to TdT. The number of ER-4 
positive cells (20~) in the bone marrow is considerably higher than 
reported by Lepault et al (1983) in earlier studies about the number of 
prothymocytes. They estimated approximately 0.1~, but in this respect 
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Wagner (1983) suggested recently that the number of prothymocytes must be 
rather high, in order to enable a selective and restrictive procedure in T-
cell differentiation, which probably already takes place in the bone 
marrow, even before the cells go to the thymus. Therefore ER-4 in 
combination with other markers of the prothymocyte might be a valuable 
marker for the further definition of the prothymocyte and T cell 
differentiation. 
Cell surface antigens 
Molecular size 
Since all antibodies reacted with virtually all thymocytes, the 
molecular weights of the surface antigens recognized by the panel of MCA 
have been determined on thymocytes. These cells were radiolabelled and 
immunoprecipitated according to Agthoven et al (1981 ). 
Thymocytes were suspended in PBS at a concentration of 2-4x10 7 
cells/ml and iodinated with mCi sodium 125 Iodide (3.7 GBq/ml; 
Radiochemical Centre, Amersham, England) using the Iodogen method (Markwell 
and Fox, 1978). Iodinated cells, separated from unbound iodine by three 
washes in PBS with 2 mM potassium iodide were extracted in 
immunoprecipitation buffer (IPB) consisting of 0.14M NaCl in 20 mM 
Triethanolamine-HCl (pH8.6) supplemented with 0.2~ (w/v) deoxycholate 
(DOC), 0.5~(w/v) Nonidet P40 (NP40), 1mM phenylsulfonylfluoride (PMSF) and 
0.1 mg/ml trypsin inhibitor at a concentration of 2-4x1o 7 cells/ml. The 
extracts were cleared of nuclei and cell debris by spinning at 10.000 g for 
15 min at 4°C. 
The supernatant was precleared with a heat-inactivated formalin 
fixed Staphylococcus aureus preparation (Pansorbin Hoechst, BRD) and 
subsequently precleared twice with a complex of Pansorbin and normal rabbit 
serum and Pansorbin and normal mouse serum or twice with preformed complex 
of mouse Ig and rabbit anti-mouse Ig each for 1 hour at 4•c. Preclearing 
was performed to remove proteins that bind with mouse Ig or with Pansorbin. 
Precleared lysates (500 ul) were incubated overnight at 4-8°C with 50 ul of 
a preformed complex of the monoclonal antibody and the rabbit anti-mouse 
Ig. 
The resulting precipitate was resuspended in IPB and washed on a 
discontinuous gradient consisting of one layer of 10~ (w/v) sucrose, 0.5~ 
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Figure >.8 Immu~~~rec1p1tat1on of lysate 
of I -labelled thymocytes 
on SDS-PAGE. Lane a. 
Control ascitis of SP2/D cell 
line lane b. W>/1>, lane c. 
ER-1 lane d. 11RC OX-7, lane 
e. ER-4 
NP40 in triethanolamine/NaCl (TBS) buffer and one layer of 30~ (w/v) 
sucrose in TBS buffer. Immunoprecipitates were dissociated with 30 ul of 
sample buffer as described by Laemmli (1970). Sodium dodecylsulphate-
polyacrylamid gelelectrophoresis (SDS-PAGE) was carried out on a gradient 
(7-18~) or continuous 12~ acrylamide vertical slab gel according to a 
modification of the Laemmli technique. For autoradiography the gels were 
exposed to a X-ray film (Kodak XAR-5,USA). The following molecular weight 
markers (Bio-Rad, USA) were used in the PAGE for reference: lysozyme 
(14.4kD), soybean trypsin inhibitor (21 .5 kD), carbonic anhydrase (31 kD), 
ovalbumin (45 kD), bovine serum albumin (66.2 kD), phosphorylase B (92.5 
kD), ~-galactosidase (116kD) and myosin (200kD). 
For some of the antibodies the immunoprecipitations of 125r-
labelled thymocytes on SDS-PAGE are shown in figure 3.8 Both W3/13 and ER-1 
were directed against a surface antigen of 95 kD, whereas MRC OX-7 and ER-4 
recognized a 25 kD antigen. The results of the remaining antibodies are 
summarized in Table 3.9. ER-2 recognizes a 52 kD molecule, which is similar 
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to the molecular size that has been reported for W3/25 by Thomas and Greene 
(1983). ER-3 and ER-7, on the other hand, still have to be defined, since 
both antigens appeared to be highly sensitive for oxidation during the 
procedure of precipitation. These results suggest nevertheless that ER-3 
is directed against a different antigen as MRC OX-8 and ER-10, since the 
latter antigens are not sensitive to oxidation. Furthermore, MRC OX-8 and 
ER-10 also recognize different structures on the cell membrane, since MRC 
OX-8 has been reported to label a complex of glycoproteins of 34, 39 and 67 
kD (Thomas and Green, 1983), whereas ER-10 precipitated a band in the 
Table ~.9 Molecular weight of the surface antigens recognized by 
mouse anti-rat monoclonal antibodies. 
Antibody 
ER-1 
ER-2 
ER-~ 
ER-4 
ER-7 
ER-9 
ER-10 
ER-14 
M.W.a Reference M.W.a 
Antibodies 
95 kD W~/1; 95 kD 
52 kD W~/25 52 kD 
n.d. MRG OX-19 69 kD 
25 kD MRC ox-a ~4+}9+67 
n.d. MRG OX-7 25 kD 
>100 kD 
59-62 kD 
25 kD 
References 
Standring et al, 1978 
Thomas & Green, 198~ 
Dallman et al, 1984 
Thomas & Green, 198~ 
Mason & Williams,1980 
a. The molecular weight is expressed in kilodalton (kD). 
region of 59 - 62 kD. This means that, although these three MCA. (MRC OX-8 
- ER-3 - ER-10) all react with the suppressor/ cytotoxic subset ofT cells, 
they recognize these cells through different receptors. This is well in 
agreement with the findings of small numbers of MRC OX-8-ER-3+ and MRC OX-
8-ER-10+ cells in spleen and lymph nodes. Finally the ER-1 antigen is of 
the same size as the molecular weight reported for W3/13, i.e. a 
glycoprotein of 95 kD (see also Fig. 3.8). Two of the antibodies i.e. ER-4 
and ER-14 are directed against a cell surface determinant of 25kD. 
The apparent glycoprotein of this size (25 kD) on rat thymocytes 
is the Thy-1 antigen. It is found in a high density (10 6 mol/cell) on 
these cells (Williams et al, 1980). A first indication of an anti-Thy-1 
specificity of ER-4 and ER-14 is obtained from experiments in which the 
activity of these (and other) antibodies was measured on thymocytes of AKR 
mice using a fluorescence staining technique. These mice carry the same 
allele as rats (Douglas, 1973). As shown in Table 3.10, ER-4, ER-14 and 
MRC OX-7, but not ER-2, reacted with AKR thymocytes. This is quite 
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Table ~- 10 Binding of monoclonal antibodies to Thy-1 
of the rat thymocytes 
Antibody Binding Blocking 
AKR-thymus a Thy-1b Thy-1c 
HRC OX-7 + 
ER-4 
ER-14 + + + 
ER-2 
a. All antibodies were conjugated with FITC and analysis 
done on a F ACS II 
b. Binding of antibody to purified Thy-1 was measured in 
a micro-ELISA 
c. Blocking with purified Thy-1 of the antibody 
interaction with rat thymocytes 
suggestive for a Thy-1 reactivity of the positive MCA. To get formal proof 
the actual interaction of these antibodies to Thy-1 was tested. Purified 
rat Thy-1 was kindly provided by Dr. A.F.Williams, Oxford, England. The 
binding of the antibodies was measured in a micro-ELISA system, in which 
purified rat Thy-1 was coated to the bottom of microtiter wells. Bound 
antibody was determined with 8-galactosidase conjugated rabbit anti-mouse 
antibodies as described in the previous chapter. Purified Thy-1 has also 
been used in a blocking assay. Therefore antibodies were preincubated with 
Thy-1. Subsequently the remaining activity of these antibodies was 
measured in a fluorescence assay on rat thymocytes. As shown in Table 
3.10, both antibodies i.e. ER-4 and ER-14, showed the same reaction 
pattern as the monoclonal antibody MRC OX-7. The latter antibody 
recognizes the "classical Thy-1 ·· molecule (Mason and Williams, 1980). The 
ER-2 antibody (52 kd surface antigen), on the other hand was negative in 
all three tests. It must be concluded therefore that all 3 MCA (ER-4 - ER-
14 - MRC OX-7) react with the Thy-1 molecule on the surface of rat 
thymocytes. 
Nevertheless it is obvious, that ER-4 and ER-14 have major 
differences, such as a differential recognition pattern in the thymus. ER-
14 gave a classical distribution pattern known for Thy-1 (Fig.3.9A), with 
most cells equally stained and a slightly more intensive staining of the 
subcapsular cells. ER-4, however, showed a quite different pattern. 
Although all thymocytes (96~) were stained (Table 3.2), the intensity of 
the cortical cells exceeded that of the medullary cells by manyfold 
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Figure 3.9 Immune peroxydase histology of monoclonal antibodies ER-14 (A) and ER-4 (8) on sections 
of the thymus. Legends: M, medulla; C, cortex. 
(Fig.3.9B). In the FACS analysis these two populations could actually be 
seen as two separate populations (data not shown). Also in the bone marrow 
a different recognition pattern for these antibodies exists. ER-4, for 
instance, recognized only small cells, whereas ER-14 reacted also with 
large cells (Table 3.6). The most likely explanation for these findings is 
that ER-4 and ER-14 react with different epitopes on the Thy-1 molecule, 
which are expressed differently at various cell types. 
Polymorphism 
To exclude strain differences, a possible polymorphic distribution 
of the recognized antigens was studied. Since all antibodies recognize the 
majority of the thymocytes, these cells were used for these experiments. 
Cells of eight inbred rat strains, displaying the same number of different 
RT-1 haplotypes, were coated on microtiter plates and binding of all the 
antibodies was measured using a RIA. Although a certain degree of 
variation in binding properties could be observed between these strains all 
antibodies showed a high degree of binding with all haplotypes (illustrated 
for ER-1 and ER-2 in figure 3.10). Therefore it can be concluded that none 
of these antibodies detects a surface antigen displaying a polymorphic 
distribution. 
ER 1 
ER 2 
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Figure ;.10 Binding of MCA"(A) ER-1 and (B) ER-2 to thymocytes of a panel of inbred 
rat strains with various RT-1 haplotypes. Thymocytes \Jere coated on 
microtiter plates and binding ""'s determined using a RIA. Mean background 
on the various thymocytes ""'s 500 cpm. 
The role of surface molecules in T cell function 
Not only antigen-specific receptors are involved in T cell 
functions. Nakayama et al (1979) and Shinohara and Sachs (1979), however, 
demonstrated that anti-Lyt-2/3 antibodies inhibit the specific cytolytic T 
lymphocytes. This indicates that besides the antigen-specific receptors 
also non-specific differentiation antigens on T lymphocytes may play a role 
in the functional aspects of the T cells. Since these observations many 
surface molecules were reported to be involved in T cell functions 
(Ledbetter and Seaman, 1982; Swain, 1983; Reinherz et al, 1983 and Gunter 
et al , 1 984) . 
In order to get an impression of the functional relevance of the 
recognized cell surface receptors on T cells, we studied the effect of 
various MCA on a panel of in vitro T cell responses, such as mitogenic 
activation, mixed lymphocyte reactivity and cytotoxic T cell response. We 
focussed in these experiments on the pan-T cell antibodies ER-1, W3/13 and 
MRC OX-19, the helper-T cell antibodies ER-2 and W3/25, the 
suppressor/cytotoxic T cell antibodies ER-3 and MRC OX-8 and MCA ER-9. The 
latter was selected for its highly interesting distribution pattern. First 
of all a possible mitogenic effect of the antibodies for resting T cells 
was tested, since such an activity has been described for the OKT3 antibody 
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Figure ~.11 Influence of MCA ER-1 (A) and w:;;u (B) on the proliferative response 
of spleen cells cultured with Con A. The MCA were tested in 
concentrations of 0 (0), 0.1 (e), 1.0 (Ll.), 10 (D) and 100 ~g/ml (•). 
IJg/ml 
(Reinherz et al, 1980). The following culture system was used (Rozing and 
Vaessen, 1979): Spleen cells were isolated and the cells were suspended in 
Hepes-buffered (30mM) RPMI-1640 medium supplemented with 2 g/L sodium 
bicarbonate, 20mM L-glutamin, 100 U/ml penicillin, 0.1 mg/ml streptomycin 
and 2x1o-5 M 2-mercaptoethanol (MLR-medium) with 10% autologous heat-
inactivated rat serum (ARS). The wells contained 200 ul of medium with 
3x1o 5 spleen cells, supplemented with antibody (0 0.1 10 
100ug/ml). The cells were cultured in flat bottom microtiter plates 
(Costar, Cambridge, MA, USA) for 2, 3 and 4 days at 37'C in humidified air 
containing 5% co2 . During the last four hours 1 uCi of (methyl 
3H)-
thymidine (5 Ci/mmol; Radiochemical Centre, Amersham, England) was present 
in the cultures. The cells were harvested and the incorporation of 3H-
thymidine was determined by liquid scintillation counting. All tests were 
done in triplicate and the incorporation is shown as mean counts per minute 
(cpm). None of the antibodies tested had a mitogenic effect by itself 
(data not shown). However, several antibodies reacting with T cells of the 
rat are capable to suppress or enhance the proliferative response of 
mitogen activated T cells (Webb et al, 1979; Dallmann et al, 1982). 
Therefore spleen cells were cocultured with the mitogen concanavalin A (Con 
A) in the concentrations of 1.2 - 2.5 - 5.0 ug/ml. 
an 
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From the panel of tested antibodies the MCA W3/13 and ER-1 induced 
increased 3H-thymidine incorporation in a dose dependent way from 
approximately 50.000 cpm for the control experiment, without antibody, to 
approximately 160.000 cpm after addition of 100 #g/ml of antibody (Fig. 
3.11A and B). Also MRC OX-19 (data not presented) did show ,a comparable 
effect on the mitogenic response, which is in agreement with data reported 
by Dallman et al (1984) for this antibody. These three antibodies appeared 
to act in a synergistic way with mitogen, since unstimulated cells were not 
affected. No proliferation was observed when only MCA was added to the 
culture. Only after the inductive signal of the mitogen they were able to 
increase the degree of proliferation. The other antibodies (ER-2, ER-3, 
ER-9, W3/25 and MRC OX-8) did neither increase nor suppress the 
proliferative response induced by Con A, as illustrated for MRC OX-8 and 
ER-9 in figure 3.12. The experiments were repeated several times using 
various rat strains (DA/Olac, AGUS/Olac, WAG/Rij, AO/Olac and PVG/Olac) 
with similar results. 
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Figure 3.12 The effect of MCA ER-9 (0) and MRC OX-8 <el on the mitogen 
response of Con A (5pg/ml) stimulated spleen cells. 
Subsequently the effect on the specific T cell response induced by 
allogeneic surface antigens i.e. the mixed lymphocyte reaction (MLR) was 
determined. MLR experiments were performed under the same conditions as 
described for the mitogen response: responder cells of DA/Olac rats (3 x 
105 cell/well) were cultured with the same number of irradiated (3000 rad) 
g 
e 
~ 
B-
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stimulator spleen cells of RP/Rij rats. The cells were cultured during 5, 
6 and 7 days and 3H-thymidine was added 8 hours before the termination of 
the cultures. 
The various antibodies showed a clear difference in their effect on 
the proliferative response of the mixed lymphocyte reaction. MCA ER-3 had 
no influence on the MLR (data not shown). ER-2 and W3/25, however, did 
almost completely suppress the MLR. For both antibodies the inhibition of 
the MLR displayed a similar dose dependent fashion (Fig.3.13A). MRC OX-19, 
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Figure 3.13 The influence of MCA on the proliferation induced by the MLR. In A the effect 
of ER-2 (0) and W3/25 <•> and in B the effect MRC OX-19 <•>. ER-1 (0) and 
W3/13 (.6) are sho\rln. Spleen cells of the DA rats 111ere used as responders and 
irradiated RP spleen cells were added as stimulators cells. 
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W3/13 and ER-1, on the other hand, all seemed to increase the proliferation 
(Fig.3.13B) in the MLR, which is comparable to data reported by Dallman et 
al (1984) for MRC OX-19 and by Webb et al (1979) for W3/13. ER-9 
suppressed the proliferative allogeneic response in a dose dependent way as 
is illustrated in figure 3-14. MRC OX-8, on the other hand, failed to show 
any influence on the MLR, even in the highest doses, which is in agreement 
with results reported by Green (1984). Repeating the experiments with 
other combinations of rat strains, such as DA/Olac and AO/Olac or AO/Olac 
and Agus/Olac provided similar results. ER-9, in the range of 10 
100~g/ml, did almost reduce the proliferation to the background level. The 
surface antigen defined by ER-9 seems therefore to be involved in the 
specific alloreaction, since no effect of this MCA was seen on the 
mitogenic response induced by Con A. 
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Figure ;.14 The influence of MC~ ER-9 (e) and MRC OX-8 (0) on the MLR. Responder cells of D~/Olac rats were cultured 
during 6 days together with irradiated stimulator spleencells of RP/Olac rats. ~11 tests were done in 
triplicate and the incorporation at various antibody concentrations are expressed as mean cpm. 
In the last series of experiments the antibodies were studied for 
their effect on the cytotoxic T cell activity. Because cytotoxic effector 
cells are generated in the MLR, the antibodies can be tested on the 
generation of the cytotoxic T cell response by adding antibody in the MLR. 
By supplementing antibody in the cell mediated lympholysis assay the effect 
can be tested on the effector CTL . MLR cultures were set up between DA 
and RP spleen cells. Various concentrations of MCA were added at the 
initiation of the cultures to analyse their effect on the generation of 
cytotoxic T cells. Responders cells (2x107 spleen cells) were cultured 
with an equal number of stimulator cells (irradiated spleen cells) in 10 ml 
of MLR-medium supplemented with 10%- autologous rat serum (ARS). These 
cells were grown for 6 days in 75 ml TC-flasks (Costar, England) at 37'C in 
humidified air containing 5% co2 . The cells were collected and the viable 
cells (80-90%) were isolated using a Ficoll-Hypaque gradient (6 1 .077). 
These cells were washed and used as effector cells in the cell mediated 
lympholysis (CML) assay. 
As target cells mitogen activated spleen cells of the stimulator 
strain were used. In 275 ml TC-flasks (Costar, England) 5x10 7 spleen cells 
were cultured in 10 ml MLR-medium (5% FCS), containing 5~g of Con A, during 
72 hours. Thereafter the viable cells were isolated by using Ficoll-
Hypaque gradient and used for labelling. Ten million oells were labelled 
with 300 uCi 
England) in 
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51 Na2 Cro4 (7 -12Ci/mmol; Radiochemical Centre, Amersham, 
1 ml MLR-medium (pH 6.0-6.5; 5~ FCS). After removing of the 
free radiolabel by extensively washing the cells were used as target cells 
in the CML assay. 
The CML-assay was performed in round bottom tubes (2 ml). Target 
cells (104 cells) were combined with 10 6 , 3x1o5 and 105 of the effector 
cells, respectively, in a total volume of 200 ul of MLR-medium (5~ FCS). 
Prior to the incubation, the cells were centrifuged for 5 min at 50g, 
followed by an incubation of 3 hours at 37'C in humidified air containing 
5~ C02 . The reaction was stopped by adding 1 ml of cold (4'C) medium and 
immediately centrifuged for 5 min at 800g (4'C) in order to separate the 
cellular 51 cr from the free radiolabel. The supernatant was collected by 
decantation into counting tubes, whereafter the radioactivity was measured 
using aT-counter. The release of 51 cr in absence of effector cells 
cultured under identical conditions normally ranged between 200 - 800 cpm 
(spontaneous release). For the maximum release the labelled target cells 
were lysed with 0.5~ (w/v) NP40 buffer, which resulted in the release of 
about 90~ of the 51 chromium. For the expression of the cytotoxic activity 
the following formula was used: 
Specific release= exp.release - spont. release x 100 
max.release - spont. release 
To test the effect of the various MCA in the effector phase of the 
cytotoxic T cell response, the antibodies were added at the beginning of 
the incubation period of the CML in concentrations ranging from 0.1 to 300 
ug/ml. None of the antibodies however, had any influence on the effector 
phase of the cytotoxic T cell reaction (data not shown). With regard to 
the effect of some of the antibodies in the induction phase, however, 
striking differences could be observed. No influences were noticed when 
ER-1, ER-3, W3/13 or MRC OX-19 were added to the cultures. As could be 
expected from their effect on the proliferative response in the MLR, the 
addition of ER-2 and W3/25 to the cultures inhibited the generation of 
cytotoxic T cells completely, probably through blocking of the inducer T 
cell, which is necessary for the differentiation of precursor cytotoxic T 
cells into mature cytotoxic T cells (data not shown). In contrast to their 
different reactivity pattern in the MLR, however, both ER-9 and MRC OX-8 
inhibited the generation of the cytotoxic T cells in a dose dependent way. 
As is illustrated in figure 3.15 a dose of 10 J.<g of ER-9 reduced the 
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Figure J. 15 Effect of MCA ER-J (A), MRC ox-a (B) and 
ER-9 (C) on the generation of the cytotoxic T 
cells. Antibodies were added to IILR cultures 
of DA/Olac and irradiated RP /Rij spleen 
cells51 The cytotoxic activity was determined 
vi th Cr-labelled Con A blast cells of the 
RP rats. The effect of ER-J (e) is shown for 
a concentration of 10)Jg/ml at various ratio's 
of the target and effector cells (T/E) 
together vi th a control experiment ( 0). The 
suppressive effect of ER-9 (B) and MRC OX-8 
(C) is illustrated at a TIE ratio of 1 :JO. 
cytotoxic activity more then 90~ (Fig. 3.15B), while for MRC OX-8 a 
comparable suppression is seen at the same antibody concentration (Fig. 
3.15C). The same type of inhibition was reproducible using other rat 
strain combinations. 
When, as mentioned above, both antibodies were added in 
the effector stage of the cytotoxic T cell response (at the start of the 
CML-culture) the lysis of the targets remained unaffected (data not shown). 
Therefore it can be concluded that both MRC OX-8 and ER-9 are involved in 
the activation or differentiation of the CTL-p and not in the effector 
function. The effect of MRC OX-8 is most likely directly on the precursor 
cell, since the surface antigen of this antibody has been determined on 
both the precursor and the effector cytotoxic T cells (Dallman et al, 
1982). It is possible that ER-9 also acts directly on the precursor cell, 
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but this antibody reacts also with part of the helper T cells as defined by 
the MCA ER-2. Helper T cells are the source of IL-2 (Cantrell, 1982) and 
probably also of differentiation factors required for CTL. (Wagner et al, 
1982). Therefore the inhibitory effect of ER-9 may be caused by 
interaction of this antibody with the CTL-p or with the T helper cells or 
both. For this reason we studied a possible correlation between the 
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Figure 3.16 The correlation of the effect of MGA ER-9 and MRG OX-8 on the 
generation of the cytotoxic T cell activity. CTL were derived 
from DA rats and the stimUlator and target cells of RP rats \il'ere used. 
blocking effect of ER-9 and the effect of MRC OX-8 by adding various 
combinations of both antibodies at the same time. The results are shown in 
figure 3.16 and in row A the suppression of ER-9 is shown at various T/E 
ratios, whereas in the left column (1) the MRC OX-8 influence is 
demonstrated. These experiments were done with MLR generated spleen cells 
of DA rats tested for activity on target cells of RP rats. A maximum 
release of 10.972±373 cpm and a spontaneous release of 1 .565±20 cpm was 
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found. Both~ ·MCA were capable to increase the degree of inhibition exerted 
by the other ~antibody as can be seen in the columns 2 and 3 for an 
additional. effect of MRC OX-8 on the ER-9 influence and for the other 
combination in rows B and C. The degree of suppression between these two 
antibodies seems to be different: a complete blocking of the cytotoxic 
activity was only detected at a concentration of 10#g of MRC OX-8 in the 
1:3 T/E ratio (D1 ). ER-9, on the other hand, showed a comparable blocking 
in all the tested T/E ratio's (column 4). The suppression of 1#g MRC OX-8 
tested in the ratios of 1:100 and 1:30 (C1) was hardly increased after a 
tenfold increase of this antibody (D1 ). MLR cultures containing 1 and 10#g 
of MRC OX-8 in which no further blocking could be induced by this antibody, 
however, addition of ER-9 was able to further reduce the cytotoxicity (Fig. 
3.16, rows C and D). Also MRC OX-8 was able to an additional inhibition of 
the reduction induced by ER-9 at 0.1 and 1 .O#g/ml (Fig. 3.16, columns 1 and 
2). Although these results indicate that ER-9 acts through another 
mechanism than MRC OX-8, it remains unclear which type of cell is the prime 
target _for ER-9 to block the differentiation of the CTL-p cells. Both MCA 
may react with the same cells. On the other hand, ER-9 may also 
exclusively act through the helper T cells. 
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Figure ~.17 Lymph node cells were sorted into ER-9 positive (0) and ER-9 negative 
( \7) cell fraction. These cell populations were tested for enrichment of 
precursor CTL specific for the class I antigens. Control experiments 
consisted of unseparated cells with (e) or without ( 0) ER-9 labeling. 
In order to verify whether the precursors of the cytotoxic T cells 
express ER-9, the ER-9+ cells were isolated and subsequently tested for 
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cytotoxic activity. Spleen cells were stained with FITC-conjugated ER-9 
and the bright ER-9 positive cells were separated from the negative ones by 
sorting using flow-cytometry. MLR cultures were set up with these isolated 
fractions as responder cells. The isolated cells were supplemented with 
10% of T cell growth factor containing supernatant to exclude shortage of 
IL-2. This T cell growth factor containing medium consisted of supernatant 
of spleen cell cultures stimulated with Con A (5ug/ml) for 24 hours. In 
figure 3.17 the results of a representative experiment are shown. An 
increased ability of the ER-9 positive cells to lyse target cells was found 
and a reduced capacity of the negative cell fraction. A possible 
interference of antibody bound to the cell surface with the generation of 
effector cells could be excluded, because lysis of targets by all cells 
labelled with ER-9 did not significantly differ from unlabelled, 
unseparated cells. These results suggest that the precursor of the 
cytotoxic T cell resides within the ER-9 positive cell population. On the 
other hand, preliminary data of FACS sorted cells, which were stimulated 
with Con A and tested for IL-2 production as described by Gillis et al 
(1978), indicate that the production of IL-2 is restricted to the ER-9 
positive cells. This means that both the helper T cell and the precursor T 
Table >.11. Influence of antibodies on in vitro T cell function 
MCA Surface proliferation a cytotoxic T cell b 
antigen 
(kD) Mitogenic MLR MLR CML 
ER-1 95 +c nt 
W~/1:5 95 + nt 
ER-2 52 
W~/25 52 
MRC OX-19 69 + nt 
MRC ox-a ~4+~9+67 
ER-9 >1 00 
a. The influence of MCA on the proliferative response by 
mitogenic stimulation or MLR. 
b. The influence of MCA on the en activity when added in 
the MLR cultures or in the CML cultures. 
c. Data of the experiments described in this chapter. 
+ : increased; 0 : no effect; - : suppressed; 
nt : not tested. 
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cell do express the ER-9 surface antigen. The suppressive effect of ER-9 
on the MLR (Fig. 3.14) seems to be caused by interference of ER-9 vith the 
inducer cell, because binding of ER-9 to these cells prevents proliferation 
and the production of IL-2 and other factors. A mode of action through the 
precursor T cell, hovever, cannot be excluded. 
These data emphasize that ER-9 in combination vith antibodies such 
as ER-2 and MRC OX-8 enables a further dissection of the T cell compartment 
into functional T cell subpopulations. 
The results of the experiments studying the influences of the various 
MCA on the functional in vitro assay shov that also in the rat, besides the 
T-cell receptor, other surface molecules are involved in the T cell 
functions. In Table 3.11 the data in the rat system are summarized. At 
least five different molecules seem to be involved in T cell functions. 
Moreover ve can distinguish also four or five different reaction patterns, 
vhich are probably all effective in an early stage of T cell activation. 
PHYSICAL PROPERTIES OF THE ANTIBODIES 
Besides the cellular reactivity pattern also some physical 
properties of the selected panel of MCA have been determined, such as 
isotype, binding affinity, and complement-binding properties. This 
information is essential for the further use of these antibodies in other 
test-systems. 
Table ~- 12 lsotype and complement binding of 
the MCA 
Antibody Isotypea Complementb 
binding 
ER-1 IgG2a ++ 
ER-2 lgG1 
ER-~ lgG2a 
ER-4 IgG2a ++ 
ER-7 IgG2b 
ER-9 IgG2b ++ 
ER-10 IgG2a 
ER-14 IgG1 
a. The isotype has been determined with a 
radial immunodiffusion assay. 
b. Lysis of thymocytes using rabbit 
complement. Score: - (0-20~), + (20-
60~) and ++ (60-1 00~) 
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Isotype 
The isotype of these antibodies has been determined using a single 
radial immunodiffusion technique (Mancini et al, 1965). Gels consisting of 
a mixture of agarose (3~) and antibody, diluted in tris-barbital buffer (pH 
8.6) were prepared. Wells, punched in the gel were filled with rabbit 
anti-mouse isotype antisera (Bionetics, England) in the appropriate 
dilution and a positive reaction resulted in a precipitation ring around 
the well. The isotypes, summarized in Table 3.12, all appeared tc be of 
the IgG class. This is probably caused by the repeated immunisation 
procedure favouring a secondary response type with an increased presence cf 
IgG producing plasma blasts at the time of fusion. 
Complement binding 
Thymocytes were isolated and brought upon a concentration of 5x107 
cells/ml in RPMI-1640 supplemented with 5% FCS. From this suspension 50 ul 
were pre incubated for 30 min at o•c with antibody in various 
concentrations. Cells were washed and subsequently incubated for 30 min at 
37°C with 100 ul rabbit complement (1/7 dilut.ion v/v). Rabbit complement 
was tested for lytic activity and extensively absorbed with rat 
lymphocytes. Cells were washed and the viability was determined by 
staining the cells with 0.4% (w/v) trypan blue in 0.15 mM NaCl solution. 
The percentage of cell lysis was assessed by microscopic examination. Cell 
lysis (Table 3.12) varied from 80 - 90% for ER-9, ER-4 and ER-1, whereas 
several of the antibodies such as ER-3, ER-7 and ER-10 lysed approximately 
50~ of the cells. ER-2 and ER-14 did not show any binding cf complement, 
which is in agreement with earlier findings for the IgG1 isotype from 
studies with alloantisera (Lems et al, 1983). 
Affinity 
For some of the in vivo experiments it was necessary to determine 
the degree of affinity of several monoclonal antibodies. These experiments 
will be described in the chapter 5. The affinity has been determined by 
binding experiments using radiolabelled antibodies. The interaction of 
antibodies and antigens has been described a.o. by Fazekas de St Groth 
(1979). In the situation of equilibrium the affinity of antibody binding 
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sites (paratopes; P) for an antigen binding site (epitope;E) can be 
measured by the ratio of complexed (x) and free reactants. The equilibrium 
constant, K, in this situation is defined by the equation: 
[free epitopes] [free paratopes] [E-x][P-xl 
K • or----
[complexes] [x] 
The equation for large multivalent antigens, such as cells or bacteria, 
with a cell concentration [C], in which each cell carries n epitopes (n) 
is: 
[nC-x] [P-x] 
K • ( Fuekas de St Groth, 1979) 
[xJ 
The valency of the antibody can usually be ignored in this situation 
according to the author. In the example of a cell with n epitopes on it, 
an input concentration of [nC] epitopes which reacts with [P] paratopes, 
the separated fraction in this system will be the free antibody. When the 
fraction of complex bound antibody is ~. ranging between 0 and 1, the 
complex is defined as x : ~- Rearrangement gives the following equation: 
1-a 
K • (nC- aP)- (Fazekas de St Groth, 1979) 
Under defined conditions the equilibrium constant (K) can be determined by 
the ratio between bound antibody and the total antibody concentration. 
This ratio was defined with 125-r labelled antibodies in binding studies on 
rat thymocytes. The majority of these cells ( >90%) are recognized by all 
the tested MCA . The antibodies were purified and the concentration was 
determined using the extinction at 280 nm. Purification was done with 
gelfiltration (Sephacryl S300) and DEAE chromatography and subsequently the 
MCA was conjugated with 125-rodine as described before. The unbound 
radiolabel was subsequently removed by gelfiltration. Binding studies with 
various cell concentrations and dilutions of the antibody were done to 
determine the biological activity of the antibody and the specific cell 
concentration and antibody dilution for the binding studies. The 
biological activity expressed as the percentage of total radiolabel that is 
able to bind to cells was >80 percent for all MCA tested. 
The binding experiments were done under the following conditions: 
From a cell suspension with a concentration of 3-4 x 107 cells/ml, 100 #l 
was incubated with 150 #l of radiolabelled antibody for 3-5 hours at O'C 
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(under rotation) in order to acquire a state of equilibrium. The reaction 
was halted by adding culture medium (2 ml RPMI1640; O'C), immediately 
followed by centrifugation (5 min at 200g and O'C) and separation of the 
cell pellet and the supernatant. The radioactivity in both fractions was 
measured using aT-counter. These types of experiments require a highly 
purified source of antibody. The paratope concentration can be calculated 
from the radiolabel cpm/g purified antibody and this results for each MCA 
in the number of cpm/Mol of MCA (in this calculation for the molecular 
Table ~.13 Affinity of mouse anti-rat monoclonal antibodies 
Antibody Ra.diolabela Bound/ Epi tope cone. Para. tope Mean value 
(cpm x 103) total (nC) cone. (P) of affinity 
(Mol/l)b (Mol/1) 0 (K) 
Total e bound (Mol/1) d 
ER-1 293,0 98,0 0.322 8.50 X 10-10 1.09 X 10-9 1.04 X 10-10 
75,5 32,6 0.419 2.80 X 10-10 
21,2 9.4 o.4n 7.85 X 10-11 
5,8 2,8 0.466 2.14 X 10-11 
W~/13 437,0 38,1 0.0744 8.50 X 10-10 -9 6.97 X 10-9 1.94 X 10 
115,0 11,7 0.0890 5.11 X 10-10 
31,4 3,4 0.0965 1.39 X 10-10 
9.4 1,2 0.117 4.18 X 10-\1 
ER-2 292,0 38,4 0.119 3.99 X 10-10 7.95 X 10-10 -9 2.30 X 10 
76,9 11,0 0.131 2.09 X 10-10 
22,4 3,4 0.1~8 6.10 X 10-11 
6,5 1,1 0.160 1.76 X 10-11 
W3/25 317,0 39,5 0.112 3.99 X 10-10 8.32 X 10-10 -9 2.08 X 10 
80,1 11,1 0.126 2.10 X 10-10 
23,0 3.~ 0.131 6.03 X 10-11 
7,8 1,3 0.148 2.04 X 10-11 
a. Thymocytes (4 x 106 in 250 ~1) \Jere incubated IJith 125!-antibody. The total 
and the bound fractions 1.a1ere determined. 
b. Epitope concentration: number of determinants per cell x 4.106 x 4000 
: 2.602 X 1023 (Mol/1) 
A cpm of MCA x 4000 
c. Paratope concentration (Mol/1): ----------
cpm/g of MCA x 150,000 
A: the total of MCA (cpm) sho~o~n in column e. 
d. Mean value of equilibrium constant using the equation K = (nC-aP)(1-a/a) 
Fazekas de St Groth, 1979. 
weight of the IgG a figure of 150,000 is used). The amount of 
radiolabelled MCA in the assay system (B cpm) expressed as Mol/1: A x 4000/ 
A (factor 4000 to calculate the activity from the 250 #l to liters). The 
cell concentration combined with the number of epitopes per cell gives the 
total concentration of epitopes. The latter information was not available 
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until recent sequential immunoprecipitation experiments, which will be 
described in the next chapter. The latter experiments showed that ER-1 is 
directed against the same surface molecule as the monoclonal antibody W3/13 
and the same result could be established for ER-2 and W3/25. For these two 
antibodies 
determined 
1 .5 x 1 o4 
the density of surface molecules on thymocytes has been 
(Williams and Mason, 1980). For W3/13 3.2 x 104 and for W3/25 
determinants/thymocyte were reported. The number of 
epitopesjcell x total number of cells tested x 4000 gives the number of 
epitopes per liter. This figure has to be divided by Avogadro's constant 
to obtain the epitope concentration in Mol/1. Several binding experiments 
were done to determine the affinity. The results summarized in Table 3.13 
showed that both ER-1 and ER-2 have a comparable degree of affinity as 
W3/13 and W3/25. The antibody ER-1 has even an equilibrium constant as 
high as 10- 10 Mol/1, whereas the other antibodies range between 2.0 and 7.0 
X 10-9 Mol/1. 
Using the panel of herewith characterized MCA the second part of the 
experimental work was started: the analysis of the T cell system in 
relation to the allograft rejection. To do so two major types of 
approaches were used, in which these MCA played an essential role. Firstly 
they were used to monitor phenotypical changes in the T cell compartment 
after allogeneic kidney transplantation both in the central immune system 
and in the graft. Secondly, -they were used to specifically interfere with 
the onset of the rejection process by using them as immunosuppressive 
agents which specifically eliminate or block certain T cells in this 
process. 
The experiments describing these two experimental set-ups will be 
the main topic of the following two chapters. 
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Chapter 4 
RENAL ALLOGRAFTING IN THE RAT 
INTRODUCTION 
Transplantation research in the rat has a number of advantages as 
compared to other species. Technically it is possible, for instance, to 
perform vascularized organ grafts in rats, in contrast to mice. Also 
inbred rat strains, including congenic strains for immunogenetic research 
are readily available. In this way it is possible to study independently 
the parameters involved in the alloreaction, such as total or partial MHC 
disparities or non-MHC differences. Furtheron large numbers of animals, 
transplanted in a highly comparative donor recipient combination, enable a 
more detailed analysis of the immune status, at various times after 
transplantation. This can be done in the graft as well as in the peripheral 
lymphoid organs. Comparison of such data will provide further insight in 
the complex process of the alloreactivity after organ transplantation. 
With the availibility of an extensive panel of MCA against a variety of 
(functional) T cell markers, it became now possible to analyse the 
rejection process after allografting in detail. 
Therefore a series of transplantation experiments was performed in 
allogeneic and isogeneic donor recipient combinations. At various days 
after transplantation, animals were sacrificed for a detailed analysis of 
the several lymphoid organs and of the renal graft itself. Besides 
characterization of the phenotype .expressed by the cells involved in the 
rejection process also functional studies of the lymphoid cell population 
will be described. 
In all transplantation experiments inbred male rats were used at an 
age of 10 - 20 weeks. PVG/Olac rats served as recipient and also as donor 
in the isogeneic test group, while the same rat strain received a kidney 
from the PVG.RT-1a(DA)/Olac strain in the allogeneic combination. The PVG 
strain has a RT-1° haplotype, whereas the RT-1 system of the PVG.RT-1a(DA) 
strain has been derived from the DA strain, both strains are identical fer 
the non-MHC background. The kidney transplantation technique was 
originally described by Fischer and Lee (1965) and later slightly modified 
by Tinbergen (1971 ). The donor rat, anesthetized with ether, was 
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heparinized (Thromboliquine, Organon, Oss, The Netherlands; 500 units i.v.) 
in order to avoid clotting. The kidney was.removed and cuffs from donor 
aorta and vena cava are left on the kidney vessels. to facilitate the 
anastomosis. The graft was transplanted in the abdominal cavity of the 
recipient, which was anesthetized in the same way .as the donor. 
Transplantation consisted of end-to-side anastomosis of the renal artery 
and vein with the aorta and the vena cava of the recipient, respectively. 
The ureter-bladc;ier anastomosis was made by ,inser:tic;m of the ureter into the 
bladder, where it was fixed onto the mucosa. The ischemia times. normally 
ranged from 25 to 35 minutes. Within two days after the operation 
bilateral nephrectomy of the recipient kidneys was performed. The renal 
function of the graft was monitored by determination . of the plasma urea 
level (Pur) each day. The Pur·_was measured in 10l'l ofplasmawith 
automated kinetic methods on_a computer-directed analyzer (Provoost and 
Molenaar, 1980). 
Pur (ITV'Tloi/L) ~ suivivol 
150 
100 
,0 
100 
50 
20 
Days after tron:.plontotion Survrvc:~l (doy.:~) 
Figure 4.1 Survival of kidneys and function in PVG rats after kidney transplantation A. 
The renal function was illustrated by plasma urea levels in allografted (e) 
and an isografted <+l recipient. B. Survival of allogeneic (-) and 
syngeneic (--) transplanted recipients kidneys. Recipients (PVG/Olac) were 
transplanted with PVG/Olac (syngeneic) or PVG.RT1a(DA) (allogeneic) 
kidneys. 
First of all the graft survival of the isogeneic and the allogeneic 
transplanted groups were determined, in which the survival of the 
recipients has been taken as the endpoint of the graft survival. All 
isogeneic grafted animals survived for more than 60 days, with an excellent 
graft· function as is illustrated in figure 4.1A. The animals that received 
an allograft, however, all died between- 7 and 20 days af:ter the 
B 
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transplantation with a mean survival time (MST) of 11.:5 ± :5.9 days. 
Already four days after the operation increased plasma ureum levels (20 -
50 mmol/L) demonstrated retarded renal function. This was followed by a 
further increase until a complete renal disfunction and as a consequence of 
this, the death of the animals resulted (figure 4.1A). 
In the next series of experiments the recipients were sacrificed on 
various days after transplantation in order to evaluate in detail the 
process of the alloreaction. Kidney, spleen, mesenteric lymph nodes (MLN) 
and bloOd (heparinized) were isolated for further analysis. Part of kidney 
was snap frozen and stored at -70°C for immune histology. Another part of 
the kidney was fixed in cold phosphate buffered 4~ formaldehyde solution 
(pH 7.4), subsequently dehydrated in ethanol and embedded in paraplast. 
Sections of 5 ~ were stained with hematoxylin-eosin for immunopathology. 
Blood samples were drawn and the peripheral blood lymphocytes were 
isolated: the samples were centrifugated for 5 min. at 200 g and the 
leukocytes on top of the packed cells were isolated. This fraction, 
diluted in RPMI-1640 medium (v/v) was brought upon 2 ml of a 
Ficoll/Isopaque solution (6: 1.077 g/ml). After centrifugation (20 min at 
7:50g) the lymphocytes were isolated from the surface of the Ficoll/Isopaque 
layer and washed. 
In the following sections the results of histological examination 
of the transplanted kidneys and the composition of the T cell population 
determined in cell suspensions of spleen, mesenteric lymph nodes and blood 
using flow cytometry will be described. Furthermore the graft infiltrating 
cells will be monitored using specific immune histology. In the last 
section of this chapter, data of experiments in which cells from the 
spleen, blood and the graft were tested for donor specific response will be 
presented. 
PATHOLOGY 
Animals were sacrificed at 4, 6 and 8 days after isogeneic and 
allogeneic kidney transplantation for immunopathological examination of the 
grafts. In the isogeneic combinations no signs of rejection could be 
detected. Only one animal (day 4) showed several small foci of 
infiltrating polynuclear cells, probably caused by a bacterial infection. 
This animal also differed in its reactivity as determined in fluorescence 
analysis. Therefore this animal has been removed from the study. In the 
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other isogeneic combinations at first (day 4) some signs of acute tubulis 
necrosis (ATN) could be detected (figure 4.2A), probably caused by surgery 
damage. Two days later (day 6) no signs of ATN were detected anymore in 
any of the grafts (n=5). Both at six as well as at eight days after 
transplantion (n=5) all kidneys showed a normal structure with no signs of 
rejection. 
In the allogeneic combination a clear and acute cellular rejection 
was found as described by Porter et al (1967). At four days (n=6) 
infiltrating cells, widely scattered and mainly mononuclear in nature were 
found at perivascular, periglomerular and peritubular sites. Increased 
Figure 4.2 Pathology of the grafts after allogeneic kidney transplantation. A. ATN at three 
days after isogeneic kidney transplantation B. Allograft at 7 days after 
transplantation. Foci of RBG"s and partial tissue damage can be seen 
numbers were detected in grafts (n=7) at six days after transplantation, 
whereas at eight days (n=6) the numbers of infiltrating cells had 
significantly declined. Ischaemic damage was most likely the reason of ATN 
detected at four days. However, at six days necrosis is more severe and 
widespread, at this stage it is due to the rejection mechanism. Two days 
later ATN (day 8) is found throughout all grafts. One graft was completely 
rejected. Normal structures could not be recognized any more. 
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Interstitial oedema and foci of RBC"s were detected in increasing intensity 
in some grafts at four days and in all kidneys at six and eight days 
(figure 4.2B). Arthritis with thrombus formation could be detected in 2 
grafts at day 6 and in most of the organs at eight days. 
The phenotype of the infiltrating cells as characterized by 
specific immuno-histochemistry on cryostat sections of the kidney will be 
described. 
FLUORESCENCE ANALYSIS OF THE T-CELL POPULATION 
In order to get insight into the complex rejection mechanism after 
organ transplantation and especially in the involvement of the immune 
system of the recipient, flow cytometric analysis was performed in spleen, 
mesenteric lymph nodes and peripheral blood at various times after 
transplantation using a panel of monoclonal antibodies. Single cell 
suspensions of spleen and mesenteric lymph nodes were prepared and labelled 
with FITC-conjugated MCA as described before. At the same time blood 
samples were drawn (Heparinized) and the peripheral blood lymphocytes (PBL) 
were isolated. Analysis of the labelled cell suspensions was done on FACS 
Table 4.1 Panel of mouse anti-rat antibodies used for 
moni taring after renal transplantation 
MCA Reactivity 
Lymphoid Non-lymphoid 
ER-1 T cells, Thymocytes Non-lymphoid 
Early cells in BM Bone marrow 
B cells cells 
MRC OX-19 T cells, Thymocytes 
ER-2 Helper T cells Macrophages 
MRC OX-8 Suppr ./Cytotoxic T-cells NK cells 
ER-9 T-cell subset 
Thymocytes, Early cells in BM 
ER-4 Thymocytes, Early cells in BM 
ER-13a B-cells, Activated T cells Dendritic cells 
F17-2:;-2b B~cells, Activated T cells Dendritic cells 
MARK-1 B-cells, Plasma cells 
ED-1 Macrophages 
References 
Vaessen et al, 1985 
This thesis 
Dallman et al , 1984 
This thesis 
Barclay, 1981 
Brideau et al, 1980 
Gantrell et al, 1982 
This thesis 
This thesis 
Stet et al, 1984 
Hart & Fabre, 1981 
Bazin et al, 1984 
Dijkstra et al, 1985 
a. Ia (common) 
b. Ia (polymorphic: RT-1u and c negative and RT-1n and a positive. 
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II (Becton and Dickinson, USA) as described in the second chapter. A panel 
of MCA, summarized in Table 4.1, was used for the monitoring of the immune 
status. The composition of this panel has been defined by the reactivity 
of these antibodies against various cells involved in the alloreaction. 
The MCA ER-1 and MRC OX-19 recognize all T cells, whereas the T cell 
subpopulations are recognized by ER-2 (T helper) and MRC OX-8 (T 
suppressor/cytoxic). Besides a reactivity with the T-cells also a non-
lymphoid reactivity has been described for several antibodies (Table 4.1 ). 
Also the B-cells, 
distinguished by 
macrophages and the early T cells (ER-4 positive) can be 
MCA MARK-1, ED-1 and ED-1, respectively. For the 
recognition of the class II MHC antigen two MCA were available. One (ER-
13) is directed against the monomorphic determinant, ER-13, the other (F17-
23-2) against a polymorphic determinant. Part of these MCA were used in 
the fluorescence analysis, whereas all MCA were used in the analysis of the 
graft infiltrationg cells described in the next section. 
Besides the data as presented and discussed later in this section 
several items of general importance came out of this analysis. 
The first important phenomenon was the degree of variation between 
the results of individual animals at the same day after transplantation. 
This is illustrated in figure 4.3 with the percentages MRC OX-19 positive 
lymph node cells of allografted and isografted animals. The individual 
figures at 0, 4, __ 6, 7 and 9 days after transplantation are shown for both 
the isogeneic and the allogeneic combinations. Compared with untreated 
animals (day 0) only a minor variation can be seen in the isografted 
animals, which is in agreement with a stable and non-activated situation. 
The degree of variation the allografted animals, especially at six and 
seven days after transplantation is higher than the isografted animals. 
Because the rat strains were highly inbred, genetic variation within these 
strains is minimal and subsequently it should be expected that also the 
alloreactivity after transplantation might show a minor degree of 
variation. In allografted animals activation probably occurs with some 
time difference in the initiation of the immune response in the individual 
animals. As a result of this also the effector phase may not be 
synchronous, even in these highly identical inbred rats. Sufficient numbers 
of experimental animals will reveal changes and shifts and will help to 
resolve the mechanisms involved. But variability in data as found in this 
study makes one sceptical about the possibility to get insight into the 
ongoing process on an individual basis for diagnostic or prognostic 
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Figure 4.:5 MRC OX-19 staining figures in mesenteric lymph node cells at various days after 
kidney transplantation in allogeneic ( 0) and the isogeneic (e) combination. 
purposes, as is the case in clinical transplantation. All data shown 
furtheron are mean data of at least 5 animals. 
The second item of importance is the way in which the infiltrating 
cell population is defined i.e. which marker is used to define such cells. 
This is illustrated for the T cell population by comparing three different 
methods to stain and monitor the T cell population. The T cell population 
is analyzed by the reactivity of MCA ER-1, MRC OX-19 and a combination of 
ER-2 and MRC OX-8. MRC OX-19 reacts with all T-lymphocytes in the 
peripheral lymphoid organs (Dallman et al, 1983). However, also activated 
T cells and cells with an immature phenotype have been reported after 
transplantation (Nanni Costa et al, 1983; Chatenoud et al, 1983). The 
reactivity of MRC OX-19 with early T cells and activated T cells still 
remains to be determined. For this reason also an estimation of the T 
cells by the expression of ER-1 antigen, as well by the summation of ER-2 
and MRC OX-8 positive cells was done.The latter two approaches to enumerate 
the T lymphocyte population have a disadvantage: also non T cells express 
these surface antigens (Table 4.1 ), such as plasma cells (ER-1+), 
macrophages (ER-2+) and natural killer cells (MRC OX-8+). In Table 4.2 the 
results of these experiments are summarized for the total T cell 
population. A compari-son of-the reactivity-ef MRC- OX-19 wi-t-h- ER-1 revealed 
that only in the mesenteric lymph nodes of isogeneic grafted animals 
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comparable cell numbers were labelled, which is well in agreement with the 
reactivity detected in the lymph nodes of untreated animals (chapter 3). 
This illustrates that.the choice of the MCA to define a population is quite 
important for the interpretation of the results. All the markers indicate 
an increase of the percentage of labelled cells shortly after allogeneic 
transplantation, in lymph nodes and blood. Different patterns were found 
during the later course of the rejection. In all organs a steady decrease 
of MRC OX-19 and the ER-2 and MRC OX-8 reactivity in the last stage of the 
rejection was detected (Table 4.2). This pattern was however, not followed 
by the ER-1 reactivity. The reactivity of this marker remained unchanged 
or, as in spleen, even increased. This suggests a significant involvement 
of cells carrying the T cell determinant recognized by ER-1, but not the 
other T cell markers, as will be discussed later. This illustrates the 
necessity to bear continuously in mind that one should be reluctant to 
translate directly phenotype changes into actual cellular (functional) 
shifts. 
Table 4.2 Flow cytometric analysis of the T cell population after 
transplantation 
Days after Spleen MLN PBL 
transpl. 
A a B B c 
Isogeneic 
~4.5b 45.8 47.8 45.7 48.5 52.0 46.8 56.7 
~2.~ 45.8 45.7 4~.1 4~.8 52.~ 42.~ 57.2 
~4.2 46.4 48.~ 47.5 45.1 54.~ 47.2 62.5 
~5. 7 48.0 48.2 56.~ 47.6 
~4.2 44.0 47.9 46.6 46.8 58.8 48.5 57.7 
Allogeneic 
~~.6 45.8 47.8 46.1 48.5 52.0 46.8 56.7 
~5.5 ~8.5 46.8 57.1 54.5 79.~ 57.2 61.~ 
~~-1 42.:; 44.8 5~.8 57.1 68.~ 48.0 61.0 
21.5 42.1 44.2 60.~ ~9-~ 
2~.0 52.6 29.1 ~9. 7 50.7 51.2 ~6. 7 5~.5 
59.2 
56.9 
58.7 
61.5 
58.2 
59.2 
70.~ 
67.0 
48.6 
5~.6 
a. The total of !-lymphocytes has been expressed in three different ways: 
A. MRC OX-19 positive cells, B. ER-1 positive cells and C. cells positive 
for MRC OX-8 or ER-2. 
b. PVG recipient rats received a kidney of PVG.RT1a(DA/Olac) donors. For 
each time point after 5 animals were used for monitoring. Cells were 
and stained with directly FITC-conjugated MCA as described before. The 
standard error of the mean (SEM) did not exceed the 15 percent level 
(unless stated). 
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Thirdly, when comparing data at various times after transplantation 
one should not limit oneself to the relative reactivity as expressed in the 
percentages, but also absolute numbers should be determined. Since it has 
been. reported that after allogeneic transplantation the weight of the 
spleen highly increases (Nemlander et al, 1982), also the absolute number 
of viable nucleated cells in spleen and blood has been determined. In the 
cell suspensions, prepared from the spleen and the peripheral blood , the 
total of viable nucleated cells was determined. Within the isografted 
animals the spleen and PBL cell numbers remained rather constant, 
suggesting a quiescent lympho-hematopoietic system. In the allogeneic 
grafted animals a deprease in the total number of nucleated spleen cells 
was detected four days after transplantation (Table 4.3). Subsequently a 
recovery of the cell numbers could be observed and even a increased number 
of nucleated cells was found at day 7 and 9 after transplantation both in 
the spleen and in blood. 
Isogeneic combination 
Table 4.~ Total number of Yiable nucleated cells 
in spleen and blood after transplantation 
Day Number Spleen a Bloodb 
of rats (X 108) (x106) 
17 5.1 ± 1.8° 8.4 ± 1.8 
6 4.5 ± 1.6 6.6 ± 2.4 
9 4.5 ± 1.8 9.5 ± ~.2 
7.7 ± 1.7 14.8 ± ~.1 
7.2 ± 1.5 1~.5 ± ~-5 
a. Single cell suspensions of the spleen were 
prepared and the leukocytes were counted 
on a cell counter. 
b. Blood cells were counted after lysis or the 
red blood cells 
c. Mean values :t SEM are sho\rlll 
When the percentage of cells expressing the various markers is 
determined at various times after transplantation in the spleen, lymph 
nodes and blood of isogeneic transplanted rats, no significant changes were 
found (Table 4.2). Although a mild, transient ATN was observed in these 
animals (previous section) at day 4, this had obviously no impact on the 
immunological status of the animals as determined by phenotyping of the 
lymphoid cell population, since also no changes were observed in overall 
cellularity in spleen and blood (data not shown). 
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Shifts found in allogeneic transplanted rats can therefore be 
attributed to the allograft directed rejection process, instead of surgical 
procedures. 
Allogeneic combination 
When looking in spleen at the percentages of cells positively 
stained in the allogeneic transplanted animals for all MCA including for 
ER-2, MRC OX-8 and ER-9 (data not shown), with the exception for ER-1, a 
decrease with time was found (Table 4.2). However, when corrected for the 
total number of cells, the absolute numbers revealed-quite a different 
pattern. As shown in Table 4.4 no significant changes can be detected 
throughout the observation period for MCA MRC OX-19 and ER2 plus MRC OX-8. 
Shifts in the lymphoid cell compartment are therefore most likely caused by 
non-relevant changes in the non-lymphoid populations in the spleen. 
Table 4.4 Change in cell numbers of various T-lymphocyte 
(sub)populations in blood after allogeneic 
transplantation 
MCA 
Days ER-1 MRC OX-19 ER-2 MRC ox-a ER-9 
Spleen 
0 100a 100 100 100 100 
4 74 94 86 . 90 9~ 
81 88 9~ 72 86 
94 ~- -~. 107 
§] 102 9~ 98 9~ 
Blood 
100a 100 100 .100 
4 85 
6 ~ 2 
a. Analysis of cells after staining with FITC-MCA has 
been performed on a FACS II. The absolute number of 
positive cells are expressed as percentage of the cell 
numbers detected in untreated animals. Figures ~o~ithin 
the squares are significantly increased. compared to 
the numbers of day 0. 
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However, only the ER-1 positive population increases signiricantly in the 
spleen as the rejection process goes on. This is true both ror relative 
and absolute numbers (Table 4.2 and 4.4). These ER-1 positive cells in the 
later period or the rejection may be an indication ror the presence or 
elevated numbers of cells with an immature phenotype. Baldwin et al (1982) 
reported that in untreated animals after transplantation a 40 to 50~ 
decrease in cortical and medullary thymocytes was found. The possibility 
of immature cells was also confirmed by another MCA i.e. ER-4, which is 
mainly reactive with immature cells in the thymus (Previous chapter). In 
normal animals ER-4 reacted with 7.6 ± 2.1 percent of the spleen cells, but 
six days after allogeneic transplantation this reactivity was increased to 
36.0 ± 3.1 percent. Therefore an influx of immature T-cells derived from 
the thymus may be partly spleen bound. The most likely candidates for such 
cells, displaying an immature phenotype is the cortical population of the 
thymus i.e. cells that express the surface antigen of ER-1, ER-4, ER-2, ER-
g and MRC OX-8 and are negative for MRC OX-19, this represents the dominant 
cell population of the cortex. Any medullary cell participitation of 
thymus migration would be difficult to detect since these cells have a 
mature phenotype. The presence of W3/25+, MRC OX-8+ in an activated immune 
system was reported by Dallman et al (1985) and also preliminary results of 
double fluoresence staining indicated the presence of this type of cells 
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Figure 4.4 Fluctuation in the absolute number of T-lymphocyte subpopulations in 
blood after allogeneic kidney transplantation. The cell numbers stained 
with MGA ER-2 (D), MRG OX-8 (•) and ER-9 (•) were analyzed on a FAGS 
I I. Cell numbers are expressed as percentage of the normal values 
detected in untreated animals. The figures are shown in Table 4.4. 
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upto 10 percent of spleen cells after stimulation (data not shown). 
Although the T-cell population of the spleen after allogeneic 
transplantation seems to be in an equilibrium this is in fact a highly 
dynamic kind of equilibrium. Cell accumulation has been described after 
i.v. antigenic challenge, (Emeson, 1977). Also allografts induced an 
accumulation in the spleen (Ford, 1975; Satake et al, 1982; Kupiec-
Weglinski et al, 1982) and in the graft (Chang and Sugarbaker, 1981) in the 
initial stage of the rejection, but declined later on. Intragraft 
labelling of infiltrating cells did confirm at least for these cells a 
considerable cell traffic between the graft and the spleen (Nemlander et 
al, 1982). 
In blood variations in percentages for all of the markers analyzed 
obscured any upwards or downwards tendency, if present at all Table 4.2). 
However, if the absolute numbers were calculated a general clear-cut 
pattern was revealed (Table 4.4). All populations studied increased during 
time after transplantation, although sometimes with a different starting 
kinetics (Figure 4.4). ER-2, for instance, rises immediately at day 4, 
whereas the other markers remain at normal levels at first and get higher 
only at day 6 or later on (Table 4.4). Also the abundance of cells 
carrying the ER-2 and MRC OX-8 markers at later stages of the rejection 
period as compared to the overall T cell markers ER-1 and MRC OX-19 is 
striking. This .~s also suggestive for the presence of double positive 
cells for ER-2 and MRC OX-8 (Table 4.4). 
Hardly any differences in percentage of positive cells between 
isogeneic and allogeneic rats could be found for the MCA MRC OX-19, ER-1, 
ER-2, MRC OX-8 and ER-9. However, this "quiet" picture is disturbed when 
looking at other MCA. Large differences were found for MCA ER-13, ER-4 and 
MARK-1. These latter antibodies recognize respectively class II MHC (Ia) 
positive cells (ER-13), thymocytes and prothymocytes (ER-4) and B cells 
(MARK- 1 ). This is illustrated in Table 4.5 for day 6 after 
transplantation. This change indicates that the blood 
involved in the rejection process from the start on. 
is very actively 
Since at day 6 no 
major quantitative differences in PEL's exist between the two groups (Table 
4.3) this pattern is rather representative for what is going on in the 
blood. Normally the expression of class II MHC products is restricted to 
cells of the B cell lineage (Fukumoto et al, 1982). Since the number of B 
cells (MARK-1) did not change dramatically (Table 4.5), the higher 
expression of class II MHC antigens must be attributed to other cells than 
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B cells. Since also T cells can acquire class II MHC expression upon 
stimulation (Gillman et al, 1982) the increased ER-13 positivity is most 
likely caused by the presence of activated T cells. As in spleen also in 
the blood high numbers of cells carrying an immature T cell phenotype (ER-
4) are found after allogeneic transplantation. These results demonstrate 
that in case of the allogeneic transplanted rats a considerable number of 
activated T-lymphocytes as well as a considerable amount of cells 
displaying an immature phenotype appear in the blood circulation. These 
observations have been confirmed in human renal allografts by the 
incidental finding of CD8+/CD4+ cells in the blood (Chatenoud et al, 1984). 
Table 4.5 Phenotypic composition of PBL's after 
6 days of transplantation 
Antibody Isogeneic Allogeneic 
MRG OX-19 48.1 ± 2.1 47.2±4.1 
ER-1 62.5 ± 2.2 61.0 ± 2.7 
ER-2 n.6 ± 4.4 44.9 ± 1.9 
MRG ox-a 15.1 ± 0.9 22.1 ± ~.0 
ER-9 25.6 ± ~.0 3~.3 ± 3.8 
ER-4 10.0 ± 2.1 29.~ ± 6.9 
ER-13 17.3 ± 2.2 39.0 ± 6.8 
MARK-1 13.8±1.5 17.6 ± 2.0 
a. PBL~s "''ere isolated 6 days after transplantation, 
stained with FJTC-conjugated MGA and analyzed 
using a FAGS as described before. The mean 
percentage of positive cells ± SEM of 5 animals 
are shown for both combinations. 
Furthermore, these data show that monitoring of the total T cell 
population and the two major subpopulations provide insufficient 
information about a rejection in progress. When the ratio between the 
helper and the suppressor/cytotoxic T-cells, which is a parameter used in 
many transplantation centres (Burton and Cosimi, 1983), are calculated for 
the control animals (isogeneic) a ratio of 2.87 ± 0.57 (n=6) is found and 
for the other group (allogeneic) a ratio of 2.48 ± 0.82 (n=S) is observed. 
It will be evident that in this model these parameters are unable to 
indicate a rejection for the individual animals. Although the untreated 
rejection model as used in this study, does not entirely reflects the 
clinical situation, where a low dose of immunosuppressive agents are 
applied in non-rejecting episodes, Guttman and Poulsen (1983) reported 
comparable Th/Ts,c ratio's both in well functioning and rejecting human 
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graft. The ratio may be a useful tool for the prediction of infections 
such as cytomegalovirus (Metselaar et al, 1986), but as indicator of a 
starting renal failure episode (RFE) it is inadequate. T cell activation 
markers recognizing receptors of IL-2 (Schubert et al, 1986) and 
transferrin (Hoshinaga et al, 1986; Brando et al, 1986) or the class II 
expression of T-lymphocytes and also immature markers such as described in 
this thesis seem to be more useful markers for indication of an activated 
T-cell system. For an absolute prognostic parameter for RFE in the 
recipient, however, only the measurement of a specific anti-donor response 
will give an adequate answer. 
However, besides looking at the immune system of the recipient a 
more direct approach is monitoring of the graft itself. In the next 
section analysis of the infiltrating cells will be described using 
immunohistochemistry. 
GRAFT INFILTRATING CELLS 
To analyse the in situ'immune reactivity, transplanted kidneys were 
removed at various times after grafting and used for immune histology. 
Part of the kidney was therefore snap-frozen in liquid nitrogen. Serial 
cryostat sections of the graft were stained with a panel of MCA, which are 
summarized in Ta~!e 4.1. The MCA used in this experiment are directed 
against T-cells (ER-1 and MRC OX-19), T cell subsets (ER-2, MRC OX-8 and 
ER-9), B-cells (MARK-1 ), macrophages (ED-1) and against class II MHC 
antigen (ER-13 and F17-23-2). The reactivity of the antibodies on the 
sections was visualized using a peroxydase technique as described in the 
third chapter. Six grafts were analyzed for each time point after 
transplantation. 
As a control isogeneic grafts were stained and analyzed. In the~e 
animals small infiltrates both perivascular and peritubular, were detected 
starting at six days after transplantation, slightly increasing in number 
from day 12 on. However, the size of these infiltrates remained much 
smaller than the ones observed in the allogeneic group. Some reactivity 
was observed for ER-1, ER-2 and ED-1. Hardly any cells reacted with MRC 
OX-19 or with ER-9 in these animals, whereas only a minor part of the cells 
were MRC OX-8 positive. 
In the allogeneic grafted animals two 
infiltration can be seen after transplantation. 
different types of 
First of all part of the 
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infiltrate is located in. close vicinity of the arterioles i.e. the socalled 
perivascular Infiltrates. These infiltrating cells are found in close 
connection· with . each other, 
r·emainin:g :infilt-rating cells, 
such as is illustrated in figure 4.5. The 
the socalled peritubular cells are scattered 
throughout-the entire kidney and these cells are not found in clusters. 
The:. perivascular infi trates increase in frequency and in size 
during the course of rejection. Several small (10-30 cells) infiltrates 
and incidentally a .larger one (100-300 cells) were detected at four days 
af.ter transplantation (figure 4.5). Whereas almost all cells were class II 
positive (ER-13), approximately 60 percent reacted with ER-1 (figure 4.5A). 
No B-cells (MARK-1) were found. Nearly equal numbers (±30~) of these cells 
reacted with ER-2 (Fig.4.5B), MRC OX-8 (C), MRC OX-19 (D) and ER-9 (E). 
Also macrophages (ED-1), with a branched shaped, non-lymphoid morphology 
were detected in these infiltrates with an estimated number of 30-40 
percent (Fig. 4.5F), while ER-4 reacted with a low number of predominantly 
irregularly shaped cells. After day 3 the incidence of these perivascular 
infiltrates, but also the number of cells per infiltrate increased (day 4: 
Figure 4.6A), while at six days these infiltrates started to confluence 
(Figure 4.6B) resulting in large clusters of infiltrating cells. These 
clusters consisted of round cells and were found throughout the kidney from 
day 7 on (Figure 4.6C). In most of these infiltrates the MRC OX-8 positive 
cells were somewhat higher in number than the ER-2 reacting cells (3:2), 
whereas the ER-1 recognized approximately 70-80 percent of these cells, 
which seemed to be a summation of the cells stained by ER-2 and MRC OX-8. 
A decline of ER-9 positive cells was found, resulting in a low number of 
strong positive cells at day 6 and almost negative reactivity later on. 
Also the cells defined by MRC OX-19 decreased in number (20~ at day 6) and 
the intensity of the staining was very low. An even further reduction to 
<10~ was detected in last phase of the rejection. 
At the peritubular sites, both in the cortex and the medulla, round 
shaped cells were detected at day 3 reacting with ER-1 and ER-13. 
Increasing numbers were found at day 4 and day 6, while in a later 
these numbers tended to decline, however, damage of tissues 
phase 
by the 
rejection mechanism interfered in several of these sections with a clear 
interpretation of these data. Only part of this type of cells was 
positively stained with MRC OX-8 (Figure 4.7B), while only a low number of 
round cells reacted with ER-2. The MRC OX-8 reactivity showed a comparable 
increase in these area's as described for ER-1. Besides these cells a 
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Figure 45 Perivascular infiltrate in renal allograft at 4 days after allogeneic kidney 
transplantation. Serial sections of the graft were stained with MCA ER-1 (A), MRC 
OX-19 (B), ER-2 (C), MRC OX-8 (0), ER-9 (E), and ED-1 (F) respectively. 
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Figure 4.6 Increased numbers of infiltrating cells after 
allogeneic transplantation. The ER-1 positive 
cell population is shown at day 4 (A), day 6 (B) 
and day 7 (C) respectively. 
Figure 4. 7 T-cell subpopulations of perivascular 
area~ s at 6 days after allogeneic 
kidney transplantation. Serial 
sections of the graft \rlere stained 
with MCA ER-2 (A) and MRC OX-8 (B) 
respect! vely. 
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comparable number of monocytes (round shaped) and macrophages were detected 
in peritubular area's at day three after transplantation. These cells were 
defined by MCA ED-1. This was confirmed by the finding that a comparable 
amount of irregular shaped cells (macrophage-like) cells reacted with MCA 
ER-2 (Figure 4.7A). The number of macrophages increased at day 4 and at 
day 6 they were found in large numbers scattered throughout cortex and 
medulla. Some of the grafts at day 6 and in more cases at a later stage 
showed a declining number of these macrophages approaching the numbers 
detected at day 4- Only low numbers of ER-9 or MRC OX-19 positive cells 
were detected outside the vascular infiltrates and this reactivity even 
decreased after day 4. 
The class II reactivity in these kidneys visualized by ER-13 was 
difficult to interprete, since the tubuli themselves were also positively 
stained. Additionally the Bowman's capsules and in the last _days of the 
rejection episode also the endothelial cells of the arterioles became 
positive. From a comparison with the pattern obtained by staining with MCA 
F17-23-2, which recognizes only donor-type class II MHC antigens, it 
nevertheless clear, that also the majority of infiltrating cells, 
macrophage-like and lymphocyte-like, did express high level.s of class 
MHC antigens. 
was 
b~h 
II 
The described presence of 
(MRC OX-8) in th~graft and only a 
predominantly CDS-like positive cells 
minor population of CD4-like (ER-2) 
cells was in accordance with observations by several authors (Renkonen et 
al, 1983; Claesson et al, 1985; Bradley et al, 1985). This was 
demonstrated by both cell isolation techniques and immunohistochemistry. 
The ratio between MRC OX-8 and ER-2 observed in allogeneic grafts might be 
the result of a more pronounced role of the CDS defined population during 
the process of alloreaction against the graft. The lack of specificity of 
ER-2 and MRC OX-8 was a disadvantage for a clear interpretation of the 
results, since high numbers of large granular lymphocytes (LGL), which are 
MRC OX-8 positive (Reynolds et al, 1981) were reported by Nemlander et al 
(1983) to infiltrate the graft directly after transplantation. Also 
macrophages have been reported to infiltrate in large numbers in the graft 
(Christmas and MacPershon, 1982b; von Willebrand et al, 1979). These cells 
express the antigen defined by the MCA ER-2. In this respect a new MCA, 
specifically reacting with macrophages, (Dijkstra et al, 1985) is of 
importance. This MCA, ED-1 enabled a segregation of the macrophage and the 
helper T-lymphocyte recognition of MCA ER-2. ED-1 stained both round cells 
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(supposedly monocytes) and irregular shaped cells in the parenchyma. The 
results indicated that the T-helper cells were mainly located within the 
perivascular infiltrates together with suppressor/cytotoxic T-cells and 
some macrophages. The ED-1 positive macrophages were non-lymphoid in 
morphology, which was was in contrast to the ER-2 positive cells. The 
majority of ER-2 positive cells outside the perivascular areas showed a 
macrophage type of morphology. This seems to be confirmed by histological 
studies in man, where it has been shown that the lymphoid cells were almost 
completely located within the perivascular sites. Mononuclear phagocytes 
on the other hand were situated in other places (Christmas and MacPershon, 
1982a). 
The high expression of class II antigen on the donor type cells of 
the kidney is most likely induced by ~-interferon produced by activated T-
lymphocytes (Pober et al, 1983; Morhen et al, 1984). The MCA ER-13 and 
F17-23-2 enable a separation of the class II antigens in recipient and 
donor type. These data revealed that the infiltrating cells at the 
perivascular sites do express high amounts of class 
sites contain T-lymphocytes of the CD4-like and 
II antigens. These 
CD8-like population 
together with macrophages, which may function as antigen presenting cells. 
Therefore these perivascular cuffs seem to represent lymphoid compartments 
of the recipient with a proper microenvironment for the host reaction 
against the graft. The presence of host derived macrophages suggests that 
graft antigen might be processed by these cells. Consequently the donor 
class I antigens, but also the non-MHC antigens may be presented in a MHC 
restricted fashion to the immunocompetent cells of the recipient, as has 
been suggested by Burakoff (1985). Another source of antigen may be the 
endothelial cells of the arteriole. A positive correlation of the class II 
expression of these cells with rejection has been reported (Hayry et al, 
1981a and 1981b; de Waal et al, 1983; Milton et al, 1986) and the close 
relation of the perivascular infiltrates with the arterioles might indicate 
an antigenic role of the endothelial cells for the recipient infiltrating 
cells. In contrast to the first process this kind of response would be a 
non-MHC restricted anti donor class II response. 
For a proper distinction between T-lymphocytes and other cell types 
the MRC OX-19 MCA might be a useful marker. This is certainly true for the 
initial posttransplantation period, when the antigenic expression seems to 
be rather normal. However, later on the reactivity pattern becomes more 
complicated. In the last stage of the rejection a remarkable decrease in 
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reactivity with both MRC OX-19 and ER-9 could be notified in all grafts. 
Normally it is assumed that the non T cell reactivity of MRC OX-8 and ER-2 
(W3/25) is caused by the presence of many NK-cells (MRC OX-8) and 
macrophages (ER-2) and this causes the discrepancy between these MCA and 
MRC OX-19 (Bradley et al, 1985). As a consequence one has to assume that 
in our experimental system only a very low number of T-lymphocytes remain 
in the graft at the effector stage. This would be highly in contradiction 
with most data in rejection of grafts (Forbes et al, 1983; Christmas and 
MacPershon, 1982b; Tilney et-al, 1975). With the assistance of the MCA EO-
this partial non-lymphoid reactivity of ER-2 could be verified. In the 
perivascular sites the number of ER-2+ cells and their morphology are 
different from the ED-1 population. This suggests that at least part of 
the ER-2+ MRC OX-19 cells do not belong to the macrophage lineage. 
Although it was not possible to separate the MRC OX-8 positive cells into 
T-cells and NK-cells, Nemlander et al (1983) reported that most LGL's leave 
the graft at approximately four days. The large number of MRC OX-8 
positive cells in the graft at day 7 and later on may be in part NK-cells, 
but at least one has to assume that also a considerable number of these 
cells belong to the T-cell lineage. In contrast to the graft the cell 
numbers recognized by both MRC OX-19 and ER-9 in the recipient at the same 
time after transplantation was comparable with the other subset markers. 
Therefore this depletion seems to be specific for the graft during the 
effector phase. An explanation for this phenomenon can be found in the 
unique degree of activation, since in the graft a high degrea of specific 
activation is combined with activation induced by lymphokines. In the 
other lymphoid organs including blood only donor specific activation occurs 
and consequently the activation will not be to same extent as in the graft. 
Functional studies described in the chapter 3 showed that the surface 
molecules defined by these two MCA (MRC OX-19 and ER-9) are involved in the 
initial stage of T-cell activation. It may well be that these surface 
antigens are lost after the earliest process of activation or that 
modification of the antigen in this stage interferes with binding of these 
antibodies. In the recipient a depleted reactivity might not be observed 
in the total pool of the lymphocytes. The depletion of the MRC OX-19 
population may also be partly explained by immature T-lymphocytes. An 
influx of cortical thymocytes has been reported by Baldwin et al (1982) in 
the end stage of the rejection. The low numbers of ER-4 positive cells in 
the grafts might be an indication for this observation and also the low 
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intensity of MRC OX-19 staining in the grafts after day 6. Cortical 
thymocytes express this antigen in a lower density than medullary and 
peripheral T-lymphocytes (Dallman et al, 1982). These data, but also the 
results of the fluorescence analysis in spleen and blood after 
transplantation favour an influx of immature T-lymphocytes, which are 
probably partly MRC OX-19 negative. 
A participation of B-lymphocytes and plasma cells in the rejection 
mechanism has been described by several authors (Duarte et al, 1981; 
Renkonen et al, 1983; Garovoy et al, 1979). Besides an indication of 
increased numbers of plasma cells in the spleen after transplantation we 
could not confirm this, since hardly any of these MARK-1 positive cells 
could be detected in the grafts. Since the acute type of rejection is 
predominantly aT-cell defined mechanism it was suggested that the presence 
of B-cells in the graft was caused by a polyclonal activation as an spin-
off of the strong T-cell activation (Duarte et al, 1981 ), which was 
supported by in vitro findings of Garovcy et al, 1979 and Pobor et al, 
1983. Another explanation is that the B-cell response is directed against 
non-MHC antigens (Hayry et al, 1984). In the congenic strain combination 
used in our experiments no difference in non-MHC systems exists and this 
correlates with the absence of a humoral component in the rejection 
process. 
Whereas the monitoring of the immune system of the recipient only 
provided indirect indication of an ongoing rejection episode, phenotypical 
analysis within the graft itself gives more direct information. Although 
also in isografts, in a non-rejecting situation, graft infiltrating cells 
are found the high degree of class II induction is not found in these 
animals. Therefore monitoring within the graft itself seems a better 
parameter for the prognosis of a RFE than screening in the blood. The 
recently described technique of fine needle aspiration biopsy (FNAB) can be 
applied with a high frequency without causing disrupture of the organ 
(Hayry and von Willebrand, 1981 ). 
Besides the phenotype of the various populations of immunocompetent cells a 
more direct approach is to measure the donor specific immune response of 
the recipient. In the next section this donor specific response of the 
host is described. 
101 
SPECIFIC CYTOTOXIC. T-CELL RESPONSE 
In addition to studying changes in composition of defined 
lymphocyte subsets through cell surface marker. analysis after allogeneic 
organ transplantation as a reflection of an ongoing rejection, one can.also 
focus on the specific allogeneic response itself and try to correlate such 
measurements with the data obtained in the other types of analyses. 
Although such a response comprises a variety of immunological effector 
functions we limited ourselves to the cytotoxic T cell reaction, since this 
is considered to be a major contribution to the actual damaging process 
during rejection (Cerottini and Brunner, 1974; Moreau et al, 1985; Bradley 
et al, 1985). This section describes experiments, which were performed to 
analyze on a comparative and quantitative basis the specific cytotoxic T 
cell (CTL) response both in the central lymphoid system as well as in the 
graft at various times after transplantation. In order to do so the number 
of precursor CTL was determined using the method of limiting dilution assay 
(LDA), which was extensively described by Lefkovits and Waldman (1979). 
The CTL activity was determined with a micro assay system of the MLR for 
the generation of CTL. The method, basically comparable to the macro assay 
described in the previous chapter, needed adaptation to cell growth under 
limiting dilution conditions. 
Assay system 
The precursors of the CTL (CTL-p) were determined in the spleen, 
the blood and in the graft at various times after transplantation. Both 
single cell suspensions of spleen and the isolation of PBL were done as 
described before. The renal graft was isolated and minced into small 
pieces and subsequently carefully squeezed through a vitallium wire mesh 
(0.003 inch). This suspension was filtered through nylon-gauze to obtain a 
single cell suspension, whereafter the lymphocyte fraction was isolated by 
Ficoll/Isopaque gradient (o 1 .077) centrifugation as described before. The 
viability of such cells always exceeded the 90 percent value. Variable 
cell numbers of responder cells were injected into wells of microtitration 
plates (round bottom shaped) together with 105 of irradiated stimulator 
cells (3000 rad). The cell mixture was grown in RPMI-1640 culture medium 
supplemented with growth sustaining factors, which will be described in 
detail. Cells were grown for 6 days in a total volume of 200 ~1 of medium. 
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After six days the CTL activity was determined. by the capacity to lyse 
target cells in a CML-assay. The target cells used in the CML were Con A 
stimulated (72 hrs) spleen cells, that were labeled with 51cr and lysis of 
the target cells results in release of the 51 cr. For the CML-assay 104 
target cells (20 ul of medium) were injected in each well and the 
suspension was carefully mixed by pipetting. After four hours of 
incubation the supernatants were collected with supernatant harvesting 
cartridges (Skatron, Oslo, Norway) and the radioactivity was determined in 
T-counter. 
For a proper LDA it is necessary to test the sensitivity of the 
culture conditions in order to verify that only the tested cells are 
present in limiting amounts. The optimalization of the culture system 
requires much attention, for example IL-2 containing supernatant was 
described as an essential component for this test system (Wagner et al, 
1980; Miller, 1982). The medium was supplemented therefore with FCS and T-
cell growth factor (TCGF) as a source of exogenous IL-2 and other 
differentiation factors. The source of FCS was selected by testing several 
batches of FCS for growth sustaining under limiting dilution conditions as 
described in the second chapter. For these experiments FCS of Boehringer 
(Mannheim, Germany), batch nr. 688.829 has been used in a final 
concentration of 10 percent. As a source of TCGF supernatant Con A 
stimulated spleen cells harvested after 48 or 72 hours of culture was used. 
The supernatants were tested for IL-2 content using a IL-2 dependent T cell 
line (CTLL) as described before (Gillis et al, 1978). TCGF supernatant was 
added to the culture medium in a concentration of 5~ (vfv). Besides these 
two factors also 2 x 105 irradiated thymocytes of the responder strain as 
feeder cells were added to each well. Furthermore the availibility of 
adequate numbers of accessory cells for the growth, differentiation and 
function of the CTL-p cells need attention, while on the other hand also 
suppressor cells might introduce a complicating factor to the system 
(Corley et al, 1978). 
The sensitivity of the LDA to 
with spleen cells of DA/Olac 
transplantation of a kidney of RP/Rij 
detect CTL-p in the rat, 
(RT-1a) rats at four 
(RT-1u,l) rats. Spleen 
was tested 
days after 
cells were 
isolated and MLR cultures of these cells with irradiated spleen cells of 
the donor strain were started. In the CML-assay the presence of effector 
cells was tested on target cells of the WAG/Rij strain, which express the 
same class I MHC antigen as the donor strain. The spleen cells were tested 
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Figw-e 4.8 Donor specific cytotoxicity of spleen cells under limiting dilution conditions. Cells of 
DA rats were cultured with irradiated cells of RP rats and the effector cells were tested 
for specif1c5~ytotoxicity with target cells of WAG rats. In the first collumn the 
spontaneous Chromium release and the maximal release are shown. The specific release of 
the cultures has been expressed as percentage of the maximal release. 
in numbers of 60 to 1.2 x 104 cells per well and each dilution was tested 
in 8-fold replicate cultures. The percentage of lysis was expressed as: 
cpmexp./cpmtotal x 100, in which cpmexp. is the radioactivity in the 
culture supernat~t of test cultures and cpm total is the maximal release, 
defined by lysis of the same number of target cells, as described before. 
Cultures were regarded to be positive, when the radioactivity counted in 
the culture supernatant exceeded the value of the spontaneous release plus 
3 times the standard deviation. At a cell dose of 5 x 102 per well 
incidental cultures became positive, whereas at a cell number of 1 .2 x 104 
all cultures showed a positive target cell lysis (Figure 4.8). In the 
macro system described in the previous chapter the same number of target 
cells were used, but in that system 105 effector cells were required to 
obtain a reproducible target cell lysis. This indicates that the culture 
system used in this experiment is more sensitive than the one used in the 
macro system. 
For the estimation of the frequency of the CTL-p within a cell 
population it should be defined whether the data of the dose response 
experiments correspond with a single hit model. This model assumes that 
one single CTL-p cell is needed for a positive cytotoxic reponse. With the 
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Figure 4. 9 The estimated frequency of the donor class I specific cn.-p in unseparated 
spleen cells at 8 days after transplantation. The frequency has been 
calculated by the method of weighed mean estimation and the 9~% confidence 
interval is show (TaslJell, 1981). Each dose of spleen cells ws tested in 
24 fold replicate cultures and the fraction of negative responding cultures 
ws determined as described in the text. 
assumption that the test cell suspension is homogeneous the distribution of 
these cells is described by the Poisson probability distribution (Haight, 
1967). In the single-hit model only a discrimination between positive and 
negative cultures is made and distinction between cultures with one or more 
responder cells is not possible. Therefore the incidence of the negative 
cultures is the important factor in LDA analysis. The fraction of negative 
cultures (no cytotoxic activity) is defined by the zero term of the Poisson 
distribution: Fo = e-u. This can be transformed in its logarithimic form: 
u = -ln Fo, in which Fo is the ratio of negative cultures and the total of 
tested cultures and u is the mean number of CTL-p per well. When the 
fraction of negative cultures reaches the value of 0.37 the number of CTL-p 
per well (u) has the value 1. When the fraction of the non-responding 
cultures, on a log scale, are plotted against the cell input per well, on a 
linear scale, a straight line corresponds with single hit kinetics 
(Lefkovits and Waldman, 1979). More complex statistical methods to 
calculate the frequency and test the single hit model were described by 
Taswell ( 1981 ) . 
To test 
CTL-p, spleen 
transplantation 
the 
cells 
were 
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applied culture conditions for detection of a single 
of DA recipients at 8 days after allogeneic 
isolated and MLR-cultures with limiting amounts of 
these responder cells were started and each dose was tested in 24 replicate 
cultures. In the CML-assay the specific target cell lysis was determined 
with WAG derived target cells and subsequently the fraction of responding 
versus the nonresponding cultures was determined and plotted (figure 4.9) 
as described above. The CTL-p frequency was calculated using the method of 
the weighed mean estimation with the 95% confidence interval (CI) as 
described by Taswell (1981 ). The frequency of donor specific (class I 
antigen) CTL-p in the spleen had an estimated value of 0.000679 ± 0.000084 
with a 95% CI between 0.000842 and 0.000515 i.e 1 CTL-p cell on 1473 spleen 
cells. 
A primary criterion for the validity of this estimation is the 
agreement of the data with the expected Poisson distribution. A plot of 
the fraction of nonresponding cultures against the cell dose should give a 
straight line for single-hit kinetics. Fitting of these data to a straight 
line can be tested by the Chi square test of goodness of fit, which gives a 
corresponding probability value for the tested hypothesis. The results of 
the experiment was tested and a Chi square value of 2.5582, with 5 degrees 
of freedom was calculated, which corresponds with a probability value of 
0.42 (Tables of c~i-square distribution). This value allows a satisfactory 
acceptance of the single-hit model for the the tested cell population, 
since the hypothesis is not rejected on a 5% level of significance 
(Lefkovits and Waldman, 1979; Taswell, 1982). The culture conditions 
applied in the micro assay system are therefore adequate to sustain cell 
growth in limiting numbers. Furthermore these data indicate that no 
suppressor cells are actively involved in this system. The latter would 
result in a highly different kind of kinetics (Lefkovits and Waldman, 
1979). Although the Poisson distribution decribed above can be taken as 
evidence that a single CTL-p is detected, it must be emphasized that the 
efficiency of detection of CTL-p cannot be assessed with certainty. 
Therefore the frequency values described in the remaining sections should 
be regarded as minimal estimates. 
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Transplantation analysis 
In a series of transplantation experiments the fluctuation of the 
estimated frequency of the CTL-p was determined in spleen, blood and in the 
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Figure 4.10 Variation of the estimated CTL-p frequency after allogeneic (day 8) 
transplantation. Spleen cells of 3 recipients ~o~ere isolated and tested in in a 
single experiment. Each cell dose has been tested in 8 fold replicate cultures. 
graft. For several reasons a somewhat different setting of the 
experimental approach was chosen. First of all no data exist on either the 
values of allospecific CTL-p frequencies in the rat system or on the degree 
of variation after transplantation. Therefore a wide range of different 
cell doses had to be tested in order to make sure that the relevant cell 
doses were included in the test range. Furthermore we focussed on the MHC 
class I directed CTL activity by using specific cell targets. For a 
correct comparison the time schedule for transplantation was designed in 
such a way, that on the same day always two animals of each time point (day 
4,6 and 8) and one control animal (day 0) were available for testing in one 
experiment. Data below represent a minimum of the separate experiments in 
which at least five individual rats were tested for each time point. DA 
rats were sacrificed at 4, 6 and 8 days after transplantation (RP donors). 
The cell doses were tested in 8 or 16 fold replicate cultures. After the 
MLR phase with RP derived stimulator cells, the generated CTL were tested 
for target cell lysis of two different types of target cells. The class I 
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directed CTL activity was determined with eels derived ~rom WAG rats, which 
share the same haplotype ~or the class I antigens with RP rats. The lysis 
with PVG (RT-1°) targets was determined ~or the estimation o~ the 
nonspeci~ic activity. 
Table 4.6 Estimated values of the frequency 
of CTL-p in DA rats. 
Day Spieen Blood Kidney 
1/U,402 1/25,900 nt 
1/~,28} 1/2,690 1/10,491 
1/486 1/7>1 1/2,871 
1/2,594 1/486 1/669 
a. The results are sho\Jll of a representative 
experiment. All animals were sacrificed at 
the same day and tested as described. 
Although a low number o~ cultures was tested ~or a speci~ic 
reponder cell dose the variation o~ the estimated CTL-p ~requency remained 
acceptable as is illustrated in ~igure 4.10. Three independent LDA o~ 
spleen cells, 8 days ~ter transplantation gave estimated CTL-p ~requencies 
o~ 1/2,541, 1/1,923 and 1/2,871 respectively. 
The data o~ a representative experiment in which the CTL-p were 
determined at various days a~ter transplantation are shown in ~igure 4.11 
and the calculated CTL-p ~requencies are summarized in Table 4.6. In the 
unprimed animals (day 0) the donor speci~ic CTL-p ~requency o~ 1/13,400 in 
the spleen and 1/24,900 in blood. Four days a~ter transplantation a 4 ~old 
increase was observed in the spleen (1/3,283) and even a 10 ~old increase 
in blood (Figure 4.11A and B). A ~urther increase o~ the CTL-p cells was 
noti~ied two days later:,a 34 ~old increase in spleen (1/731) compared with 
day 0 and a 26 ~old elevation in blood. In the last phase o~ the rejection 
(day 8) a reduction o~ the CTL-p in the spleen (1/2,594) was ~ound, whereas 
the high incidence in the blood remained at the same level (1/480). 
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Figure 4. 11 The influence of allogeneic kidney transplantation on the number of the CTL population 
directed against the class I MHC antigen of the donor. The results of a representative 
experiment are shown in which the CTL activity has been determined in spleen (A), blood 
(B) and the graft (G) at various days after transplantation. The experimental conditions 
are described in the text. 
As shown in figure 4.11 the CTL-p frequency in the graft itself 
started to increase later than in spleen and blood. At four days after 
transplantation the incidence of CTL-p in the graft (1/10,491) was 3 to 4 
times lower than in spleen and blood. The estimated frequency within the 
graft reached a value at day 6 of 1/2,871, which is comparable to the 
values detected in blood and spleen at day 4. In contrast to the spleen 
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the level kept increasing after that. This resulted in a frequency of 
1/669 at 8 eight days after transplantation, which is approximately the 
same value as detected in blood. 
In order to test the presence of non-specific target cell lysis the 
51 cr-release of PVG target cells was determined under identical conditions 
as described for the specific CTL response. With an exception of blood and 
allograft at day 8 all experiments showed a frequency corresponding with a 
value of <1/100,000. In blood the frequency increased at day 8 towards a 
frequency of with 1/26,000 and 1/35,000, which is only 1.4- 1.8 percent of 
the specific CTL-p frequency. In the graft a non-specific killing was 
detected at the same time with a frequency of 1/18,779 - 1/27,010 
correlating with 3.6 and 2.5~ of the donor specific target cell lysis. 
These data prove that the obtained values of the class I directed CTL-p 
frequencies are not influenced by elevated numbers of nonspecific CTL. 
Table 4. 7 Frequency of precursor CTL in spleen, 
blood and kidney after allogeneic 
transplantation. 
Day Spleen Blood Kidney 
9 - 16b >25 n.t. 
2.8 - 4.1 1.6 - ~.2 10.1 - 14.1 
0.~ - 1.0 0.5 - 1.1 1.9 - 2.9 
1.8 - 2.6 0.4 - 1.~ 0.5 - 1.0 
a. Frequency is expressed as the number of cells 
(x 10~) containing one precursor of a donor 
specific cytotoxic T-cell. The results of 
representative experiment are show. 
b. The range of the data determined In four 
independent experiments are shown. 
n. t.: not tested 
The estimated frequency of the CTL-p in the spleen of untreated 
rats ranged from 1/9,000- 1/16,000, which seems to be lower than values 
reported in other species. MacDonald et al (1980) reported in mice 
frequencies ranging between 1/170 1/1000 and Buurman et al ( 1983) 
described in dogs a frequency estimate of 1/1.900 1/3.000 in blood. 
Lefkovits and Waldman (1979) on the other hand reported estimated values in 
unseparated spleen and lymph node populations in mice between 1/1,000 and 
1/10,000. These figures are however, determined in fully mismatched 
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combinations i.e. both MHC and non-MHC differences were involved. This is 
also the case in outbred species, such as man and dog. In mice the anti 
class I CTL-p frequency ranged from 1/500 - 1/3,000 (MacDonald et al, 
1980). The low frequency of CTL-p in the rat might be caused by species 
differences. Definite speculations however should await more data from a 
variety of combinations of rat strains to exclude differences 
allogeneity or responder status between the various rat strains. 
0 20 
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Figure 4. 12. The frequency of the estimated donor specific rn population after 
transplantation in the recipient, as determined in spleen ( 0), blood ( & ) , 
and graft ( • ) . 
DISCUSSION 
Donor specific cytotoxic T cell activity 
in 
The results of the described experiments showed that allografting 
has a clear impact on the number of donor specific CTL in blood and spleen 
(Table 4.7 and Fig. 4.12). In both organs a maximal level is reached at 6 
days after transplantation, whereafter a reduction in the spleen was found. 
The elevation detected in blood is even more pronounced when it is 
expressed in absolute numbers than in relative figures, since during the 
later stage of the rejection an increased number of nucleated cells is 
found in the blood (Fig.4.12). The reduction of the CTL in the spleen may 
be correlated an increase. Nemlander et al (1982) demonstrated that during 
the first days after transplantation large numbers of cells migrate to the 
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graft, but also a comparable number could be found to leave the graft. 
After 5 - 6 days the cell traffic declines, whereafter the immune response 
in the graft seems to evolve independently. 
The maximal levels of CTL are reached at a rather late stage of the 
rejection process, especially within the graft itself (day 8). Assuming 
that a high density of antigen-on the target cells correlates with an 
increased vulnerability, the kinetics of the class I expression on the 
graft cells seems in agreement with a late role of the specific CTL. The 
expression of this MHC-antigen on the graft tissue is highly increased, 
starting at day 1 , but a maximal expression of this antigen was found at 
day 5 approaching a 30 fold increase as compared to control animals (Milton 
et al, 1986). Also the in vitro analogue of the CTL reactivity requires a 
MLR-culture of six days for optimal CTL response. Although the in vivo 
activation process may be different, an important role of the specific CTL 
in the initial phase of the rejection is highly doubtful. Specific CTL 
response is a rather late event. Nevertheless both histologically and 
functionally already during the first days clear signs of rejection are 
found. Significant numbers of MRC OX-8 positive cells are already present 
in the graft from day 4 on. The presence of such cells with the supposed 
phenotype of cytotoxic T cells seems to be in contradiction with the 
functional data, which suggest only a later involvement of CTL in the 
rejection proces~. However, the presence of MRC OX-8 positive cells may at 
least in part be due to an influx of LGL in the graft early after 
transplantation (Nemlander et al, 1983). LGL, which are also MRC OX-8 
positive, are supposed to be the rat analogue for NK cells (Reynolds et al, 
1981 ). In this respect it is striking that the immunospecificity of the 
infiltrating cells early after transplantation is indeed rather low (Tilney 
et al, 1978; Tilney and Ford, 1974). 
T cell subpopulations in allograft rejection 
Major changes early after transplantation, however, seem to be in 
the ER-2 positive helper/inducer subset. The role of the various T-cell 
subpopulations in allograft rejection has been a highly controversial 
matter. Already for a long time it was generally accepted that the donor-
specific cytotoxic T-lymphocyte was the dominant cell type in mediating 
graft rejection (Cerottini and Brunner, 1974). Transfer experiments in 
thymectomized, irradiated and bone marrow reconstituted mice and rats also, 
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showed that not the cytotoxic T-cell subset, but the helper T-cell 
subpopulation is required to restore the skin graft immunity (Loveland et 
al, 1981; Dallman et al, 1982; Loveland and MacKenzie, 1982a). Moreover 
Loveland and MacKenzie (1982b) demonstrated a correlation of the ability to 
reject skin allografts and to mount a delayed-type hypersensitivity (DTH) 
reaction to alloantigens in B-mice reconstituted with helper T-cells. They 
suggested that the alloreaction was mediated by cells with a helper T-cell 
phenotype, which mediate a DTH reaction. Heidecke et al (1984) furthermore 
performed experiments in which they investigated the relative role of T 
cell subsets and IL-2 for the rate of the rejection. Transfer of all T-
cells, supplemented with IL-2 conditioned medium into allografted B-rats, 
gave acute rejection. The same type of rejection was seen after transfer 
of helper cells and Ts/c cells in a normal ratio in the presence of IL-2. 
Transfer of only helper cells on the other hand resulted also in rejection, 
but the rate of rejection was never as fast as for the the other two 
combinations. Moreover IL-2 conditioned medium alone did not change the 
rejection time. These studies reemphasized the role of the DTH in 
allograft rejection originally suggested by Brent et al (1962). However, 
the interpretation of these data became obscured by the observation of Hall 
et al, who described many MRC OX-8 positive cells within the graft after 
pure T-helper reconstitution of B-rats. These cells might belong to the 
NK-cell lineage, but Dallman (Ph.Phil. thesis) was able to show that 
precursors of cytotoxic T-cells of recipient origin were still present in 
such animals. Moreover LeFrancois and Bevan (1984) provided evidence in T-
cell deprived mice, 
(only differing in 
which were reconstituted with syngeneic T-helper cells 
Thy-1 haplotype) that during allograft rejection the 
majority of the newly generated cytotoxic T-cells were host derived. 
Thus at present there remains a large deal of controversy over the 
dominating cell type mediating the allograft rejection. Lowry and 
coworkers (Lowry et al, 1983; Gurley et al, 1983; Lowry and Gurley, 1983) 
on one hand emphasized the role of the DTH activity in the process of graft 
rejection. ·They noticed clear graft rejection without any detectable MRC 
OX-8 positive cells in the graft. The observed dominance of W3/25 (ER-2) 
positive cells in their experiments, by them explained as DTH effector-
inducer cells, could be due, however, to other factors as well. For 
instance also the anti-class II cytotoxic T cell and its precursor seems to 
be W3/25 (ER-2) positive. This latter category of cells was suggested by 
similar results in mice (Dialynas et al, 1983), man (Krensky et al, 1982; 
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Spits et al, 1982) and in rats (Mason et al, 1983). 
On the other hand the role of specific cytotoxicity in the 
rejection of allografts has been emphasized by a variety of data. In 
Cyclosporine A (CyA) treated, non rejecting allograft recipients the 
nonspecific cytotoxicity remained unchanged, whereas the specific activity 
was markedly decreased (Mason and Morris, 1984). Also in enhanced grafts 
an absence of allo-antigen specific CTL was demonstrated, while NK-activity 
was comparable to untreated recipients (Bradley et al, 1985). Moreover a 
high frequency of the T-cell clones established from rejecting human 
kidneys were cytotoxic to donor lymphocytes (Moreau et al, 1985). 
Illustrative is also the fact that treatment of transplanted monkeys with 
MCA directed against CDS+ cells resulted in prolonged skin graft survival 
(Jonker et al, 1985; Jonker et al, 1986). 
Allograft rejection 
The most likely explanation for the observed duality in data seems 
to be that allografts can and will be rejected by both delayed type 
hypersensitivity reactions and specific cytotoxic T cells. In untreated 
and fully mismatched donor recipient combinations both mechanisms may be 
involved. Only the time of action and the actual site will probably 
differ. 
Our data suggest that effective levels of specific cytotoxicity 
appear rather late during acute rejection. Nevertheless, as mentioned 
before, rejection starts almost immediately after transplantation. At 
first, aspecific infiltration occurs, since also in isografts and 
autografts some infiltrating cells are seen (our data, Hayry et al, 1979; 
Christmas and MacPershon, 1982b). In the case of an allograft, however, at 
that moment the first activation process starts. Donor specific T-
lymphocytes within the infiltrate may be directly activated by graft 
derived cells such as class II positive dendritic cells (Lechler and 
Batchelor, 1982) and passenger leukocytes (Guttman et al, 1969). Indirect 
activation may take place by cell debris, caused by ischaemia damage, 
phagocytized by macrophages and subsequently presented to immunocompetent 
cells. Both T-helper cells for the CTL differentiation and for DTH 
reactivity seem to be involved in this initial stage. An important role 
for MHC class II antigens seems to be indicated in this process, since 
treatment of allografted mice (skin) with monoclonal anti-Ia antibody not 
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only prolonged the graft survival, but also suppressed the delayed 
hypersensitivity response. (Williams and Perry, 1985). The activation of 
these cells results in the production of IL-2, T-cell differentiation 
factors and ~-interferon, which subsequently induce differentiation and 
maturation of donor specific CTL. On the other hand lymphokines produced 
by a TDTH cells might be the explanation of some confusing observations. 
The role of infiltrating macrophages remains poorly understood, since these 
cells were also detected in isografts, CyA treated grafts and in enhanced 
situations (Mason and Morris, 1984; Bradley et al, 1985). Assuming that 
such cells require an activation factor for active participation of the 
graft rejection, the macrophage arming factor produced by the the TDTH cell 
would be a likely candidate. Analogous to the macrophages, ~-interferon 
produced in this stage has been reported to activate and potentiate the 
function of NK-cell populations (Kawase et al, 1981 ). Milton et al (1986) 
reported a difference in the time that the class I expression starts to 
increase on graft cells as compared to the induction of class II 
expression. Lymphokines that activate macrophages and other leukocytes, 
which produce ~-interferon (Clemens and McNurlan, 1985) might explain the 
difference between class I and class II expression, because this factor 
induces only the class I expression (Fellous et al, 1982). In a later 
stage elevated levels of ~-interferon produced by activated T-cells will 
result in the induction of class II ·expression and a further increase of 
class I expression. 
There might also be a difference in the site were the various 
immune responses against the graft take place. Infiltrating cells will be 
activated at the graft site, but macrophages, after phagocytosis and 
remigration to the spleen, are likely candidates for the immune response 
outside the graft. The high degree of cell traffic from the graft to the 
spleen indicates that a large number of sensitized cells migrate to the 
spleen. Cells do probably not selectively enter the spleen, since no 
specific homing receptors are known sofar, but it is assumed that antigen-
induced cellular trapping occurs (Frost and Lance, 1974; Frost, 1974; Zatz 
and Gershon, 1974). Such trapped cells find a proper microenvironment in 
the spleen for activation resulting in differentiation and proliferation. 
Shortly after transplantation such a spleen located immune reaction seems 
more suited for the CTL differentiation, since the conditions in the graft 
are probably not optimal for the complex cellular interactions required for 
this CTL-differentiation. Therefore the spleen is most likely the prime 
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source o~ speci~ic CTL in the initial phase, which is in agreement with the 
earlier appearance o~ increased numbers o~ speci~ic CTL in spleen, compared 
to the gra~t (our data). Speci~ic CTL leave the spleen and they accumulate 
pre~erentially within the gra~t. not by a speci~ic migration, but probably 
by speci~ic trapping in the gra~t (Tilney et al, 197S; Tilney and Ford, 
1974). 
Finally, also another component o~ the allogra~t response should be 
pointed out. Although the alloresponse in general is thought to be 
primarily non-MHC restricted, one can envisage the existence o~ certain 
MHC-restricted responses directed against anti-non-MHC antigen in the 
process o~ allogra~t rejection as suggested by Bukaro~~ (19S5). In this 
respect the high concentration o~ in~iltrating cells in the close vicinity 
o~ the arterioles must be remembered. Since these arterioles are donor 
derived, this environment could well be the obvious site ~or such types o~ 
reaction in the gra~t. Also outside the gra~t such a response might have 
an important impact on the overall reactivity pattern, both ~unctionally 
and phenotypically. 
In conclusion 
Research on the mechanism o~ allogra~t rejection is inhibited by a 
number o~ compLicating ~actors. Function and phenotype o~ a cell are not 
absolutely correlated. Also di~~erences in place and time between various 
immune reponses are ~ound. Furthermore the role o~ minor subpopulations in 
the mechanism o~ rejection is obscure. 
Although the phenotypical expression o~ a cell is a valuable tool 
in immune research it is also a highly con~using parameter. Rat cells 
which express the CD4 (ER-2) antigen may belong to the ~allowing ~unctional 
populations: (1) T cells with a DTH reactivity, (2) anti class II CTL, (3) 
cells with a helper ~unction ~or anti-class I CTL di~~erentiation, (4) 
class II restricted anti-non MHC CTL and (5) macrophages. On the other 
hand cells carrying the CDS (MRC OX-S) antigen are involved in (1) NK 
activity, (2) non restricted anti MHC CTL activity, (3) class I restricted 
anti non MHC or (4) anti class II responses. Even more complicating is the 
~actor that cells may not be restricted to the expression o~ either the CD4 
or the CDS antigen. The presence o~ elevated numbers o~ CD4+cns+ cells in 
highly activated situations may re~lect a possible phenotypical switch o~ 
the CD4+ or ens+ T cell populations. T-cell clones con~irm a ~lexibility 
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of the phenotypical make-up versus cell function. CDS+ clones, secreting a 
whole variety of factors·, including IL-2, -r-interferon and MAF were 
described (Widmer and Bach, 1981), while CD4 + T-cell clones exerted 
cyt·otoxic activity in combination with production of various T cell 
factors. When in vitro T-cell clones are a reflection of the functional 
potential of T-lymphocytes in vivo, it must be also considered that the 
normal immune system found in healthy, non-stimulated individuals may be a 
poor reflection of what actually goes on in the immune reponse during a 
rejection period. It may well be that normally infrequent cells, become 
important in highly activated situations such as an allograft rejection. 
This might especially be true in situations where a normal immune reaction 
is blocked by immunosuppressive treatment. 
Although as described above two dominant types of rejection are 
favoured by most investigators several alternative pathways of the immune 
response are suggested. These different immune responses will most likely 
collaborate in the rejection mechanism, acting at different times and 
different sites in the graft. Depending on the experimental system the 
results will be in favour of one of these pathways. The importance of such 
alternative pathways of alloreaction remains to be determined. For 
instance the class II directed CTL seems rather low in number for an 
effective participitation of the rejection mechanism. At specific sites, 
for instance in the perivascular sites in close proximity with class II 
positive endothelial cells of the arterioles, they could play an important 
role in rejection. 
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Chapter 5 
IMMUNOSUPPRESSIVE PROPERTIES OF MCA 
INTRODUCTION 
In man immunosuppressive treatment after transplantation will 
always be necessary to suppress the alloreaction of the immune system of 
the recipient towards the graft. The current immunosuppressive agents are 
not specific and also the normal immune response is inhibited. A more 
specific immunosuppression is therefore wanted. One of the approaches has 
focussed on the cells that are responsible for the rejection, i.e. the 
lymphocytes. The immunosuppressive potential of antisera that are directed 
against lymphocytes, the socalled anti-lymphocyte sera (ALS), was 
discovered about three decades ago. The first demonstration of this 
immunosuppressive activity of ALS is ascribed to Inderbitzin (1956), who 
reported the inhibition of skin reaction of delayed type hypersensitivity 
after treatment with ALS. Later on Waksman et al (1961) also found an 
inhibition of autoimmune disease and a prolongation, although weak, of skin 
graft survival. The main interest in ALS, however, started after a 
striking prolongation of skin graft survival in ALS treated rats as 
described by Woodruff and Anderson in 1963 and 1964. After these 
publications man~ studies have been performed on the antigen specificity as 
well as the antibody properties, which are essential for the 
immunosuppressive properties of ALS (reviewed by Lance et al in 1973). 
ALS is a complex reagent, directed against a multitude of 
antigen specificities and it consists of a mixture of different types of 
antibodies. This is a major problem for the elucidation of its mode of 
action. Several cell types, mainly lymphoid in nature, can be used as 
immunogens. As far as specificity is concerned, lymphocytes are an 
essential component of the cell mixtures used in the immunization 
procedure. With regard to the antibody itself, it is emphasized that the 
activity is almost completely restricted to the IgG fraction. The IgM 
fraction can not prolong graft survival in a normal test system. Only a 
minimal immunosuppr.essive activity could be demonstrated for this fraction, 
when administered in a high dose in closely spaced intervals after 
transplantation. Moreover Capel et al (1983) showed, that after 
fractionation of a polyclonal mouse anti-rat serum into an IgG1 fraction 
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and an IgG2 fraction, the immunosuppressive activity was exclusively 
detected within the IgG2 subclass. The IgG1 subclass failed to do so in 
all experiments. However, this finding seems to be rather species 
specific, since the same authors (Lems et al, 1983) found that in 
polyclonal rat anti-mouse sera the IgG1 and the IgG2 fraction showed a 
comparable immunosuppressive activity. The necessity of an intact IgG 
molecule was shown by Lance et al (1973), since neither F(ab) 2 nor Fab' 
fragments had any effect on the graft survival, Possibly the Fe portion of 
the molecule, which mediates many diverse functions, such as complement 
fixation and opsonization, is an important factor for the immunosuppressive 
activity of the antibody. Another relative simple explanation of the 
differences in the activity of the IgG fraction on one side, and the IgM 
fraction or the IgG fragments on the other side may be found in a variation 
of the biological half life time of such inocula. IgG has a rather low 
rate of elimination in blood (6-7 days), whereas IgM (2-2,5 days), F(ab) 2 
and Fab' fragments (about 6 hours) are much faster removed from the 
circulation (Lance et al, 1973 review; Spiegelberg and Weigle, 1965), 
Thus, a lot of uncertainties and controversies still exist about 
the relative importance of the antibody composition of immunosuppressive 
ALS. Furthermore the importance of the antigen specificity of ALS remains 
to be solved. MCA offer a simple solution to address the problems in both 
area's. Moreover if MCA can substitute ALS, a constant and unlimited 
source of antibody can be achieved. 
Immunosuppression 
With the availibilty of a panel of well defined MCA against rat 
cell surface markers, as described in the previous chapters, it became thus 
possible to address the main questions on the immune properties of ALS. 
The questions are: Which are the target antigens or cells, that are 
important for immunosuppression and which are the restrictions on the side 
of the antibody for immunosuppression? 
For this purpose ascites fluids containing the various MCA were 
tested for immunosuppressive activity in a skin graft model. 
Transplantation was done as described by Capel et al (1983): tail skins of 
PVG.RT-1a(DA) rats were grafted onto the dorsal flank of PVG rats. The 
grafts were fixed with NobecutaneR spray and the recipients were treated 
i.p. with 0.5 ml of ascites fluids at days 0, 2 and 4 after grafting. All 
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ascites were tested for active binding before use. 
The results of these experiments are shown in Table 5.1. Untreated 
animals rejected the graft in 9-10 days (Mean survival time: MST 9.5). Out 
Table 5.1 The effect of MCA on the graft survival in the rata 
Target antigen Antibody 
Control 
Leukocyte common antigen ER-17 
ER-18 
ER-19 
All T cells 
T helper cells 
T cytotoxic/suppressor 
T cell subset 
ER-1 
ER-1 F(ab) 2 
HIS-17c 
W3/13 
ER-2 
W3/25 
MRC OX-8 
ER-3 
ER-10 
ER-7 
ER-8 
ER-9 
ER-11 
MRC OX-22d 
Subclass MST(days) 
9.5b 
IgG1 10.7 
lgG2a 10.1 
lgG2a 9.9 
IgG2a 12.:1 
F(ab) 2 10.6 
IgG1 1hl. 
IgG1 9.2 
lgG1 .!.2..,_Q 
IgG1 !1.,1 
IgG1 8.5 
IgG2a 8.1 
JgG2a 9.2 
IgG2a 9. 7 
IgG1 8.9 
IgG2a 7.5 
IgG2a 8. 7 
JgG1 8. 7 
a. Tail skin of PVG.RT-1a(DA) rats was grafted on PVG recipient 
rats. The recipients were treated with 0.5 ml ascites fluid on 
days 0,2 and 4 after grafting. 
b. HST is the mean survival time of 5 animals. Underlined figures 
represent significant prolonged graft survivals. SEM ranged 
betiJeen 1 and 1.5 days. 
c. Kroese et al , 1985 
d. Spickett et al, 1983 
of the 16 MCA tested in this model only four proved to be 
immunosuppressive. The negative results of the other MCA were not caused 
by low antibody concentration in the ascites fluids, since increasing the 
amount of antibody per administration did not influence the results (data 
not shown). It appears that also for MCA an intact molecule is required 
for immunosuppression, because the prolongation of the graft survival of 
ER-1 (Table 5.1) is completely abrogated when F(ab) 2 fragments of this 
antibody are tested in the same concentration. 
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Much to our surprise three out of the four immunosuppressive 
antibodies (HIS-17, ER-2 and W3/25) were of the IgG1 subclass (Table 5.1 ), 
which seems ,to .be in contradiction with the results obtained with the 
polyclonal IgG1 fraction as described by Capel et al (1983). 
An explanation_ for this finding could be that the antigenic 
specificities of these MCA are normally not found in the IgG1 fraction of 
polyclonal antisera. Therefore it was tested whether the fine 
specificities of these antibodies are present within the normal repertoire 
of a polyclonal ALS. The MCA were radiolabelled with 125-Iodine and 
binding to spleen cells of PVG rats as well as the ability of mouse anti-
Table 5.2 lnhibit!on of binding of MCA 
to PVG spleen cells 
HCA Percentage of inhibitiona 
ER-1 
W~/13 
HIS-17 
ER-2 
W~/25 
MARS 
87c 
54 
81 
75 
8~ 
0 
~ 
a. 
1251 IICA and serum (1/2 dilution) 
were incubated with spleen cells (PVG). 
b. NMS: normal mouse serum 
c. Inhibit!on:Bound MCA (cpm) - Bound MCA 
+ MARS/NMS (cpm) x 100/ Bound MCA 
rat serum (MARS) to inhibit this binding was determined using a similar 
technique as described in the second chapter. As can be seen in Table 5.2, 
MARS is capable to inhibit the binding of all tested antibodies, varying 
from 54~ of W3/13 binding up to a 87~ suppression of the ER-1 binding. 
Thus the specificities defined by these MCA are present in the normal 
repertoire of MARS. A restriction of these specificities to the IgG2 
subclass in polyclonal sera was neither the case, as illustrated for ER-2. 
As shown in figure 5.1 both the IgG1 and the IgG2 fractions of polyclonal 
ALS were able to block the binding of MCA ER-2, demonstrating that both 
fractions contain antibodies against this specificity. The data of the 
blocking experiment (Fig. 5.1) and the immunosuppressive properties of MCA 
of the IgG1 isotype indicate, that also the polyclonal IgG1 fraction 
contains suppressive antibodies. Problably the frequency and the 
efficiency of immunosuppressive antibodies within the IgG2 subclass is the 
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highest, but potentially also antibodies of the other Ig (sub)classes can 
be immunosuppressive. A lower frequency combined with a lower efficiency 
of the IgG1 antibodies in pclyclonal sera may be the cause of the negative 
results observed fer the IgG1 fraction. The observation that, in contrast 
to IgG1 of polyclonal MARS, monoclonal IgG1 antibodies can be 
immunosuppressive is therefore probably due tc a very powerful selection by 
the hybridoma technique of normally, existing specificities in the IgG1 
fraction of MARS. This data is once more an indication· that MCA do not 
always behave in a similar way as their polyclonal members of the family. 
As far as the antigen specificities of the immunosuppressive MCA in 
this study are concerned, it is obvious that all of them are reactive with 
T cells. ER-1 and HIS-17 (Kroese et al, 1985) react with all T cells, 
whereas ER-2 and W3/25 recognize the T helper population. This indicates 
that the cell population recognized by the MCA is an important factor for 
immunosuppression: In this model only MCA against all T cells or the helper 
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Figure >. 1 . Inhibi t!on of ER-2 binding on rat spleen cells by polyclonal anti-lymphocyte serum 
(MARS: o ) , the IgG1 fraction (MARG1: A. ) or the IgG2 fraction (MARG2: • ) . Control 
is normal mouse serum (NMS: <> ) . 
T cell population were suppressive. All MCA against surface antigens on 
the suppressor/cytotoxic T cells failed to prolong graft survival in our 
model. However, in other systems MCA specific for such cells were 
effective, since immunosuppressive activity of anti-CD8 antibodies in 
humans have been reported (Jonker et al, 1986; Cosimi, 1983). Very 
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recently Claesson et al (1985) also reported prolongation of survival of 
heart and kidney in rats with MRC OX-8. The model used and especially the 
precise time course of the MCA treatment in relation to the onset and 
progress of the rejection of the transplant are probably essential for the 
desired immunosuppressive effect of the MCA, as will be discussed in detail 
later in this chapter. 
The leukocyte common antigen (LCA) is expressed on all 
leukocytes, including all T lymphocytes. Nevertheless all MCA against this 
antigen did fail to influence the graft survival in this study. This is in 
agreement with earlier findings of Fabre et al (1981) with polyclonal as 
well as monoclonal anti-LCA antibodies. These results indicate that 
reactivity with the proper cell population is not conclusive, but also the 
surface molecule on those cells is an important factor for 
immunosuppression. 
The MCA against all T cells (ER-1, W3/13 and HIS-17) and against 
all helper T cells (ER-2 and W3/25) were selected for further study, on the 
mechanism of immunosuppression. Strikingly only 2 out of 3 pan-T cell 
antibodies were suppressive (ER-1 and HIS-17 versus W3/13). These 
differences in immunosuppressive behaviour were not caused by variations in 
physical properties between the various MCA. As described in chapter 3 
also affinity differences between the antibodies cannot account for the 
variation in their immunosuppressive potential (ER-1/W3/13: chapter 3; HIS-
17 was determined at a comparable K: 2.6 x 10-10 mol/1) Also complement 
binding properties (chapter 3) and the isotype of these antibodies do not 
give any correlation with the immunosuppressive activity. 
To exclude furthermore the possibility of significant differences 
in specific antibody content in the various ascites fluids, a dosis-
response study was done with the selected MCA. For a proper comparison of 
the various MCA the specific biological activity of each was determined. 
Therefore the MCA were labeled with 125-Iodine and the ratio of bound 
antibody (cpm) versus the total radiolabel (bound/total) was determined on 
spleen cells. The ratio of bound/total in the situation of an excess of 
antigen (5 x 108 cells) reflects the degree of 'biological activity' i.e. 
antibody, which is able to bind with the surface antigen on the target 
cells. The dose of the ascites is corrected according to this ratio and it 
is expressed as dose specific activity. If for example ascites is 
radiolabelled and binding experiments with high cell numbers show a maximum 
of 55 percent of the radiolabel to bind to the cells, the specific activity 
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is 55% of 1 ml, i.e. o.55 ml. The dosis effect of the panel of antibodies 
expressed in this way is shown in figure 5.2. As can be seen from this 
figure W3/13 remains non-suppressive even when high doses of MCA were used 
for treatment. The differences between ER-1/HIS-17 and W3/13 can not be 
attributed to simple dose differences in antibody concentration. The 
prolongation induced by ER-2 and W3/25 treatment (Fig. 5.2A) is much more 
profound than the effect of ER-1 and HIS-17 (Fig. 5.2B). These results 
indicate again, that probably the surface antigen is one of the important 
factors defining the extent of suppressive activity of the antibody. 
24 
20 
~ 
·>-
"' 
"' 16 
I-
"' 
"" 
12 
16 
14 
12 
10 
Soecific activity lml/101 Scecific activity lml/10] 
Figure 5.2 The survival of skin grafts in relation to antibody dose (ml). A. Treatment of 
the recipient with ER-2 (D) and W3/25 (•). B. Treatment of recipients with 
MCA W3/U (.), ER-1 (.o .. ) and H!S-17 (D). 
We focussed our attention more in detail on the surface antigens 
recognized by these MCA. First, we determined whether the MCA with a 
comparable reactivity pattern might recognize the same determinant on the 
target cells. Therefore ER-1, W3/13 and HIS-17 on one hand and W3/25 and 
ER-2 on the other hand were studied for their blocking capacities in a 
binding assay. Purified MCA were labelled with 125-Iodine as described 
before and their binding on thymocytes was tested using a RIA system. 
Various concentrations of unlabelled antibodies were incubated together 
with the radiolabelled antibody and the binding of the latter antibody was 
measured. 
The results of the binding studies of ER-2 and W3/25 were somewhat 
confusing. Even in the highest excess of ER-2 the binding of labelled 
2 
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W3/25 was not affected (Fig. 5.3D), but surprisingly in the reciprocal 
situation low amounts ofW3/25 inhibit the binding of labelled ER-2 up to 
50 percent (fig. 5.3C). Increasing amounts of W3/25, however, did not 
further influence the binding of labeled ER-2. The determinants recognized 
by W3/25 and ER-2 therefore have to be located within a short distance from 
each other, either on the same molecule or on closely associated molecules. 
To investigate the target molecule of these antibodies immunoprecipitation 
studies were performed. Thymocytes were surface labelled and the lysates 
were used for immunoprecipitation of the various MCA as described in 
chapter 3. For the target antigens of ER-2 and W3/25 the same molecular 
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Figure 5.3 The influence of MCA on the binding of several antibodies to rat thymocytes. Fixed 
amounts of 125 -Iodine conjugated antibody were mixed with a increasing amount or unlabelled 
antibody. Binding of the labelled antibody IJ3S subsequently measured using a RIA (as described 
before). Binding of labelled MCA A: ER-1, B: HIS-17, C: ER-2 and D: W3/25 are shown. 
Unlabelled MCA HIS-17 (.A.), ER-1 (D) and W3/13 <•> (A and B); ER-2 (D) and W3/25 <•> 
(C and D). 
0 
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weight (52 kD) was determined (Table 5.3), which is in agreement with the 
data reported for the W3/25 antigen by Thomas and Green (1983). To clarify 
whether these molecular weights represent different molecules of the same 
size or that W3/25 recognizes a different epitope on the same surface 
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molecule as ER-2, sequential immunoprecipitation of these antibodies was 
necessary. Cells were surface labelled ( 125-Iodine) and separate portions 
of the same cell lysate were repeatedly precipitated with control ascitis 
(SP2/0) (Fig.5.4,lane A), ER-2 (lane B) and W3/25 (lane E) respectively. 
The last two lysates were precipitated with the same antibodies until no 
more antigen could be detected by autoradiography. Since no ER-2 antigen 
and W3/25 antigen, respectively is present in these lysates (lanes C and 
F), they were tested for the presence of the other antigen by precipitation 
with W3/25 and ER-2 respectively. W3/25 did not precipitate any antigen 
(lane D), whereas for ER-2 only a small band could still be detected (lane 
Figure 5.4 Sequential 1mmunoprec1p1tat1on of ER-2 and W~/25 ~o~!th surface labelled rat 
thymocytes. Autoradiography of !mmunoprecipitates on gels after SDS-PAGE are 
sho~o~n of Sp2/0 (control) : lane A. MGA ER-2: lane B and W~/25: lane E. Lysates 
~o~ere cleared by repeated precipitation of the antigens of ER-2: lane G and W~/25: 
lane. F. Both antigen free lysates were subsequently precipitated with the other 
antibody. Lane D: prec!pititation ~o~ith W>/25 of ER-2 antigen cleared lysate and 
lane G: precipitate ~o~ith ER-2 of W~/25 antigen cleared lysate. 
G). If two independent antigens had been recognized this band should have 
the same intensity as the one of the initial lysate which is shown in lane 
B. Therefore this small band in lane G must be ascrioed to a technical 
cause. Therefore these data support the notion "''at ER-2 and W3/25 are 
directed against different, closely linked, epitopes on the same surface 
molecule. 
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In ·figure 5.3A the results of the binding assay with radiolabelled 
ER-1 are shown.. First of all a complete inhibition of binding of labelled 
ER~1 is demonstrated by the unlabelled form of this antibody. Also HIS-17 
is capable to inhibit the binding of ER-1 upto about 80 percent (Figure 
5.3A). A comparable inhibitory effect of ER-1 on the binding of labelled 
HIS-17 has been found (Fig. 5.3B). This pattern of mutual blocking 
capacities indicates that ER-1 and HIS-17 recognize most likely the same 
molecule. The minor variation in the degree of blocking between unlabelled 
ER-1 and HIS-17 on labelled ER-1 and labelled HIS-17, respectively might 
point out that these two antibodies react with different, but closely 
linked epitopes on the same molecule. Even in the highest concentrations 
W3/13 fails to influence the binding of either labelled ER-1 (Fig. 5.3A) or 
the binding of labelled HIS-17 (Fig.5.3B). This means that the determinant 
recognized by W3/13 is either located on another surface molecule or, when 
the determinant is located on the same molecule as ER-1 and HIS-17, it is 
not in a close range. 
ER-1, HIS-17 and W3/13 give a similar reaction pattern with all T 
cells in terms of histology, FACS analysis and all other criteria tested 
sofar. Of these three MCA ER-1 and HIS-17 were shown in the above 
described blocking experiments to recognize similar or closely related 
epitopes on the same cell surface molecule. W3/13 might react with another 
molecule or with a non-associated epitope on the same molecule. Therefore 
the molecular size of these antibodies was determined using 
immunoprecipitation. As could be expected ER-1 and HIS-17 (Table 5.3) are 
directed against surface antigens of the same size. The figure of 95 kD is 
the same as the one reported by Standring et al (1978) for the W3/13 marker 
(Table 5.3). In the same type of sequential immunoprecipitation 
experiment, as described for ER-2 and W3/25, also ER-1 and W3/13 were 
Table 5.; Molecular weight of surface antigens 
Antibody Mol. weight a Antibody Mol.weighta 
(kD) (kD) 
ER-1 95 ER-2 52 
HIS-17 95 w;/25 52 
w;;u 95 
a. Molecular weights of the surface antigens were 
determined using immunoprecipititation experiments 
as described in the chapter :S. 
133 
tested. From the results o~ this experiment (data not shown), it could be 
established that ER-1 and W3/13 are directed against the same sur~ace 
molecule. This proves, that W3/13 is directed against another epitope on 
the same 95 kD molecule as the one o~ ER-1 and HIS-17. 
The data so~ar show that testing o~ a panel o~ MCA representing 11 
di~~erent sur~ace molecules on the same cells, only antibodies directed 
against two molecules possess immunosuppressive activity in the model used. 
Even a di~~erential reactivity pattern o~ antibodies directed against the 
same molecule can be observed, as illustrated by the cluster o~ antibodies 
reacting with the 95 kD molecule. Since the only apparent di~~erence seems 
to be on the level o~ the epitope, this suggests that recognition o~ a 
certain sur~ace antigen alone is not s~~icient, but also the epitope is 
important ~or immunosuppression. The role o~ the epitope is also con~irmed 
by human data o~ MCA directed against the CDS antigen. Only part o~ these 
antibodies are immunosuppressive (Jonker et al, 19S6), which indicates the 
existence o~ an active site on the CDS molecule, which has to be recognized 
~or immunosuppression. In mice, Lems et al (19S5) suggested the presence 
o~ socalled dominant epitopes, that are decisive ~or immunosuppression. 
In vivo behaviour 
Di~~erences in e~~ectiveness o~ monoclonal antibodies might be 
caused by trivial reasons as antibody degradation rate and variations in 
distribution. Besides the ~ine antigen speci~icity there~ore also the in 
vivo behaviour o~ the ~ive antibodies was studied. First o~ all biological 
li~e time in the blood has been determined. PVG rats were i.v. injected 
with mg o~ puri~ied antibody and at various times blood samples were 
drawn, wherea~ter the plasma ~raction was isolated and stored at -20 'C. 
These samples were tested ~or the presence o~ speci~ic antibodies by 
binding to thymocytes using a highly sensitive Elisa technique. All 
antibodies showed the same type o~ clearance in the circulation, which is 
illustrated ~or W3/13 in ~igure 5.5. Within ~our hours the concentration 
reached a maximum, which was maintained until 4S hours ~ter injection. 
Therea~ter a gradual decrease was Observed until a~ter approximately 90 
hours the concentration reached the background level. 
Subsequently the localization o~ injected antibody was monitored in 
various organs. Antibodies were radiolabelled with 125 Iodine and S-12~g o~ 
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Figure 5.5 Serum levels of HCA W3/U after a single dose (LY.). 
Specific antibody binding on thymus cells has been 
determined using an Elisa technique (described in chapter 
2). The extinction of the reaction product was measured 
at 405 nm. 
antibody was i.v. injected in PVG male rats (10-12 weeks of age). The rats 
were sacrificed after 24, 48 and 72 hours respectively: for each antibody 
five animals per time 'point were used. After isolation of the organs the 
radioactivity was counted using a ~-counter and the localization was 
expressed as cpm/g organ. 
After 24 hours, all antibodies, with the exception of W3/13, showed 
a high preference for the spleen, while in the mesenteric lymph nodes the 
localization ranged from high for ER-2 to hardly any for W3/25, 
intermediate levels were found for the other antibodies. A fast decrease 
of antibody in time is especially found in organs with a high specific 
localization such as the spleen (Fig. 5.6). Almost a complete 
disappearance of the antibodies from the blood could be seen within 24 
hours after injection, with exception of W3/25 and W3/13. This is in 
contradiction to the results of the biological half life time (Figure 5.5). 
The low dose of antibody used in these studies (8-12~g), compared to the 
experiment of the biological life time (1 mg) 'is most likely the reason for 
the a faster removal of antibody from the circulation for some of the 
tested MCA compared with the results of the biological life time. 
The low amount of localization of W3/13 in all tested organs (except 
in the blood) might be explained by inabilility of 125 I-W3/13 to bind to 
cells or by aggregation of this antibody. However, when this labelled 
antibody was tested for specific binding to spleen cells it appeared to 
have a good binding capacity. The possibility of aggregation was tested by 
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i.v. injection of comparable amounts of antibody in Balb/c mice. Almost 
all of the antibody remained in the blood and hardly any antibody was found 
within the liver and other organs. Aggregated antibody should correlate in 
these mice with elevated activity in the liver, which was not detected. In 
experiments with the other MCA the same type of localization in Balb/c mice 
was detected. Therefore it can be concluded that these results of W3/13 
cannot be explained by the inability of this antibody to bind to the target 
cells or by aggregation. 
A low activity was detected for all antibodies in the thymus 
despite of the high cell numbers that express the relevant surface antigens 
in that organ. It appears therefore that direct entry into the thymus is 
blocked for these antibodies. Since neither an increased activity was 
found after 48 and 72 hours, it seems that also indirect entry of the 
20 40 60 80 20 40 60 
Time lhcursl Time lhcursl 
Figure 5.6 Localization of MCA in spleen(+). lymph node (0), blood (•), liver (D) 
and thymus (A.) at 24, 48 and 72 hours after a single i. v. dose. 
The results are shown for A. ER-1, B. W:>/1), C. W)/25 and for 
D. ER-2. 
80 
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antibodies via the lymph system does not occur on a large scale. This 
limited entrance into the thymus of the rat, confirmed by Holmdahl et al 
(1985) for W3/13, W3/25 and MRC OX-8, is in contrast to the results of 
Kruisbeek et al (1983 and 1985) in the mouse. The latter authors showed 
that MCA directed against Class II (Ia) molecules freely enter the thymus. 
The 'classical' thymus-blood barrier (Raviola and Karnovski, 1972) seems 
not to function for all antibodies, since apparently some are able to 
penetrate through the blood-thymus barrier. 
A likely explanation for the absence of accumulation of W3/13 in the 
spleen was provided by data described by Holmdahl et al (1985). They 
showed that after W3/13 treatment no W3/13 positive T-lymphocytes could be 
demonstrated anymore in the spleen and lymph nodes already after two hours. 
After 14 days a recovery could be noticed. It took however as long as 5 
weeks before a normal cellular distribution in the spleen was observed. 
Staining with W3/25 and MRC OX-8 in the same spleen of the W3/13 treated 
animals revealed nevertheless only a partial depletion of T-lymphocytes. 
Therefore it can be concluded that after W3/13 treatment, only part of the 
cells leave ~he spleen and furtheron that the remaining cells within the 
spleen have lost the ability to bind the W3/13 antibody. This explains our 
findings, that we were unable to detect any W3/13 binding in the lymphoid 
organs at 24 hours after injection. After treatment with ER-1, HIS-17 
(data not shown), ER-2 and W3/25 a high activity was detected in the spleen 
(figure _5.6), especially at 24 hours after injection. These observations 
suggest that for these antibodies, in contrast to W3/13, both cells and 
surface antigen are still present. This is in accordance with the findings 
for W3/25 by Holmdahl et al (1985). They did not detect any discernable 
change in the cellular distribution pattern in the spleen after W3/25 
treatment: the cells as well as the surface antigen are still present. 
The same experimental approach as was described for determination 
of the biological life time in blood was used for analysis of the effect of 
injected MCA on the peripheral blood lymphocytes (PBL) after a single dose 
of antibody (1 mg antibody; i.v.). At various times after injection blood 
samples were drawn and the peripheral blood lymphocytes were isolated: the 
samples were centrifuged for 5 min. at 200 g and the-leukocytes on top of 
the packed cells were isolated. This fraction, diluted in RPMI-1640 medium 
(v/v) was brought upon 2 ml of Ficoll/Isopaque solution (d: 1.077 g/ml). 
After centrifugation 
the surface of the 
(20 min at 730 g) the lymphocytes were isolated from 
Ficoll/Isopaque layer. Alterations within the 
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lymphocyte population were monitored by staining with FITC-conjugated 
antibodies and analyzed using a FACS. The availability of several MCA 
against the same lymphocyte population enabled a more detailed analysis. 
First of all the cell population can be monitored, but also fine analysis 
of the surface antigens can be done. The cells can still be present, while 
the surface antigens are lost by shedding or modulation. It is evident 
that cells cannot be detected by staining with antibodies directed against 
an antigen, which is lost. For this reason also staining with MCA directed 
against other surface antigens on the same cells was done. MRC OX-19, 
reacting with all T-cells (Dallman et al, 1984), is such a MCA, since this 
antibody is directed against a surface molecule of 69 kD. Therefore the 
presence of the T-lymphocytes was analyzed for the MRC OX-19 reactivity. 
For analysis of the surface antigens on these cells, MCA directed against 
different epitopes on the same surface molecule may be used. In the 
blocking studies (Fig. 5.5) it was shown that W3/13 does not interfere with 
binding of ER-1 or HIS-17. 
Treatment with ER-1 resulted in a fast elimination of T lymphocytes 
from the blood. This is illustrated in figure 5.7A by the MRC OX-19 
staining 4 hours after ER-1 treatment, together with the fluorescence 
profile of untreated PEL's. At the same time after W3/13 treatment the MRC 
OX-19+cells are also decreased (figure 5.7B), but the depletion ofT-cells 
by this antibody was less dramatic than observed after injection of ER-1. 
Also after a single dose of ER-2 and W3/25 part of the cells disappeared 
from the circulation. In figure 5.7C the PEL's were stained with MRC OX-
19, 2.5 hours after a single dose of ER-2. The fluorescence profile shows 
a decreased number of MRC OX-19 positive cells. In figure 5.7D it is 
illustrated that cells carrying the surface antigen of W3/25 are completely 
disappeared at 2.5 hrs after treatment with MCA W3/25, since no ER-2 
positive cells could be detected. The cells are are disappeared and not 
only the surface antigen is lost from the cells. This can be concluded, 
because the reduction of ER-2 positive cells is of the same magnitude as 
the one that could be observed for MRC OX-19 (illustrated in Fig. 5.7C and 
D). In all experiments antibody treatment resulted in elimination of the 
cells that express the specific surface antigens. None of these 
experiments using these antibodies indicated the existence of modulation of 
the surface antigens or only a coating by the antibodies. The data of T-
lymphocyte fluctuations after MCA treatment are shown in figure 5.8. The 
number of MRC OX-19 positive cells at a given time was ·;ompared with the 
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Figure 5.7 Fluorescence staining profiles of PBL's of PVG rats after a single dose of 
I'ICA (i.v.). Horizontal axis: Fluorescence intensity, vertical axis: 
number of events. Fluorescence staining of treated (2) and control 
(1) animals are shown. A. PBL's stained with I'IRC OX-19 at 4 hrs after a 
ER-1 dose. B.PBL's stained with HRC OX-19 at 4 hrs after a W~/1~ dose. 
C.PBL"s stained with HRC OX-19 at 2.5 hrs after a ER-2 dose. D. PBL's 
stained with ER-2 at 2.5 hrs after a W~/25 dose. The arrows indicate 
the separation between positive cells and negative cells. 
cell number of untreated animals. A dramatic decrease of T lymphocytes in 
the blood is detected after one dose of ER-1 and even after three days the 
recovery of T-cells is only 20 percent of the original number. The 
fluctuations after W3/13 and HIS-17 treatment are less severe, but also for 
these antibodies only a partial recovery is detected. The influence of ER-
2 and W3/25 is somewhat different since the drop of T-cell numbers is less 
dramatic and within three days the recovery phase has already started 
(Fig. 5 .8B). 
These experiments showed no difference between the non-
immunosuppressive MCA W3/13 and the other immunosuppressive MCA (ER-1 and 
HIS-17) on elimination ofT cells in the blood. The observation, that 
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Figure 5.8 Effect of 1.v. treatment of MGA on peripheral blood lymphocytes. A. treatment 
~o~ith MCA ~}/n (<)), ER-1 (_,.)and HIS-17 (.).B. ER-2 (.)and ~}/25 (.to.). 
PBL's ~o~ere stained ~o~ith MRC OX-19 and analyzed ~o~ith a FACS II. The positive 
labelled were expressed as percentage of the control figures. 
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effective elimination of the target cell population is not totally 
correlated with immunosuppression, was confirmed too by the data obtained 
with ER-9. This non-suppressive antibody is highly effective in 
elimination of its target cell population from the blood (data not shown). 
Comparable observations have been reported for human anti-CD4 and anti-CDS 
antibodies: immunosuppression did not fully correlate with properties such 
as elimination, coating or modulation (M.Jonker, personal communications). 
These in vivo experiments intended to compare the behaviour of 
immunosuppressive and non-suppressive MCA in the organism. The biological 
life time may be important for a suppressive status of antibodies, but this 
was not the case for the tested antibodies, since a comparable fluctuation 
was detected in the blood. Immunosuppression was not correlated with the 
effect on the T-lymphocytes either. Treatment resulted in elimination of 
the T cells from the blood for all these antibodies. Non-suppressive 
antibodies eliminated as effective as the suppressive ones. Strikingly, a 
different kind of localization in spleen was observed for W3/13, as 
compared to the other antibodies. Only part of the cells were eliminated 
by W3/13 treatment, but the remaining cells did not express the W3/13 
determinant anymore. Most likely W3/13 cannot block the T cell function, 
due to the modulation of the determinant and as a consequence a normal T 
cell activation after transplantation and rejection is still found. 
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The above described in vivo experiments Yere done in untreated 
animals, in which the immune system Yas not activated. The introduction of 
a graft will result in an activation of the immune system. The 
immunosuppressive effect of the antibodies will most certainly be affected 
by the alloreaction of the recipient towards the graft. 
The in vitro experiments described in the chapter 3 showed that 
both the 95 kD antigen and the 52 kD antigen are involved in the function 
of the T-lymphocytes. The data on the 95 kD antigen indicate that this 
antigen acts early in the activation process in a co-stimulatory way. 
W3/25 and ER-2 acting on the 52 kD molecule, on the other hand, caused a 
clear inhibition of the MLR response (see for W3/25 data also: Webb et 
al,1979; our data). This effect acts directly on T cells and not through 
antigen presenting cells (Mason et al, 1980). Jefferies et al (1985) 
showed that the 52 kD antigen in the rat is the analogue of the CD4 antigen 
in man. CD4 is important in the cellular interaction between T cells and 
antigen presenting cells. It has been suggested that this molecule binds 
to a nonpolymorphic part of the class II antigen, whereas for the CDS 
antigen a comparable binding to the class I antigen has been suggested 
(Swain, 1983). The evidence, however, remains conflicting (Dialynas et al, 
1983; Watts et al, 1984; Greenstein et al, 1984 and Strassman et al, 1984). 
Table 5.4 summarizes the influence of several monoclonal antibodies on the 
in vivo T cell function. The data of the in vivo (Table 5.1 and 5.4) and 
Table 5.4 Influence of MCA on in vivo 
T cell funct1ona 
MCA Surface In vivo a 
molecule T cell 
(kD) function 
ER-1 95kD 
w;;u 9>kD 
HIS-17 9>kD 
ER-2 52kD 
w;;z; >2kD 
MRC OX-19b 69kD 
a. Effect of MCA on the skin graft 
survival as described in this 
chapter 0 : no effect; 
- : suppressed 
b. Data reported by Claesson et al, 
(1985) 
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of the in vitro (summarized in Table 3.11) experiments indicate a positive 
correlation between immunosuppression and surface antigens, that are 
directly involved in the T cell function. This is supported by data of 
other species. Prophylactic treatment with anti-CD4 and anti-CD8 
antibodies in man (Cosimi et al, 1981) and primates (Jonker et al, 1984) 
and by antibodies directed against 'activation' markers such as treatment 
with anti-Ia antibodies (Lems et al, 1986), MCA directed against the 
Interleukin-2 receptor (Shapiro et al, 1987; Kupiec-Weglinski et al, 1986) 
and the MCA CLB1 (Billing et al, 1984), are in support of such a 
correlation. We therefore propose the following model: the immune 
regulation is controlled by surface molecules on T lymphocytes, that are 
directly involved in their function. Only antibodies that are directed 
against certain epitopes on such surface antigens are immunosuppressive. 
Data of the CD4 molecule are in agreement with this model. This 
molecule is involved in the interaction of T cells and antigen presenting 
cells (APC). ForT cell activation two signals or a combination of these 
two signals are required: first binding of the T cell receptor and secondly 
binding to the 52 kD antigen. Binding of antibody (W3/25 or ER-2) to the 
CD4 molecule interferes with the interaction between the T cell receptor 
and its antigen. Thus T cell activation either in vitro (MLR) or in vivo 
(alloresponse) is suppressed by these antibodies. 
Also the 95 kD molecule is involved in the T cell function. The in 
vitro data suggest that binding to this molecule gives a co-stimulatory 
signal during mitogenic or allogeneic activation. The in vivo results, 
however, seem to be in conflict with a co-stimulatory function, because 
suppression of the immune response was found for ER-1 and HIS-17. This 
indicates that the in vivo stimulation may occur through another mechanism 
than the in vitro activation. In this respect it is tempting to speculate 
on the nature of the antigen presentation in both systems. The antigenic 
stimulus in an in vitro MLR assay is supposedly a direct non-restricted 
allogeneic signal. In such a system antibodies against the 95kD molecule 
would give an additional signal and do not interfere with this process of 
non-restricted allo-stimulation. 
Besides this non-restricted alloreactivity as can be observed in in 
vitro systems one can imagine the existence of a restricted anti-
alloresponse in vivo. In the latter system the allo-MHC antigens should be 
recognized in the context of self-MHC. The most likely site for this type 
of antigen presentation, would be at the level of the APC. The APC might 
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express on its oell surface processed allo-antigens in association with 
self-MHC determinants to the T cell system. Perhaps this type of reaction 
is the most prominent mode of activity early after transplantation, which 
would fit in well with the observed primary reactivity of (class II MHC 
restricted) CD4+ cells early after allografting. In this way the early 
steps in T cell activation in vivo after allografting would be more MHC-
restricted anti-allo responses. In that case, one has to assume that also 
in the in vivo situation, antibodies against the 95 kD molecule give a 
stimulatory signal. However, by binding to the molecule these antibodies 
interfere with the MHC-restricted interaction process, thereby preventing 
the specific activation mechanism. In this proposed model ER-1 and HIS-17 
would bind and interfere. As a result no activation of the T cell system 
and no rejection would occur. W3/13 on the other hand, has a strong 
modulating effect on the 95 kD molecule, resulting in the disappearance of 
the specific epitope on the receptor. As a consequence the cell receives 
its stimulatory signal, but since the epitope is no longer present, the 
antibody can no longer bind to the cell, and will not interfere with any 
cell function. As a result normal activation of the T cell system occurs 
and the allograft will be rejected. Obviously the MHC-restricted anti-
alloresponse is only part of the rejection mechanism. The residual 
activity is not hampered by MCA binding. Therefore activation will take 
place, as can be concluded from the fact that also with ER-1 and HIS-17 
only a prolongation of graft survival is found and never a complete 
abolishment of the rejection. 
For the mechanism of immunosuppression defined by these MCA the 
time of application, i.e. presence during the initial phase of 
transplantation is probably essential. In experimental studies in which 
antibodies were used for treatment of a renal failure episode the mechanism 
is basically different from the treatment in the initial phase. In the 
former situation the immune system is in an activated state. During this 
rejection episode a massive depletion of T cells, after for instance anti-
thymocyte globuline (ATG) treatment, appears to be-effective for a reversal 
of the alloreaction (Shield et al, 1979; Simonian et al, 1983). The 
approach of our studies involved a non-activated T cell system and 
interference in the recognition phase of the immune response. As a 
consequence different surface molecules are most likely involved and 
immunosuppression will be controled at another level. Whether a comparable 
type of immunosuppression is possible in an activated status, as proposed 
for the recognition phase remains to be defined. 
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Conclusion 
The data cf these studies show that several restrictions exist for 
an antibody to be immunosuppressive. Although the affinity of the 
antibodies may be important, these experiments give no further information 
about this factor, since all tested antibodies had a high affinity for 
their respective determinant. Furthermore the IgG2 subclass appears to be 
the most suited isotype (at least in the rat), though another isotypes can 
also be immunosuppressive. The complement binding capacity of the IgG2 
isotype may even be a negative factor, because in the clinical situation a 
massive cell death resulting from treatment with such an antibody will 
cause unwanted side effects. This would favour the production of MCA of 
other isotype such as the IgG1 subclass. The data strongly indicates that 
an immunosuppressive MCA has to be directed to surface antigens, that are 
directly involved in T cell function. MCA directed against such surface 
molecules showed that also the epitope that is recognized is decisive for 
immunosuppression. The results described in this chapter have to be 
evaluated in regard to the time of application of the antibodies. They 
were injected only in the initial phase of the allogeneic reaction and this 
will be most certainly an important factor in the observed interpretation 
of the results. A model for the mechanism of immunosuppression has been 
proposed, which can be tested with the panel of antibodies. Furtheron the 
proposed mechanism of immune regulation has to be evaluated in other 
approaches such as treatment in combination with cyclosporin A or treatment 
of an rejection episode. 
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Chapter 6 
CONCLUDING REMARKS 
Today it has been almost thirty years ago, that the first clinical 
organ transplantation was performed. Since that time major progress has 
been achieved and the knowledge of the factors controlling the fate of the 
graft has been greatly improved. Especially the introduction of modern 
technology, such as monoclonal antibodies, T cell cloning and DNA 
recombinant techniques, has deepened our understanding. 
Both patient and graft survival has been increased as compared to 
those pioneering days of clinical transplantation. Improvement in the 
fields of surgical techniques, organ preservation and matching of donor and 
recipient for the most important genetic factors as well as better 
protocols for immunosuppression are responsible for this progress. The 
knowledge about the major genetic complex involved in rejection, i.e. the 
MHC has expanded over the last years. The high doses of immunosuppressive 
agents used in the first protocols have been replaced by more specific and 
other methods of immunosuppression. In earlier protocols for instance 
azathioprine and prednisolone were used for immunosuppression, whereas 
nowadays especially cyclosporin A has is favoured as an immunosuppressive 
agent in transplantation. Also combined regimes of ATG with other 
immunosuppressive agents or pretransplant blood transfusions have been 
shown to prolong graft survival. 
However for the immune status after transplantation and especially 
during a renal failure episode (RFE), many transplantation centres still 
rely predominantly on clinical parameters and direct measurement of the 
renal function. After the introduction of the first anti-lymphoid subset 
MCA's in man many efforts were done to establish a prognostic or diagnostic 
value for these reagents in relation to an RFE. At first monitoring of the 
helper and cytotoxic/suppressor T cell population in transplant patients 
seemed hopeful. However in Cy A treated patients these values do not 
change significantly during the course of rejection. 
Thus, in spite of the improved knowledge of factors involved in 
transplantation, 
poorly understood. 
the actual mechanism of induction and rejection remains 
This is mainly caused by the complex composition of the 
immune system, which is a network of interconnected cell interactions and 
feed back loops. The immune system has furthermore various alternative 
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pathways to accomplish its task, i.e. the elimination of foreign tissue. 
Transplantation research in man is hampered by several complicating 
factors. For instance the genetic variation within the human species is 
extensive and it is almost impossible to find genetically identical 
individuals. Moreover the clinical background of patients, but also 
methods of immunosuppressive treatment differ. Additionally, extensive 
variations in methods applied for monitoring and matching between centres 
exist. Therefore comparison of clinical transplantation data should be 
done with utmost care. 
For these reasons transplantation research in animals is essential 
for fundamental research of the mechanism of the rejection process. 
Experimental studies in animals as described in this thesis have several 
major advantages as compared to the clinical situation. In contrast to the 
This makes human system experiments can be performed with inbred animals. 
it possible to compare the individual results and to 
experimental conditions for more detailed studies. The 
reproduce. the 
basics of the 
immune response against the graft can be investigated in untreated animals 
with a defined course of rejection. Both the effects induced by the graft 
in the recipient as well as within the graft itself can be analyzed. For 
such an analysis one needs the availibility of sufficient tools to be able 
to dissect the immune system to a certain extent. Such tools include among 
other things the possibility to recognize and test a variety of immune cell 
sub-populations in these experimental animals. The first part of this 
thesis deals therefore with the development and fine characterization of a 
panel of monoclonal antibodies, directed against specific cell surface 
determinants on T cells of the rat. Much attention was payed to analyse 
the overall recognition patterns of these MCA's, since it is unknown what 
type of data would come out of the use of such antibodies in the analysis 
of a highly activated immune system as one can expect after allogeneic 
organ transplantation. Correct interpretation of the results obtained can 
only be achieved through such a "complete" insight into the fine 
specificity of the MCA's. From this point of view it was also important to 
specify the precise cell surface molecule recognized by an MCA and its 
possible involvement in specific cell functions. 
With this knowledge a multidirectional approach was started to 
analyse the factors involved in the rejection process. To minimize the 
variations and complicating contributions to the allogeneic response, 
alterations in the immune response were investigated in a donor-recipient 
149 
combination only differing in antigens coded by the MHC. In such 
recipients changes in immune status were measured at various times after 
kidney transplantation both in the graft as well as in the immune system of 
the recipient. These phenotypical data were correlated with a simultaneous 
analysis of functional changes within the T cell system. 
These type of experiments and the results obtained indicated the vaste 
complexity of the rejection phenomenon. Even in a defined model as used in 
these studies a variety of processes occur. The experiments here should be 
considered as a first trial to look at the alloresponse after organ 
transplantation from a variety of angles. Therefore, conclusions drawn 
from these studies can only point out at which level further investigations 
are needed. 
In immunosuppressed individuals the mechanism will be even more 
complicated. For instance Cy A interferes with T cell activation and 
prevents production of lymphokines. Still irreversible rejection episodes 
are found in such patients. This illlustrates that the immune system can 
escape from suppression under certain conditions. During immunosuppression 
normally infrequent and supposedly insignificant types of immune responses 
may become important. The class II restricted CTL"s and other peculiar 
cells may dominate in immunosuppressed situations. 
Finally, also more specific means of immunosuppression are 
required, since the immunosuppressive treatments used sofar in 
transplantation all have the major disadvantage that they affect the whole 
immune system. Only the undesired response against the graft should be the 
target of an ideal method of immunosuppression. One way to achieve this 
goal would be the use of very specific MCA"s as immunosuppressive agents. 
In the final part of this thesis a start was made to get insight in this 
complex material. We could show, that not only by massive removal of 
certain T cells, but more importantly also by direct interference with 
essential T cell functions anti-T cell MCA"s can be very efficient in 
preventing or at least delaying the onset of rejection. Several important 
features in terms of recognition of the relevant MCA"s in relation to their 
immunosuppressive properties were discovered. A model of interaction of 
these MCA"s with the immune system during rejection was proposed and 
discussed. Although up till now only prolongation of graft survival and 
not a complete abolishment of the rejection process could be achieved, 
these studies indicate the enormeous potential of this type of approach in 
the future. 
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SUMMARY 
The integrity of an organism needs an intraorganismic defense 
system to protect itself against disease-causing microorganisms. This 
socalled immune system is in vertebrates provided by two systems, which are 
both capable to respond specifically to most foreign substances. Generally 
one of these two is favoured, depending on the place, the actual form and 
the way the antigenic substance is presented to cells of the immune system. 
An allogeneic transplant is for the immune system a foreign substance and 
the graft will induce a normal type of activation of the immunocompetent 
cells, whereupon a cascade of recruited cells will destroy the graft. From 
studies with T cell deprived animals we know that both the initiation of 
the immune response as well as the final effector phase against the graft 
are predominantly caused by cells of the T cell system. Therefore most of 
the immunological transplantation research has been focussed on the T cell 
system. The T cell system is, however, a complex network of various 
specialized cells, which have regulatory and/or effector functions. The T 
cell system exists of myriads of cellular interactions and the system 
possesses various alternative pathways to obtain the desired result. Cell 
functions takes place through specialized surface molecules. Specific 
antibodies against such surface determinants make it possible to recognize 
the various cell populations. 
This thesis describes an experimental study of the T cell system in 
relation with allogeneic organ transplantation. The experiments were 
performed in rats. Inbred rat strains as well as congenic rat strains are 
readily available. These inbred strains enable transplantation in fixed 
donor-recipient combinations. Data obtained from one allografted animal 
can therefore directly be compared with data obtained from another animal. 
For a dissection of the T cell system of the rat in these type of studies 
specific antibodies were required directed against various subpopulations 
of the T cells. Since hardly any of such antibodies were available for the 
rat, the first part of this thesis describes the development of such 
antibodies, using the hybridoma technique. Since in the course of the 
alloreaction due to activation and differentiation the phenotypical 
expression of cells may change it was necessary to characterize the MCA's 
in regard to .the surface antigen, which they recognize, the cells that 
carry these antigens and their function during T cell activation. 
The literature indicates conflicting data about the mechanism of 
151 
the rejection. Two different routes of activation of the lymphoid system 
and graft destruction have been described. In the first model the 
rejection process 
cell-contact will 
is mediated through cytotoxic T cells, which by direct 
lyse and destroy the foreign material. The second 
response mechanism is the delayed type hypersensitivity reaction, in which 
regulator T cells through mediators arm the mononuclear phagocytic system, 
which thereafter acts as the effector mechanism in graft rejection. The 
role of small subpopulations of immature T cells or mature T cells in the 
alloreactions is unknown. The aim of these studies was to perform a 
multiparameter analysis of the T cell system during rejection. First of 
all a panel of MCA's was selected to define quantitative changes in the 
major subpopulations, to detect signs of activation and a possible presence 
c.q. influx of .other subpopulations. Both in the graft and in the 
recipient the transplantation induced alterations, which were screened at 
fixed time intervals. Besides mere monitoring of the major cell 
also the graft directed response of the recipient was studied. 
the interference with the rejection process was studied by a 
number of the MCA's. In this work the mode of action 
immunosuppressive effects of antibodies was studied in detail. 
streams 
Finally, 
selected 
of the 
In chapter 1 the fundamentals of the immune system are described. 
Illustrations of basic forms of defense both aspecific and specific are 
given. A high degree of specialization of the immune system is found in 
the vertebrates with specialized cells, both in regulatory and effector 
functions. 
One of the most appealing examples of foreign invasion is the 
transplantation of allogeneic organs or tissues. The genetics controling 
the alloreaction of the immune system, especially in the rat, is reprted. 
Cells of the T cell system play an central role in the allograft reaction 
and the differentiation and maturation of cells of this lineage are 
described. 
The 
alloreaction 
study of 
of the 
the T cell system of the rat in the course of the 
recipient towards the grafts requires specific 
antibodies, which are directed against various components of this system. 
For this purpose the hybridoma technique was the obvious choice for the 
production of such antibodies. 
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In chapter 2 several aspects of the hybridoma technique have been 
described. Large numbers of growing hybrid cells require a fast and 
sensitive method of selection. Therefore three techniques were compared 
for application in the hybridoma technique. Both the RIA and ELISA were 
shown to be excellent techniques for the primary selection of hybrid cells. 
Analysis with the fluorescence activated cell sorter seems not sensitive 
enough to detect a low concentration of antibody, but in a later stage with 
selected hybrid clones this technique provides additional information about 
the cellular reactivity of MCA's. The hybridoma technique was subsequently 
used in a series of experiments in which a large number of hybrid cells 
were obtained producing specific monoclonal antibodies directed against a 
variety of rat leukocytes. 
The further characterization of these MCA's directed against rat 
leukocytes is described in chapter 3. Immune histology on spleen and 
thymus revealed information about the reactivity of these antibodies with 
the lymphocyte populations in these organs. Quantitative data of the 
cellular reactivity of selected antibodies were obtained using flow 
cytometric analysis. A majority of lymphocytes in the thymus and a variety 
of cell numbers in the lymphoid organs reacted with these MCA's. Using 
double marker and two colour fluorescence analysis it could be defined that 
these antibodies recognize T cells and not B cells, moreover they react 
with various parts of the total T cell population in the periphery. 
For a proper application in transplantation research it was 
necessary to define the precise recognition of these MCA's also with cells 
in the early stages of the T cell differentiation. Almost all MCA's 
reacted with a substantial number of bone marrow cells indicating a 
recognition of other cells in early st~es of the myeloid differentiation 
lines. A monoclonal antibody could be selected that does react with 
thymocytes and precursor T cells, but not with mature T cells. 
The size cf the various surface antigens recognized by these newly 
developed MCA's was defined. An example of two MCA's, directed against 
different determinants of the same surface molecule and displaying 
divergent reactivity patterns is shown. Furthermore several of these 
antigens could be shown to be directly involved in the T cell function. By 
testing the influence of monoclona~ antibodies on a variety of in vitro 
immunological assays several patterns of stimulatory or inhibitory nature 
were established. Most active MCA's were directed against determinants 
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invloved in early stages of the activation process after allogeneic 
stimulation. Some exerted their effect through the inducer subset, others 
through the precursor cytotoxic subset. Finally the physical properties of 
these MCA's, such as isotype, complement binding abilities and affinity, 
which are important for the biological effects of these antibodies are 
described. 
Based on these results a panel of MCA's "as selected. This panel 
was used in the study of the mechanism of the allograft rejection. 
Chapter 4 sho"s data of experimental studies on the mechanism of 
the graft rejection. Inbred congenic rat strains were used for kidney 
transplantations. The donor recipient combinations only differed for the 
MHC complex. After defining the model by functional and pathological 
parameters the immune system was analyzed in situ in the recipient as well 
as in the graft at various times after transplantation. 
Flow cytometric analysis of the immune system in the spleen and in 
blood after transplantation has been done. The results emphasize once more 
the importance of using inbred strains for such experiments. Reduction of 
the variation in the results is necessary for a clear evaluation of the 
results. Also the consequences of the method to define subpopulations must 
be taken into consideration. Furthermore the absolute cell numbers of T 
cell subpopulations are a better reflection of the ongoing rejection 
process than the relative numbers. MCA's directed against mature T cell 
markers seem to indicate a rather unaffected immune system in the spleen. 
Data with other markers, however, indicate a dynamic situation in this 
organ as illustrated for instance by the influx of immature T cells, 
probably thymus derived. In blood the helper T cell population reacts 
shortly after transplansplantion by a significant increase in cell numbers. 
The other subpopulations seem to be involved in a later stage of the 
rejection. The situation is illustrated in blood at six days after 
transplantation showing that monitoring of the normal lymphocyte 
subpopulations does not reflect the activated status of the immune system 
in contrast to analysis with antibodies directed against activation markers 
and socalled immature T cell markers. 
-The graft infiltrating cells are analyzed using specific immune 
histology. In allografted animals t"o major types of infiltrating cells 
are found. Cell concentrations in close connection with the arterioles of 
the graft (perivascular infiltrates) and scattered cells throughout the 
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graft (tubular infiltrates). Both infiltrates increase in cell numbers 
during the course of rejection. In the perivascular infiltrates the 
cytotoxic/suppressor T cells are detected in higher numbers than the helper 
T cells. Macrophages enter the graft right after transplantation and they 
are located in beth infiltrates. The high class II expression on graft and 
host cells indicate a high degree of activation of the cells of the immune 
system. The helper T cells are predominantly located in the perivascular 
clusters. These compartments, containing both T cell subpopulations and 
macrophages may be the site of a specific immune reponse of host cells 
against the graft. 
One of the major participants of the immune reponse against a graft 
i.e. the donor class I antigen directed CTL was functionally determined. 
The determination of the precursors of the CTL's in the rat using the 
technique of limiting dilution is described. Using this technique the 
frequency of the CTL-p has been determined at various days after allogeneic 
transplantation. Data of spleen and blood, but also in the graft is 
described. During the first days after transplantation the frequency 
highly increases in the recipient spleen and blood. The number of donor 
specific CTL-p's in the graft on the other hand increases only at a later 
stage during the rejection process. Our data indicate an 
the T-helper cell population, possibly both as cells 
activity as well as cells involved in the induction 
early role for 
displaying DTH 
of the CTL 
differentiation. Lateron a more pronounced role both phenotypically and 
functionally of the-cytotoxic T cell subset is found. 
In chapter 5 the application of MCA's as immunosuppressive agents 
in transplantation is described. A large number of MCA's were tested in a 
skin graft model. Only a few antibodies, reacting either with all T cells 
or with helper T cells, have the ability to prolong the graft survival. 
Five MCA's were selected for studying the factors, that are decisive for 
the immunosuppressive properties of an antibody. In contrast to polyclonal 
antibodies the immunosuppressive MCA's are not restricted to specific 
isotypes. Furthermore the immunosuppressive ability of these antibodies 
seems to be correlated with particular epitopes on some specific surface 
molecules. The in vivo behaviour of these MCA's such as the biological 
half life time, the localization in various organs and the analysis of the 
T cell population in blood was studied after a single dose of MCA. 
Elimination of the T cell population in blood was found both for the 
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immunosuppressive antibodies as well as for the antibody lacking this 
ability. In the spleen a rather different type of localization was found 
for the non-suppressive antibody compared with the suppressive ones. The 
in vitro experiments in chapter 3 showed that both surface molecules 
recognized by these 5 MCA's are involved in the function of the T cells. 
The immunosuppressive properties of antibodies are probably connected with 
this function. Based on the data of these experiments a hypothesis on the 
mechanism of immunosuppression is suggested: immunosuppressive antibodies 
have to be directed against surface molecules, that are directly involved 
in the T cell function. The data of these experiments are discussed in 
view of this model. Besides the specific T cell receptor complex several 
surface molecules are involved in cell interaction processes. Binding to 
such antibodies results in blocking of these interactions and consequently 
suppression of the immune response. 
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SAMENVATTING 
cvoor de integriteit van een organisme is een intraorganistische 
afweer noodzakelijk om zich te kunnen beschermen tegen micro-organismen, 
die ziekten kunnen veroorzaken. Dit zogenaamde immuunsysteem bestaat in 
vertebraten uit twee afzonderlijke systemen, die beide in staat zijn om 
specifiek te reageren tegen de meeste vreemde substanties. 
heeft een van beide systemen de voorkeur, afhankelijk van 
In het algemeen 
de plaats, de 
precieze vorm en de manier waarop de antigene stof aan de cellen van het 
afweersysteem wordt aangeboden. Een allogeen transplantaat is voor het 
immuunsysteem een vreemde substantie en dit transplantaat zal een normale 
activatie van de immuuncompetente cellen veroorzaken, waarna een groat 
aantal gerekruteerde cellen het transplantaat zullen vernietigen. Studies 
met dieren, waaruit de T cellen zijn verwijderd, hebben ons geleerd, dat 
deze cellen een centrale rol vervullen bij de initiele en de effector fase 
van de immuunresponse tegen het transplantaat. Daarom heeft een 
aanzienlijk deel van het transplantatieonderzoek zich gericht op de cellen 
van het T eel systeem. Dit systeem is echter een zeer complex netwerk van 
verschillende cellen, die een regulerende en/of een effector funktie 
bezitten. Het T eel systeem bestaat uit een zeer groot aantal cellulaire 
interacties en het systeem heeft verschillende mogelijkheden om een bepaald 
doel te bereiken. Celfunkties worden via speciale oppervlaktemolekulen 
uitgevoerd en met behulp van specifieke antilichamen, gericht tegen 
dergelijke moleculen is het mogelijk om de afzonderlijke celpopulaties te 
herkennen. 
Dit proefschrift beschrijft een experimentele studie van het T eel 
systeem in relatie tot de allogene orgaantransplantatie. De experimenten 
werden uitgevoerd in de rat. Momenteel zijn inteeltstammen en congene 
stammen voor de rat gemakkelijk te verkrijgen. Met behulp van deze inteelt 
stammen is het mogelijk om in gedefinieerde donor-ontvanger combinaties te 
transplanteren. Gegevens van allogeen getransplanteerde dieren kunnen 
daarom onderling vergeleken worden. Voor een juiste evaluatie van het T 
eel systeem van de rat in dit type onderzoek is het noodzakelijk om de 
verschillende T eel subpopulaties te onderscheiden met behulp van 
specifieke antilichamen. Omdat dit soort antilichamen nauwelijks 
beschikbaar zijn voor de rat beschrijft het eerste deel van dit 
proefschrift de ontwikkeling van dergelijke antilichamen met behulp van de 
hybridoma techniek. Tijdens het proces van de allogene reaktie zullen 
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cellen veranderen van fenotype als gevolg van aktivatie en differentiatie. 
Daarom was het noodzakelijk om de monoklonale antilichamen (MCA's) te 
karakteriseren ten aanzien van het oppervlakteantigeen, die ze herkennen, 
de cellen die het antigeen tot expressie b_rengen en de funktie van dit 
antigeen tijdens T eel aktivering. 
De literatuur geeft tegenstrijdige gegevens voor het mechanisme van 
de afstoting. Twee verschillende modellen worden beschreven voor de 
aktivering en de destructie van het transplantaat. In het eerste model 
wordt het afstotingsproces gemedieerd door cytotoxische T cellen, die via 
direct celkontakt de vreemde materie zullen lyseren en vernietigen. Het 
tweede response mechanisme is de vertraagd type overgevoeligheids reaktie, 
waarbij regulerende T cellen d.m.v. mediator en het mononucleaire 
fagocytaire systeem zullen aktiveren. Dit laatste systeem fungeert 
vervolgens als effector mechanisme voor de afstoting van het transplantaat. 
Naast deze twee response types blijft de rol van kleine subpopulaties 
onrijpe T cellen of uitgerijpte T cellen in de allogene reaktie een 
onbekende factor. Het doel van deze studies was een multiparameter analyse 
van het T eel systeem tijdens de afstoting. In de eerste plaats werd een 
panel MCA's geselekteerd om kwantitatieve veranderingen in de belangrijkste 
subpopulaties te kunnen bepalen en om aanwijzingen van aktivatie en een 
mogelijke influx van andere subpopulaties te kunnen ontdekken. Zowel in 
het transplantaat als in de ontvanger zullen veranderingen worden 
geinduceerd door het transplantaat. Behalve monitoring van de 
belangrijkste veranderingen in de samenstelling van de celpopulatie werd 
ook de repons, die gericht is tegen het transplantaat bestudeerd. Ten 
slotte werd een studie gemaakt van de beinvloeding van het afstotingsproces 
m.b.v. een selektie van MCA's. Hierbij werd het mechanisme van de 
immunosuppressieve werking van de antilichamen in detail bestudeerd. 
In hoofdstuk 1 wordt de fundamentele werking van het immuunsysteem 
beschreven. Dit wordt gel:llustreerd met basale vormen van zowel 
aspecifieke als specifieke manieren van verdediging. In vertebraten 
treffen we een hoge mate van specialisatie van het immuunsysteem aan. Dit 
wordt gemedieerd door speciale cellen, die een regulerende hetzij een 
effectorfunktie bezitten. 
Een van de meest aansprekende voorbeelden van vreemde substantie is 
de transplantatie van allogene organen of weefsels. De genetische controle 
van de allogene reaktie van het immuunsysteem, met name in de rat, wordt 
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besproken. Bij de transplantaatafstoting spelen de cellen van het T eel 
systeem een centrale rol en daarom wordt de differentiatie en de maturatie 
van de. cellen van deze lijn beschreven. 
Voor de studie van het T eel systeem in de loop van de allogene 
reaktie van de transplantaatontvanger tegen het transplantaat zijn 
specifieke antilichamen nodig, die verschillende componenten van dit 
systeem herkennen. Voor de produktie van dergelijke antilichamen was de 
hybridoma techniek een logische keuze. 
In hoofdstuk 2 worden verschillende aspecten van de hybridoma 
techniek beschreven. De aanwezigheid van grote aantallen groeiende hybride 
eel len maken een snelle en een gevoelige methode voor selektie 
noodzakelijk. Daarom werden drie verschillende technieken met elkaar 
vergeleken in het kader van de specifieke condities voor gebruik in de 
hybridoma techniek. Zowel de RIA als de Elisa blijken uitstekende 
technieken te zijn voor de primaire selektie van hybride cellen. Analyse 
met behulp van de fluorescence activated cell sorter (FAGS) is niet in 
staat om lage concentraties antilichamen te detecteren. In een later 
stadium echter, na selektie van hybride clonen, geeft deze techniek extra 
informatie over de cellulaire reaktiviteit van de geproduceerde MCA's. 
Vervolgens werd de hybridoma techniek toegepast in een aantal experimenten, 
waarin een groot aantal hybridoma's werden verkregen, die specifieke 
monoklonale antilichamen produceren gericht tegen verschillende leukocyten 
van de rat. 
In hoofdstuk 3 wordt een meer gedetailleerde karakterisering 
beschreven van deze MCA's, die gericht zijn tegen leukocyten van de rat. 
Met behulp van immuunhistologie op milt en thymus kan informatie verkregen 
worden over de reaktiviteit van deze antilichamen met de 
lymfocytenpopulaties in deze organen. Kwantitatieve gegevens van 
geselekteerde antilichamen ten aanzien van de cellulaire reaktiviteit 
werden verkregen met behulp van een flow-cytometrische analyse. Het 
grootste deel van de lymfocyten in de thymus en een variabel deel van de T 
cellen in de periphere lymfoide organen reageerden met deze MCA's. Gebruik 
makend van dubbelmarker en twee kleuren fluorescentietechnieken kon worden 
vastgesteld, dat deze antilichamen T cellen en niet B cellen herkennen en 
tevens, dat zij met verschillende delen van de totale T eel populatie 
reageren. 
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Voor een optimale toepassing in het transplantatieonderzoek was het 
noodzakelijk om de exacte herkenning van deze antilichamen, ook die ten 
aanzien van cellen in de vroege fase van de T eel differentiatie te 
bepalen. Bijna alle antilichamen reageren met een aanzienlijk deel van de 
cellen in het beenmerg, hetgeen een indicatie is, dat ook cellen, in een 
vroeg stadium van de andere myeloide differentiatie reeksen, worden 
herkend. Voor een monoklonaal antilichaam kon worden vastgesteld, dat dit 
antilichaam reageert met thymocyten en met precursor T cellen, maar niet 
met rijpe T cellen. 
De grootte van de verschillende oppervlakte antigenen, die door 
deze nieuw ontwikkelde MCA's worden herkend, werd vastgesteld. Een 
voorbeeld wordt gegeven van twee MCA's, beiden gericht tegen verschillende 
determinanten van hetzelfde oppervlakte molecuul, echter met een divers 
reaktiepatroon. Tevens kon voor een aantal van deze antigenen worden 
aangetoond, dat zij direct zijn betrokken bij de funktie van de T eel. 
Door de invloed van de monoklonale antilichamen te testen in een aantal 
immunologische in vitro bepalingen werden verscheidene patronen gevonden, 
die een stimulerend hetzij een remmend karakter, vertoonden. De meeste van 
deze actieve MCA's waren gericht tegen determinanten, die in een vroege 
fase van het activeringsproces na allogene stimulatie zijn betrokken. 
Sommige antilichamen oefenen hun effect uit op de inducer subpopulatie, 
terwijl anderen via de precursors van de cytotoxische subpopulatie werken. 
Tenslotte worden fysische eigenschappen van deze MCA's beschreven, zoals 
het isotype, het vermogen om complement te binden en de affiniteit. Dit is 
van belang voor de biologische activiteit van deze antilichamen. 
Gebaseerd op deze gegevens werd een panel monoklonale antilichamen 
geselekteerd. Gebruik makend van dit panel werd het mechanisme van de 
allogene transplantaat afstoting bestudeerd. 
Hoofdstuk 4 geeft de data, die betrekking hebben op experimentele 
studies van het mechanisme van de transplantaat afstoting. Hiervoor werden 
niertransplantaties uitgevoerd met behulp van congene inteeltrattestammen. 
In de combinatie van donor en ontvanger was alleen een verschil ten aanzien 
van het MHC complex. Na de defin1ering van het model door middel van 
funktionele en pathologische parameters werd een analyse van het 
immuunsysteem van de ontvanger in situ, maar ook in het transplantaat op 
verschillende dagen na transplantatie uitgevoerd. 
Analyse van het immuunsysteem na transplantatie werd uitgevoerd in 
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de milt en het bloed met behulp van flow-cytometry. Het resultaat 
benadrukt eens te meer het belang van inteeltstammen voor dit type 
onderzoek, omdat voor een duidelijke evaluatie van de resultaten het 
noodzakelijk is om de variatie in de gegevens te minimaliseren. Men dient 
zich bewust te zijn van de konsekwenties, die het gevolg zijn van de 
methode, die gekozen is om een bepaalde subpopulatie te defini~ren. Verder 
blijken de absolute celaantallen een betere reflektie te zijn van het 
afstotingsproces dan de relatieve eel aantallen. MCA's, die gericht zijn 
tegen rijpe T celmarkers, laten in de milt bijvoorbeeld nauwelijks 
veranderingen van het immuunsysteem zien, wanneer de relatieve celaantallen 
worden gehanteerd. Gegevens verkregen met behulp van andere markers echter 
laten zien, dat dit een dynamische situatie is. Dit wordt byvoorbeeld 
getllustreerd door de influx van onrijpe T cellen, waarschijnlijk afkomstig 
uit de thymus. In het bloed reageert de helper T eel populatie kort na 
transplantaties met een duidelijke toename in aantal cellen. De andere 
subpopulaties schijnen pas in een later stadium van de afstotingsreaktie 
betrokken te zijn. Monitoring van de normale, rijpe lymfocytenpopulaties 
geeft in tegenstelling tot analyse met antilichamen gericht tegen 
activerings markers of zogenaamde onrijpe T eel markers, geen juist beeld 
van de geactiveerde status van het immuunsysteem. Dit laatste wordt 
geillustreerd door de situatie in het bloed op 6 dagen na transplantatie. 
De cellen, die infiltreren in het transplantaat werden geanalyseerd 
met behulp. van specifieke immuunhistologie. In de allogeen 
getransplanteerde dieren werden twee belangrijke types infiltrerende cellen 
waargenomen. Celconcentraties in de nabijheid van de arteriolen van het 
transplantaat (perivasculaire infiltraten) en cellen, die door het hele 
transplantaat voorkomen (tubulaire infiltraten). Beide infiltraten nemen 
toe in celaantal tijdens het verloop van de afstoting. In perivasculaire 
infiltraten worden meer cytotoxische/suppressor cellen aangetroffen dan 
helper T cellen. Macrofagen komen direct na de transplantatie het 
transplantaat binnen en worden in beide infiltraattypes aangetroffen. De 
hoge expressie van het klasse II antigeen op de cellen van het 
transplantaat en die van de ontvanger suggeren een hoge mate van activatie 
van de cellen van het immuunsysteem. De helper T cellen zijn voornamelijk 
gelokaliseerd in de perivasculaire clusters. Mogelijk zijn deze 
compartimenten, die zowel T cellen als macrofagen bevatten, de lokatie van 
de specifieke immuunresponse van ontvangercellen gericht tegen het 
transplantaat. 
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Een van de belangrijkste participanten van de immuun response werd 
funktioneel bepaald. Dit is de aktiviteit van de cytotoxische T lymfocyten 
(CTL's) tegen het klasse I antigeen van de donor. De bepaling van de 
precursor cellen van de CTL's (CTL-p) in de rat werd uitgevoerd met behulp 
van de limiting dilution assay (LDA). Met behulp van deze techniek is het 
mogelijk om een inzicht te krijgen in de frekwentie van de CTL-p op 
verschillende tijdstippen na transplantatie. Gegevens van de milt en het 
bleed, maar ook in het transplantaat zelf worden beschreven. Tijdens de 
eerste dagen na transplantatie neemt de frekwentie sterk toe in de milt en 
in het bleed van de ontvanger. In het transplantaat zelf neemt het aantal 
donor specifieke CTL-p's pas in een later stadium van de afstoting toe. 
Onze gegevens indiceren een vroege rol veer de helper T eel. Dit kunnen 
cell en zij n, 
brengen of 
die een vertraagd type overgevoeligheidsreactie tot expressie 
cellen die betrokken zijn bij de inductie van de CTL 
differentiatie. In een later stadium wordt een meer geprononceerd rol veer 
de cytotoxische T eel subpopulatie gevonden, zeals blijkt uit fenotypische 
en functionele gegevens. 
In hoofdstuk 5 wordt de toepassing van MCA's als immuunsuppressieve 
agentia beschreven. Een greet aantal MCA's werd getest in een huid 
transplantatiemodel en hierbij bleek, dat slechts enkele antilichamen in 
staat zijn een verlenging van de transplantaatoverleving te 
bewerkstelligen. Deze MCA's herkennen alle T cellen of alleen de helper T 
cellen. Vijf antilichamen werden vervolgens geselekteerd veer een studie 
van de factoren die bepalend zijn veer de immuunsuppressieve eigenschappen 
van een antilichaam. In tegenstelling tot polyklonale antilichamen is 
immuunsuppressie bij monoklonale antilichamen niet beperkt door het 
isotype. Verder lijkt er een correlatie te bestaan tussen de 
immuunsuppressieve eigenschappen van deze antilichamen en bepaalde epitopen 
op enkele specifieke oppervlaktemoleculen. Het in vivo gedrag van deze 
antilichamen werd bestudeerd na een enkelvoudige dosis van het MCA d.m.v. 
bepaling van de biologische half waarde tijd, de lokalisatie in 
verschillende organen en de analyse van de T eel populatie in het bleed~ 
Eliminatie van de T eel populatie in het bleed werd aangetoond voor zowel 
de immuunsuppressieve MCA's als voor het antilichaam, dat deze eigenschap 
mist. In de milt werd voor dit laatste antilichaam een afwijkende 
lokalisatie gevonden in vergelijking met de andere MCA's. Uit de in vitro 
experimenten beschreven in hoofdstuk 3, blijken deze twee 
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oppervlaktemoleculen, waartegen de 5 MCA's zijn gericht, ook betrokken te 
zijn bij de funktie van de T eel. De immuunsuppressieve eigenschappen van 
deze antilichamen zijn hoogst· waarschijnlijk gerelateerd met deze funktie. 
Gebaseerd op de gegevens van deze experimenten werd een hypothese 
voorgesteld voor het mechanisme van immuunsuppressie: Immuunsuppressieve 
antilichamen moeten gericht zijn tegen antigenen, die direct betrokken zijn 
bij de funktie van de T eel. De resultaten van deze experimenten worden in 
het kader van deze hypothese bediscusseerd. Naast het T eel 
receptorcomplex zijn verscheidene andere oppervlaktemoleculen ook betrokken 
bij het proces van celinteractie. Binding van antilichamen, die gericht 
zijn tegen dergelijke antigenen zal resulteren in een blokkering van de 
celinteractie en als gevolg daarvan zal een suppressie van de 
immuunresponse plaats,vinden. 
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